doxorubicin/NN induced/VBN cardiomyopathy/NN
doxorubicin/NN caused/VBN cardiomyopathy/RB
doxorubicin/NN therapy/NN accompanies/VBZ dysfunction/NN cardiomyopathy/NN
indinavir/NN receiving/VBG describe/VBP features/NNS calculi/NNS ureteric/JJ
indinavir/NN receiving/VBG describe/VBP features/NNS calculi/NNS
Pilsicainide/NNP due/JJ Death/NNP Sudden/NNP
Pilsicainide/NNP due/JJ Death/NNP Cardiac/NNP
Pilsicainide/NNP due/JJ Death/NNP
Pilsicainide/NNP due/JJ Death/NNP Case/NN Pointes/NNP Torsades/NNP
Pilsicainide/NNP due/JJ Death/NNP Case/NN Pointes/NNP de/FW
Pilsicainide/NNP due/JJ Death/NNP Case/NN Pointes/NNP
pilsicainide/NN received/VBD developed/VBD death/NN sudden/JJ
pilsicainide/NN received/VBD developed/VBD death/NN cardiac/JJ
pilsicainide/NN received/VBD developed/VBD death/NN
pilsicainide/NN dose/NN low/JJ impaired/JJ high/JJ produce/VB torsades/NNS
pilsicainide/NN dose/NN low/JJ impaired/JJ high/JJ produce/VB torsades/NNS de/IN
pilsicainide/NN dose/NN low/JJ impaired/JJ high/JJ produce/VB torsades/NNS pointes/NNS
pilsicainide/NN concentration/NN high/JJ produce/VB torsades/NNS
pilsicainide/NN concentration/NN high/JJ produce/VB torsades/NNS de/IN
pilsicainide/NN concentration/NN high/JJ produce/VB torsades/NNS pointes/NNS
terbinafine/JJ combination/NN induced/VBN bradycardia/NN
metoprolol/NN combination/NN induced/VBN bradycardia/NN
cisplatin/NN induced/VBN injury/NN acute/JJ
cisplatin/NN induced/VBN injury/NN renal/JJ
cisplatin/NN induced/VBN injury/NN
Cisplatin/NN treatment/NN adopted/VBN induce/VB ability/NN affect/VB increase/VB score/NN acute/JJ
Cisplatin/NN treatment/NN adopted/VBN induce/VB ability/NN affect/VB increase/VB score/NN tubular/JJ
Cisplatin/NN treatment/NN adopted/VBN induce/VB ability/NN affect/VB increase/VB score/NN necrosis/NNS
Cisplatin/NN treatment/NN adopted/VBN induce/VB injury/NN acute/JJ
Cisplatin/NN treatment/NN adopted/VBN induce/VB injury/NN kidney/NN
Cisplatin/NN treatment/NN adopted/VBN induce/VB injury/NN
cisplatin/NN receptor/NN injury/NN acute/JJ
cisplatin/NN receptor/NN injury/NN kidney/NN
cisplatin/NN receptor/NN injury/NN
cisplatin/NN challenged/VBN examine/VB role/NN receptor/NN injury/NN acute/JJ
cisplatin/NN challenged/VBN examine/VB role/NN receptor/NN injury/NN kidney/NN
cisplatin/NN challenged/VBN examine/VB role/NN receptor/NN injury/NN
cisplatin/NN involved/VBN induced/VBN injury/NN acute/JJ
cisplatin/NN involved/VBN induced/VBN injury/NN kidney/NN
cisplatin/NN involved/VBN induced/VBN injury/NN
dexmedetomidine/NN bradycardia/NN Vasovagal/VB
dexmedetomidine/NN bradycardia/NN syncope/JJ
dexmedetomidine/NN bradycardia/NN
dexmedetomidine/NN administration/NN year/NN syncope/NN bradycardia/NN
aminoglycoside/JJ nephrotoxicity/NN
aminoglycoside/NN induced/VBN nephrotoxicity/RB
aminoglycosides/NNS cause/VB indicate/VBP cause/VBP glomerular/NN
aminoglycosides/NNS cause/VB indicate/VBP cause/VBP glomerular/NN or/CC
aminoglycosides/NNS cause/VB indicate/VBP cause/VBP glomerular/NN dysfunction/NN tubular/JJ
aminoglycosides/NNS cause/VB indicate/VBP cause/VBP glomerular/NN dysfunction/NN
aminoglycoside/NN levels/NNS therapy/NN duration/NN increase/VB risk/NN nephrotoxicity/NN
aminoglycoside/NN pathophysiology/NN developing/VBG useful/JJ induced/VBN nephrotoxicity/RB
fluoxetine/NN improved/VBN dyskinesias/NNS
apomorphine/NN agonist/NN challenge/NN evaluated/VBN severity/NN dyskinesias/NNS
fluoxetine/NN administration/NN apomorphine/NN agonist/NN challenge/NN evaluated/VBN severity/NN dyskinesias/NNS
apomorphine/NN induced/VBN dyskinesias/NNS
fluoxetine/JJ treatment/NN was/VBD improvement/NN apomorphine/NN induced/VBN dyskinesias/NNS
fluoxetine/NN transmission/NN reduce/VB dyskinesias/NNS
pilocarpine/NN model/NN seizures/NNS
pilocarpine/NN produced/VBN seizures/NNS
pilocarpine/NN induces/VBZ seizures/NNS
pilocarpine/NN induces/VBZ seizures/NNS epilepticus/NNS status/NN
pilocarpine/NN induces/VBZ seizures/NNS epilepticus/NNS
pilocarpine/NN produced/VBN seizures/NNS
phenylbutazone/NN non/NN effect/NN investigate/VB designed/VBN seizures/NNS
sodium/NN salicylate/NN non/NN effect/NN investigate/VB designed/VBN seizures/NNS
salicylate/NN non/NN effect/NN investigate/VB designed/VBN seizures/NNS
pilocarpine/NN produced/VBN seizures/NNS
pilocarpine/NN induced/VBN damage/NN seizures/NNS
pilocarpine/NN induced/VBN damage/NN seizures/NNS rats/NNS seizure/NN
pilocarpine/NN threshold/NN modulate/VBP seizures/NNS
Isoproterenol/NNP injected/VBN induce/VB infarction/NN myocardial/JJ acute/JJ
Isoproterenol/NNP injected/VBN induce/VB infarction/NN myocardial/JJ
Isoproterenol/NNP injected/VBN induce/VB infarction/NN
fenfluramines/NNS had/VBD association/NN PPH/NNP
fenfluramines/NNS specificity/NN association/NN PPH/NNP
fenfluramines/NNS specificity/NN association/NN magnitude/NN consistent/JJ studies/NNS indicating/VBG related/VBN PPH/NNP
fenfluramines/NNS related/VBN indicating/VBG studies/NNS consistent/JJ magnitude/NN association/NN PPH/NNP
fenfluramines/NNS related/VBN PPH/NNP
levodopa/NN effect/NN hypotensive/JJ
levodopa/NN effect/NN hypotensive/JJ
levodopa/NN competing/VBG acid/NN reduced/VBD effects/NNS hypotensive/NN
levodopa/NN effects/NNS hypotensive/NN
levodopa/NN has/VBZ action/NN hypotensive/NN
phenytoin/NN administration/NN developed/VBD failure/NN hepatic/JJ
phenytoin/NN administration/NN developed/VBD failure/NN
FZP/NNP toxocity/NN Signs/NNS included/VBD salivation/NN convulsions/NNS
FZP/NNP protected/VBN convulsions/NNS
FZP/NNP doses/NNS lower/JJR those/DT cause/VB convulsions/NNS
amiodarone/JJ therapy/NN initiation/NN weeks/NNS have/VB failure/NN bradycardia/NN hypothermia/NN
amiodarone/JJ therapy/NN initiation/NN weeks/NNS have/VB failure/NN bradycardia/NN
amiodarone/JJ therapy/NN initiation/NN weeks/NNS have/VB failure/NN bradycardia/NN respiratory/NN
amiodarone/JJ therapy/NN initiation/NN weeks/NNS have/VB failure/NN
haloperidol/JJ synthesis/NN Sub/NNP catalepsy/NN
haloperidol/NN drugs/NNS cause/VBP catalepsy/RB
haloperidol/NN NOARG/VBG investigate/VB induced/VBN catalepsy/NN
haloperidol/NN NOARG/VBG NOARG/VBG induced/VBN catalepsy/RB
angiotensin/NN therapy/NN frequency/NN angio/NN
angiotensin/NN therapy/NN frequency/NN oedema/NN
converting/JJ inhibitor/NN frequency/NN angio/NN
converting/JJ inhibitor/NN frequency/NN oedema/NN
enzyme/NN inhibitor/NN frequency/NN angio/NN
enzyme/NN inhibitor/NN frequency/NN oedema/NN
inhibitor/NN frequency/NN angio/NN
inhibitor/NN frequency/NN oedema/NN
ACE/NNP inhibitors/NNS introduction/NN reported/VBN bouts/NNS angio/NN
ACE/NNP inhibitors/NNS introduction/NN reported/VBN bouts/NNS angio/NN oedema/NN
inhibitors/NNS introduction/NN reported/VBN bouts/NNS angio/NN
inhibitors/NNS introduction/NN reported/VBN bouts/NNS angio/NN oedema/NN
ACE/VB angio/NN
ACE/VB angio/NN oedema/NN
inhibitors/NNS ACE/VB angio/NN
inhibitors/NNS ACE/VB angio/NN oedema/NN
pilocarpine/JJ model/NN epilepticus/NNS status/NN
pilocarpine/JJ model/NN epilepticus/NNS
lithium/NN 801/CD actions/NNS model/NN epilepticus/NNS status/NN
lithium/NN 801/CD actions/NNS model/NN epilepticus/NNS
pilocarpine/NN lithium/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS status/NN
pilocarpine/NN lithium/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS
pilocarpine/NN prior/RB anticonvulsants/NNS administration/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS status/NN
pilocarpine/NN prior/RB anticonvulsants/NNS administration/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS
lithium/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS status/NN
lithium/NN induced/VBN seizures/NNS block/VB easy/JJ difficult/JJ terminate/VB epilepticus/NNS
pilocarpine/NN 30/CD epilepticus/NNS status/NN
pilocarpine/NN 30/CD epilepticus/NNS
pilocarpine/NN model/NN damage/NN role/NN epilepticus/NNS status/NN
pilocarpine/NN model/NN damage/NN role/NN epilepticus/NNS
lithium/JJ model/NN damage/NN role/NN epilepticus/NNS status/NN
lithium/JJ model/NN damage/NN role/NN epilepticus/NNS
pilocarpine/NN NMDA/NN doses/NNS synergistic/JJ resulting/VBG epilepticus/NNS status/NN
pilocarpine/NN NMDA/NN doses/NNS synergistic/JJ resulting/VBG epilepticus/NNS
valproate/JJ therapy/NN fatty/VBP Nonalcoholic/NNP
valproate/JJ therapy/NN fatty/VBP
valproate/JJ therapy/NN fatty/VBP disease/NN liver/NN
valproate/JJ therapy/NN fatty/VBP disease/NN
VPA/NNP treatment/NN developed/VBD obesity/RB
VPA/NNP treatment/NN developed/VBD child/NN arising/VBG disease/NN nonalcoholic/JJ
VPA/NNP treatment/NN developed/VBD child/NN arising/VBG disease/NN fatty/JJ
VPA/NNP treatment/NN developed/VBD child/NN arising/VBG disease/NN liver/NN
VPA/NNP treatment/NN developed/VBD child/NN arising/VBG disease/NN
VPA/NNP treatment/NN developed/VBD child/NN arising/VBG disease/NN NAFLD/NNP
VPA/NNP treatment/NN associated/VBN suggests/VBZ obesity/NN hyperinsulinemia/NN
VPA/NNP withdrawal/NN reversible/JJ suggests/VBZ obesity/NN hyperinsulinemia/NN
VPA/NNP treatment/NN associated/VBN suggests/VBZ obesity/NN
VPA/NNP withdrawal/NN reversible/JJ suggests/VBZ obesity/NN
VPA/NNP treatment/NN associated/VBN development/NN NAFLD/NNP
VPA/NNP withdrawal/NN reversible/JJ suggests/VBZ associated/VBN development/NN NAFLD/NNP
VPA/NNP treatment/NN associated/VBN suggests/VBZ obesity/NN resistance/NN insulin/NN
VPA/NNP treatment/NN associated/VBN suggests/VBZ obesity/NN resistance/NN
VPA/NNP withdrawal/NN reversible/JJ suggests/VBZ obesity/NN resistance/NN insulin/NN
VPA/NNP withdrawal/NN reversible/JJ suggests/VBZ obesity/NN resistance/NN
cisplatin/NN high/JJ induced/VBN Efficacy/NN granisetron/NN prevention/NN nausea/NN vomiting/NN
cisplatin/NN high/JJ induced/VBN Efficacy/NN granisetron/NN prevention/NN nausea/NN
cisplatin/NN prophylaxis/NNS administered/VBN assess/VB induced/VBN nausea/NN vomiting/NN
cisplatin/NN prophylaxis/NNS administered/VBN assess/VB induced/VBN nausea/NN
cisplatin/NN received/VBD patients/NNS %/NN vomiting/NN
cisplatin/NN received/VBD prevented/VBD vomiting/NN
dexamethasone/NN lactoferrin/NN effects/NNS hypertension/NN
Dexamethasone/NNP hypertension/NN
Dex/JJ hypertension/NN
Dex/NNP administration/NN investigated/VBD stress/NN hypertension/NN
Dex/NNP induced/VBN hypertension/NN
Dex/NNP improved/VBD reduced/VBD induced/VBN hypertension/NN
cobalt/NN cardiomyopathy/NN
doxorubicin/NN dogs/NNS failure/NN heart/NN
doxorubicin/NN dogs/NNS failure/NN
Ethacrynic/JJ acid/NN induced/VBN convulsions/NNS
acid/NN induced/VBN convulsions/NNS
ethacrynic/JJ acid/NN accelerated/VBD mouse/NN convulsive/JJ
acid/NN accelerated/VBD mouse/NN convulsive/JJ
ethacrynic/JJ acid/NN convulsions/NNS
acid/NN convulsions/NNS
5/CD Fluoxetine/NNP improves/VBZ deficits/NNS memory/NN
5/CD Fluoxetine/NNP improves/VBZ deficits/NNS
fluorouracil/VB 5/CD Fluoxetine/NNP improves/VBZ deficits/NNS memory/NN
fluorouracil/VB 5/CD Fluoxetine/NNP improves/VBZ deficits/NNS
Phenytoin/NN encephalopathy/NN
phenytoin/NN case/NN seizures/NNS encephalopathy/RB
DPH/NNP case/NN seizures/NNS encephalopathy/RB
gentamicin/NN scavengers/NNS effects/NNS Mechanisms/NNPS nephropathy/NN
gentamicin/NN nephropathy/NN
GM/NNP gentamicin/NN nephropathy/NN
GM/NNP Administration/NNP sc/VBP days/NNS rats/NNS induced/VBN flow/NN damage/NN tubular/JJ
GM/NNP Administration/NNP sc/VBP days/NNS rats/NNS induced/VBN flow/NN damage/NN
GM/NNP observed/VBN mediated/VBN nephropathy/RB
GM/NNP effects/NNS have/VBP differ/VBP nephropathy/NN
GM/NNP role/NN play/VBP have/VBP differ/VBP nephropathy/NN
aspirin/NN damage/NN renal/JJ
aspirin/NN damage/NN
aspirin/NN jj/NN treated/VBN p/VBN lesions/NNS increase/NN rats/NNS jJ/VBP jj/NNP accompanied/VBN evidence/NN damage/NN renal/JJ
aspirin/NN jj/NN treated/VBN p/VBN lesions/NNS increase/NN rats/NNS jJ/VBP jj/NNP accompanied/VBN evidence/NN damage/NN
pilocarpine/NN reticulata/NN Damage/NN epilepticus/NNS status/NN
pilocarpine/NN reticulata/NN Damage/NN epilepticus/NNS
pilocarpine/NN reticulata/NN Damage/NN
pilocarpine/NN reticulata/NN of/IN
pilocarpine/NN reticulata/NN substantia/NN
pilocarpine/NN reticulata/NN nigra/NN
pilocarpine/NN reticulata/NN pars/NNS
pilocarpine/NN reticulata/NN
pilocarpine/NN injection/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN injection/NN induced/VBN epilepticus/NNS
pilocarpine/JJ MK/NNP induced/VBN seizure/NN
MK/NNP induced/VBN seizure/NN
801/CD augments/NNS pilocarpine/JJ MK/NNP induced/VBN seizure/NN
pilocarpine/NN 801/CD effects/NNS model/NN seizure/NN
MK/NNP effects/NNS model/NN seizure/NN
801/CD effects/NNS model/NN seizure/NN
pilocarpine/NN injection/NN induced/VBN tonic/NN
pilocarpine/NN injection/NN induced/VBN tonic/NN and/CC
pilocarpine/NN injection/NN induced/VBN tonic/NN seizure/NN clonic/JJ
pilocarpine/NN injection/NN induced/VBN tonic/NN seizure/NN
pilocarpine/NN induced/VBN seizure/NN
MK/NNP seizure/NN
801/CD did/VBD pilocarpine/NN induced/VBN seizure/NN
pilocarpine/NN appeared/VBD seizure/NN
pilocarpine/NN seizure/NN
pilocarpine/NN treatment/NN augmented/VBN seizure/NN
pilocarpine/NN induced/VBN seizure/NN augmented/VBN treatment/NN pilocarpine/NN seizure/NN
pilocarpine/NN induced/VBN seizure/NN
MK/NNP seizure/NN
801/CD treatment/NN pilocarpine/NN seizure/NN
MK/NNP seizure/NN pilocarpine/NN treatment/NN augmented/VBN seizure/NN
801/CD treatment/NN augmented/VBN seizure/NN
Pilocarpine/NNP produced/VBD death/NN neuronal/JJ
Pilocarpine/NNP produced/VBD death/NN
pilocarpine/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN induced/VBN epilepticus/NNS
PEG/NNP chemotherapy/NN encephalopathy/NN vasospasm/NN cerebral/JJ
PEG/NNP chemotherapy/NN encephalopathy/NN vasospasm/NN
asparaginase/JJ cytarabine/NN encephalopathy/NN vasospasm/NN cerebral/JJ
asparaginase/JJ cytarabine/NN encephalopathy/NN vasospasm/NN
cytarabine/NN encephalopathy/NN vasospasm/NN cerebral/JJ
cytarabine/NN encephalopathy/NN vasospasm/NN
cytarabine/NN administration/NN sided/VBD encephalopathy/NN evidenced/VBN changes/NNS hallucinations/NNS visual/JJ
cytarabine/NN administration/NN sided/VBD encephalopathy/NN evidenced/VBN changes/NNS hallucinations/NNS
cytarabine/NN administration/NN sided/VBD encephalopathy/NN evidenced/VBN changes/NNS incontinence/NN
cytarabine/NN administration/NN sided/VBD vasospasm/NN cerebral/JJ
cytarabine/NN administration/NN sided/VBD vasospasm/NN
cytarabine/NN administration/NN sided/VBD weakness/NN
cytarabine/NN administration/NN sided/VBD encephalopathy/NN evidenced/VBN changes/NNS aphasia/NN
crack/NN use/NN associated/VBN ulcers/NNS Corneal/JJ
crack/NN use/NN associated/VBN ulcers/NNS
cocaine/NN use/NN associated/VBN ulcers/NNS Corneal/JJ
cocaine/NN use/NN associated/VBN ulcers/NNS
crack/NN use/NN associated/VBN ulcers/NNS corneal/JJ
crack/NN use/NN associated/VBN ulcers/NNS
cocaine/NN use/NN associated/VBN ulcers/NNS corneal/JJ
cocaine/NN use/NN associated/VBN ulcers/NNS
crack/NN use/NN associated/VBN development/NN ulcers/NNS corneal/JJ
crack/NN use/NN associated/VBN development/NN ulcers/NNS
cocaine/NN use/NN associated/VBN development/NN ulcers/NNS corneal/JJ
cocaine/NN use/NN associated/VBN development/NN ulcers/NNS
artesunate/NN described/VBN Cases/NNS anemia/NN hemolytic/JJ
artesunate/NN described/VBN Cases/NNS anemia/NN
suxamethonium/NN pressure/NN Increase/NNP fasciculations/NNS muscle/NN
suxamethonium/NN pressure/NN Increase/NNP fasciculations/NNS
suxamethonium/NN caused/VBN fasciculations/NNS muscle/NN
suxamethonium/NN caused/VBN fasciculations/NNS
suxamethonium/NN caused/VBD significantly/RB fasciculations/NNS muscle/NN
suxamethonium/NN caused/VBD significantly/RB fasciculations/NNS
suxamethonium/NN incidence/NN inhibits/VBZ kg/VBP fasciculations/NNS muscle/NN
suxamethonium/NN incidence/NN inhibits/VBZ kg/VBP fasciculations/NNS
pentobarbital/NN denopamine/NN Improvement/NNP failure/NN cardiac/JJ
pentobarbital/NN denopamine/NN Improvement/NNP failure/NN
methotrexate/JJ enhancement/NN images/NNS patients/NNS leukoencephalopathy/NN
warfarin/NN fibrillation/NN aged/VBN People/NNS rate/NN hemorrhage/NN
warfarin/NN 76/CD aged/VBN people/NNS determine/VB incidence/NN hemorrhage/NN
warfarin/NN use/NN obtained/VBN strokes/VBZ MEASUREMENTS/NNS Information/NNP episodes/NNS bleeding/VBG
warfarin/NN rate/NN low/JJ high/JJ rate/NN hemorrhage/NN
warfarin/NN treatment/NN is/VBZ demonstrating/VBG low/JJ high/JJ rate/NN hemorrhage/NN
picrotoxin/NN antagonism/NN relationships/NNS Structure/NNP seizures/NNS
picrotoxin/NN induced/VBN seizures/NNS
picrotoxin/NN diazepam/NN 8/CD seizures/NNS
chlorpromazine/VBD induced/VBN syndrome/NN extrapyramidal/JJ
chlorpromazine/VBD induced/VBN syndrome/NN
chlorpromazine/NN plays/NNS EPS/NNP
chlorpromazine/NN treated/VBN gene/NN 59/VBN EPS/NNP
chlorpromazine/NN treated/VBN gene/NN 59/VBN EPS/NNP
remifentanil/JJ i/NN anesthesia/NN induced/VBN anesthesia/NN hypotension/NN
propofol/JJ anesthesia/NN induced/VBN anesthesia/NN hypotension/NN
remifentanil/NN caused/VBN anesthesia/NN hypotension/NN
propofol/NN caused/VBN anesthesia/NN hypotension/NN
remifentanil/JJ infusion/NN rates/NNS using/VBG using/VBG period/NN achieved/VBN hypotension/NNP
remifentanil/NN dose/NN rates/NNS using/VBG using/VBG period/NN achieved/VBN hypotension/NNP
remifentanil/NN doses/NNS hypotension/NN allowed/VBD provided/VBD management/NN using/VBG anesthesia/NN hypotension/NN
remifentanil/NN doses/NNS hypotension/NN
indinavir/NN treated/VBN leukocyturia/NNP associated/VBN function/NN impaired/VBN
indinavir/NN treated/VBN leukocyturia/NNP associated/VBN function/NN renal/JJ
indinavir/NN treated/VBN leukocyturia/NNP associated/VBN function/NN
indinavir/NN monitor/VB study/NN DESIGN/NNP nephrotoxicity/NN
indinavir/NN treated/VBN children/NNS DESIGN/NNP nephrotoxicity/NN
indinavir/NN discontinued/VBN nephrotoxicity/NN
Indinavir/NNP monitored/VBN nephrotoxicity/NN
indinavir/JJ L/NNP curve/NN area/NN years/NNS age/NN leukocyturia/NN factors/NNS children/NNS monitored/VBN nephrotoxicity/NN
enflurane/NN halothane/NN induced/VBN hypotension/NN
isoflurane/NN halothane/NN induced/VBN hypotension/NN
labetalol/NN induced/VBN hypotension/NN
halothane/NN induced/VBN hypotension/NN
enflurane/VB halothane/VB studied/VBN feasibility/NN using/VBG agent/NN hypotensive/JJ
isoflurane/VB halothane/VB studied/VBN feasibility/NN using/VBG agent/NN hypotensive/JJ
labetalol/NN using/VBG agent/NN hypotensive/JJ
halothane/VB studied/VBN feasibility/NN using/VBG agent/NN hypotensive/JJ
E/NN %/NN 0/NNP concentration/NN +/CD 0/NNP concentration/NN hypotension/NN
I/NN %/NN concentration/NN +/CD 0/NNP concentration/NN hypotension/NN
H/NNP concentration/NN hypotension/NN
isoflurane/JJ group/NN level/NN returned/VBD rose/VBD hypotension/NN
isoflurane/JJ group/NN level/NN returned/VBD rose/VBD hypotension/NN
labetalol/NN induces/VBZ hypotension/NN
methoxyflurane/NN acidosis/VBZ Hepatitis/NNP tubular/NNS renal/JJ
methoxyflurane/NN acidosis/VBZ Hepatitis/NNP tubular/NNS
methoxyflurane/NN acidosis/VBZ
methoxyflurane/NN acidosis/VBZ Hepatitis/NNP
methoxyflurane/JJ anesthesia/NN operated/VBN man/NN year/NN acidosis/NNS renal/JJ
methoxyflurane/JJ anesthesia/NN operated/VBN man/NN year/NN acidosis/NNS tubular/JJ
methoxyflurane/JJ anesthesia/NN operated/VBN man/NN year/NN acidosis/NNS
methadone/NN receiving/VBG users/NNS syndrome/NN long/JJ
methadone/NN receiving/VBG users/NNS syndrome/NN QT/NNP
methadone/NN receiving/VBG users/NNS syndrome/NN
methadone/JJ treatment/NN prolongation/NN QT/NNP
methadone/JJ treatment/NN prolongation/NN interval/JJ
methadone/JJ treatment/NN prolongation/NN
methadone/JJ dose/NN addition/NN considered/VBN factors/NNS prolongation/NN QT/NNP
methadone/JJ dose/NN addition/NN considered/VBN factors/NNS prolongation/NN
methadone/JJ patients/NNS prolongation/NN QT/NNP
methadone/JJ patients/NNS prolongation/NN interval/JJ
methadone/JJ patients/NNS prolongation/NN
Methadone/JJ dose/NN potassium/VBP contribute/VBP QT/VB
Methadone/JJ dose/NN potassium/VBP contribute/VBP QT/VB prolongation/NN
methadone/NN doses/NNS occur/VB syndrome/NN Long/NNP
methadone/NN doses/NNS occur/VB syndrome/NN QT/NNP
methadone/NN doses/NNS occur/VB syndrome/NN
alendronate/NN administration/NN Diffuse/VB pain/NN
alendronate/NN administration/NN admitted/VBD out/NN clinic/NN pain/NN
doxorubicin/NN doses/NNS treatment/NN stress/VBP cardiotoxicity/NN
doxorubicin/NN cardiotoxicity/NN
DOX/NNP doxorubicin/NN cardiotoxicity/NN
DOX/NNP dose/NN associated/VBN disarrangement/NN necrosis/NNS
DOX/NNP dose/NN induced/VBN cardiotoxicity/NN
D/NNP showed/VBD necrosis/NNS tubular/JJ
D/NNP showed/VBD necrosis/NNS
AmB/NNP showed/VBD necrosis/NNS tubular/JJ
AmB/NNP showed/VBD necrosis/NNS
scopolamine/NN induced/VBN amnesia/NN
cocaine/NN patients/NNS difficult/JJ infarction/NN myocardial/JJ
cocaine/NN patients/NNS difficult/JJ infarction/NN
cocaine/NN patients/NNS difficult/JJ infarction/NN MI/NNP
cocaine/NN pain/NN admitted/VBN exclusion/NN MI/NNP
cocaine/NN use/NN admitted/VBN MI/NNP
cocaine/NN patients/NNS MB/NNP CK/NNP associated/VBN pain/NN MI/NN
haloperidol/NN induced/VBN catalepsy/NN
erythromycin/NN Cotrimoxazole/NN reported/VBD episodes/NNS manic/JJ
Cotrimoxazole/NN reported/VBD episodes/NNS manic/JJ
metronidazole/NN Cotrimoxazole/NN reported/VBD episodes/NNS manic/JJ
clarithromycin/NN showed/VBD most/JJS associated/VBN development/NN mania/NN
ciprofloxacin/NN clarithromycin/NN showed/VBD most/JJS associated/VBN development/NN mania/NN
HCTZ/NNP combinations/NNP lower/JJR incidence/NN hypokalemia/NN
HCTZ/JJ monotherapies/NNS lower/JJR incidence/NN hypokalemia/NN
HCTZ/NNP therapies/NNS associated/VBN associated/VBN hypokalemia/NN
HCTZ/NNP hypokalemia/NN
contrast/NN material/NN injected/VBN developed/VBD failure/NN acute/JJ
contrast/NN material/NN injected/VBN developed/VBD failure/NN renal/JJ
contrast/NN material/NN injected/VBN developed/VBD failure/NN
contrast/NN material/NN injected/VBN developed/VBD failure/NN ARF/NNP
misoprostol/NN administration/NN associated/VBN Delirium/NNP
misoprostol/NN discontinued/VBN improved/VBD delirium/NN
misoprostol/JJ therapy/NN resulted/VBN patient/NN experienced/VBD delirium/NN
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN
contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
contraceptives/NNS associated/VBN thromboembolism/NN
oral/JJ contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN
contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN venous/JJ
contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN
oral/JJ contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN VTE/NNP
contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN VTE/NNP
OCs/NNP contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN venous/JJ
OCs/NNP contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN
OCs/NNP contraceptives/NNS containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN VTE/NNP
OCs/NNP users/NNS gestodene/VBP progestagens/NN containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN venous/JJ
OCs/NNP users/NNS gestodene/VBP progestagens/NN containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN
OCs/NNP users/NNS gestodene/VBP progestagens/NN containing/VBG used/VBD women/NNS higher/JJR incidence/NN thromboembolism/NN VTE/NNP
OC/NNP VTE/NNP
OC/NNP preparations/NNS users/NNS estimate/VB incidence/NN VTE/NNP
OC/NNP preparations/NNS users/NNS estimate/VB did/VBD study/VBP calculate/VB ratios/NNS VTE/NNP
OC/NNP types/NNS use/NN associated/VBN VTE/NNP ratios/NNS calculate/VB study/VBP did/VBD estimate/VB incidence/NN VTE/NNP
OC/NNP types/NNS use/NN associated/VBN VTE/NNP
OCs/NNP progestagen/NN users/NNS VTE/NNP
OCs/NN use/NN associated/VBN VTE/NNP
OC/NNP users/NNS 10/CD rate/NN VTE/NNP
OCs/NNP generation/NN 10/CD rate/NN VTE/NNP
OCs/NNS users/NNS VTE/NNP
OCs/NN generation/NN users/NNS showed/VBD risk/NN VTE/NNP
OCs/NN odds/NNS 3/CD ratios/NNS VTE/NNP
carbamazepine/NN induced/VBN myocarditis/NNS eosinophilic/JJ fulminant/JJ
carbamazepine/NN induced/VBN myocarditis/NNS eosinophilic/JJ
carbamazepine/NN induced/VBN myocarditis/NNS
carbamazepine/NN induced/VBN myocarditis/NNS eosinophilic/JJ hypersensitivity/RB
carbamazepine/NN emphasis/NN mechanisms/NNS hypersensitivity/NN drug/NN
carbamazepine/NN emphasis/NN mechanisms/NNS hypersensitivity/NN
carbamazepine/NN effect/NN necrotizing/VBG fatal/JJ eosinophilic/NN myocarditis/VBZ
carbamazepine/NN effect/NN necrotizing/VBG fatal/JJ eosinophilic/NN hypersensitivity/NN
carbamazepine/NN administration/NN secondary/JJ case/NN myocarditis/NNS
carbamazepine/NN administration/NN secondary/JJ case/NN myocarditis/NNS hypersensitivity/JJ
carbamazepine/JJ myocarditis/NNS
Viracept/NN cause/VB beat/NN known/VBN bradycardia/NN
Viracept/NNP patient/NN occurred/VBD Bradycardia/NNP
Amoxicillin/NNP stands/VBZ drug/NN related/VBN DILI/NNP
clavulanate/NN stands/VBZ drug/NN related/VBN DILI/NNP
Nifedipine/NNP induced/VBN bradycardia/NN
nifedipine/NN induces/VBZ tachycardia/NN
Morphine/NNP induced/VBN seizures/NNS
morphine/NN sulfate/NN course/NN analgesia/NN neonates/NNS suffered/VBN seizures/NNS
sulfate/NN course/NN analgesia/NN neonates/NNS suffered/VBN seizures/NNS
morphine/NN received/VBD kg/NN kg/VBN hr/VB had/VBD seizures/NNS
morphine/NN cessation/NN stopped/VBD ruled/VBN reasons/NNS seizures/NNS
morphine/NN cessation/NN stopped/VBD convulsions/NNS
norpethidine/JJ cause/VB resulting/VBG attack/NN irritability/NN seizure/NN
sumatriptan/NNS colitis/NNS Ischemic/JJ
sumatriptan/NNS colitis/NNS
sumatriptan/NN treated/VBN migraine/NN patients/NNS report/VBP development/NN cases/NNS colitis/NNS ischemic/JJ
sumatriptan/NN treated/VBN migraine/NN patients/NNS report/VBP development/NN cases/NNS colitis/NNS
Diazinon/NNP associated/VBN cancer/NN lung/NN
Diazinon/NNP associated/VBN cancer/NN
diazinon/NN associated/VBN examined/VBN associated/VBN cancer/NN lung/NN
diazinon/NN associated/VBN examined/VBN associated/VBN cancer/NN
diazinon/NN days/NNS %/NN use/NN 41/CD 60/CD LT/NNP number/NN observed/VBD risks/NNS lung/NN
diazinon/NN days/NNS %/NN use/NN 41/CD 60/CD LT/NNP number/NN observed/VBD risks/NNS cancer/NN
diazinon/NN evaluation/NN CONCLUSIONS/NNS provides/VBZ evidence/NN association/NN risk/NN lung/NN
diazinon/NN evaluation/NN CONCLUSIONS/NNS provides/VBZ evidence/NN association/NN risk/NN cancer/NN
pentylenetetrazole/NN induced/VBN damage/NN seizures/NNS
pentylenetetrazole/NN observed/VBD impairment/NN cognitive/JJ
pentylenetetrazole/NN observed/VBD impairment/NN
pentylenetetrazole/NN observed/VBD designed/VBN evaluate/VB seizures/NNS
theophylline/NN reporting/VBG nausea/NN tremors/NNS
theophylline/NN reporting/VBG nausea/NN vomiting/NN
theophylline/NN reporting/VBG nausea/NN
PAN/NNP rats/NNS proteinuric/JJ
Succinylcholine/JJ apnoea/NN
succinylcholine/JJ apnoea/NN
telaprevir/NN treated/VBN Rhabdomyolysis/NNS
simvastatin/NN telaprevir/NN treated/VBN Rhabdomyolysis/NNS
Simvastatin/NNP concentration/NN increased/VBD related/VBN times/NNS toxicity/NN muscle/NN
Simvastatin/NNP concentration/NN increased/VBD related/VBN times/NNS toxicity/NN
statin/JJ patient/JJ toxicity/NN muscle/NN
statin/JJ patient/JJ toxicity/NN
statin/NN concentration/NN related/VBN times/NNS toxicity/NN muscle/NN
statin/NN concentration/NN related/VBN times/NNS toxicity/NN
gentamicin/NN alkylxanthines/NNS Effect/NN failure/NN acute/JJ
gentamicin/NN alkylxanthines/NNS Effect/NN failure/NN renal/JJ
gentamicin/NN alkylxanthines/NNS Effect/NN failure/NN
gentamicin/NN injections/NNS developing/VBG failure/NN acute/JJ
gentamicin/NN injections/NNS developing/VBG failure/NN renal/JJ
gentamicin/NN injections/NNS developing/VBG failure/NN
gentamicin/NN role/NN ARF/NNP
Prednisone/NNP induces/VBZ anxiety/NN
prednisone/NN produces/VBZ anxiety/NN
PDN/NNP prednisone/NN produces/VBZ anxiety/NN
PDN/NNP groups/NNS documented/VBN Anxiety/NN
PDN/NNP induced/VBN anxiety/NN
3/CD users/NNS Depression/NN impulsiveness/NN
4/CD 3/CD users/NNS Depression/NN impulsiveness/NN
methylenedioxymethamphetamine/NN Depression/NN impulsiveness/NN
MDMA/NNP methylenedioxymethamphetamine/NN Depression/NN impulsiveness/NN
ecstasy/NN MDMA/NNP methylenedioxymethamphetamine/NN Depression/NN impulsiveness/NN
3/CD users/NNS Depression/NN
4/CD 3/CD users/NNS Depression/NN
methylenedioxymethamphetamine/NN Depression/NN
MDMA/NNP methylenedioxymethamphetamine/NN Depression/NN
ecstasy/NN MDMA/NNP methylenedioxymethamphetamine/NN Depression/NN
ecstasy/JJ users/NNS generation/NN prognosis/NN cause/NN Given/VBN record/NN memory/NN levels/NNS impulsiveness/NN
ecstasy/JJ users/NNS generation/NN prognosis/NN cause/NN Given/VBN record/NN memory/NN levels/NNS impulsiveness/NN disturbance/NN sleep/NN
ecstasy/JJ users/NNS generation/NN prognosis/NN cause/NN Given/VBN record/NN memory/NN levels/NNS impulsiveness/NN disturbance/NN
ecstasy/JJ users/NNS generation/NN prognosis/NN cause/NN Given/VBN record/NN memory/NN levels/NNS impulsiveness/NN depression/NN
Meloxicam/NNP induced/VBN toxicity/NN liver/NN
Meloxicam/NNP induced/VBN toxicity/NN
meloxicam/VB due/JJ hepatitis/NN
meloxicam/NN administration/NN occurred/VBD hepatitis/NN
meloxicam/NN administration/NN occurred/VBD associated/VBN suggesting/VBG mechanism/NN hypersensitivity/JJ
meloxicam/JJ toxicity/NN liver/NN
meloxicam/JJ toxicity/NN
meloxicam/JJ toxicity/NN case/NN demonstrates/VBZ potential/NN drug/NN induce/VB damage/NN hepatic/JJ
meloxicam/JJ toxicity/NN case/NN demonstrates/VBZ potential/NN drug/NN induce/VB damage/NN
propranolol/NN induced/VBN block/NN sinus/VBZ Alternating/NNP
propranolol/NN induced/VBN block/NN sinus/VBZ
propranolol/NN induced/VBN block/NN rhythm/NN
propranolol/NN induced/VBN block/NN sinoatrial/NN
propranolol/NN induced/VBN block/NN
propranolol/NN daily/NN year/NN Alternating/VBN
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN rhythm/NN sinus/JJ
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN rhythm/NN
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN rhythm/NN sinoatrial/NN
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN rhythm/NN S/NNP
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN rhythm/NN S/NNP A/NNP
propranolol/NN daily/NN year/NN Alternating/VBN observed/VBN block/NN
propranolol/NN withdrawal/NN disappeared/VBD seen/VBN restarted/VBN 2/CD S/CD
propranolol/NN withdrawal/NN disappeared/VBD seen/VBN block/NN A/DT
propranolol/NN withdrawal/NN disappeared/VBD seen/VBN block/NN
lithium/NN insipidus/NNS nephrogenic/JJ
lithium/NN insipidus/NNS diabetes/NN
lithium/NN insipidus/NNS
Lithium/NNP induces/VBZ insipidus/NNS nephrogenic/JJ
Lithium/NNP induces/VBZ insipidus/NNS diabetes/NN
Lithium/NNP induces/VBZ insipidus/NNS
Lithium/NNP induces/VBZ insipidus/NNS NDI/NNP
lithium/NN induced/VBN polyuria/NN
lithium/NN localization/NN expression/NN AQP/NNP preserves/VBZ prevents/VBZ development/NN polyuria/NN
lithium/NN therapy/NN associated/VBN polyuria/NN
lithium/NN localization/NN expression/NN AQP/NNP NDI/NNP
lithium/NN therapy/NN associated/VBN polyuria/NN development/NN prevents/VBZ preserves/VBZ AQP/NNP NDI/NNP
olanzapine/NN 2/CD 4/CD were/VBD scores/NNS Extrapyramidal/JJ
olanzapine/NN 2/CD 4/CD were/VBD scores/NNS symptom/NN
risperidone/NN 4/CD were/VBD scores/NNS Extrapyramidal/JJ
risperidone/NN 4/CD were/VBD scores/NNS symptom/NN
olanzapine/NN occurred/VBD gain/VBP weight/NN
olanzapine/NN occurred/VBD gain/VBP
olanzapine/NN occurred/VBD gain/VBP weight/NN
olanzapine/NN occurred/VBD gain/VBP
risperidone/NN occurred/VBD gain/VBP weight/NN
risperidone/NN occurred/VBD gain/VBP
risperidone/NN %/NN occurred/VBD gain/VBP weight/NN
risperidone/NN %/NN occurred/VBD gain/VBP
olanzapine/NN greater/JJR caused/VBD gain/NN weight/NN
olanzapine/NN greater/JJR caused/VBD gain/NN
olanzapine/NN greater/JJR gain/NN weight/NN
olanzapine/NN greater/JJR gain/NN
lithium/NN induced/VBN insipidus/NNS nephrogenic/JJ
lithium/NN induced/VBN insipidus/NNS diabetes/NN
lithium/NN induced/VBN insipidus/NNS
lithium/NN precipitated/VBD coma/NN Hyperosmolar/JJ
lithium/NN precipitated/VBD coma/NN nonketotic/JJ
lithium/NN precipitated/VBD coma/NN
lithium/NN treated/VBN depression/NN history/NN 10/CD man/NN admitted/VBN hyperosmolar/NN
lithium/NN treated/VBN depression/NN history/NN 10/CD man/NN admitted/VBN hyperosmolar/NN coma/NN nonketotic/JJ
lithium/NN treated/VBN depression/NN history/NN 10/CD man/NN admitted/VBN hyperosmolar/NN coma/NN
lithium/NN likely/JJ insipidus/NNS induced/VBN indicated/VBD remained/VBD polyuric/JJ
lithium/NN likely/JJ insipidus/NNS nephrogenic/JJ
lithium/NN likely/JJ insipidus/NNS diabetes/NN
lithium/NN likely/JJ insipidus/NNS
ouabain/NN induced/VBN mania/NN
ouabain/NN administration/NN suggested/VBN mimic/VB symptoms/NNS mania/NN bipolar/JJ
ouabain/NN administration/NN suggested/VBN mimic/VB symptoms/NNS mania/NN
ouabain/NN induced/VBN mania/NN
ouabain/NN like/VBP provide/VB test/VB disorder/NNP bipolar/NNP
ouabain/NN like/VBP provide/VB test/VB disorder/NNP
Zolmitriptan/NNP secondary/VBZ syndrome/NN Takotsubo/NNP
Zolmitriptan/NNP secondary/VBZ syndrome/NN
Zolmitriptan/NNP secondary/VBZ apical/VB
Zolmitriptan/NNP secondary/VBZ apical/VB syndrome/NN ballooning/VBG
Zolmitriptan/NNP secondary/VBZ apical/VB syndrome/NN
zolmitriptan/NN secondary/JJ revealed/VBD associated/VBN TS/NNP
zolmitriptan/NN secondary/JJ cases/NNS vasospasm/NN coronary/JJ
zolmitriptan/NN secondary/JJ cases/NNS vasospasm/NN artery/NN
zolmitriptan/NN secondary/JJ cases/NNS vasospasm/NN
paclitaxel/NN epirubicin/NN chemotherapy/NN result/NN block/NN atrioventricular/NN
paclitaxel/NN epirubicin/NN chemotherapy/NN result/NN block/NN
epirubicin/NN chemotherapy/NN result/NN block/NN atrioventricular/NN
epirubicin/NN chemotherapy/NN result/NN block/NN
Flumazenil/NNP induces/VBZ seizures/NNS
diazepam/NN intoxications/VBZ induces/VBZ seizures/NNS
cocaine/NN induces/VBZ seizures/NNS
flumazenil/NN Administration/NNP unmask/VB seizures/NNS
cocaine/NN seizures/NNS
Flumazenil/NNP unmask/VB seizures/NNS
diazepam/NN intoxications/NNS increase/VB unmask/VB seizures/NNS
cocaine/NN model/NN increase/VB unmask/VB seizures/NNS
quinacrine/JJ hydrochloride/NN ingesting/VBG rats/NNS heart/NN involving/VBG thrombosis/VBZ Atrial/NNP
quinacrine/JJ hydrochloride/NN ingesting/VBG rats/NNS heart/NN involving/VBG thrombosis/VBZ
hydrochloride/NN ingesting/VBG rats/NNS heart/NN involving/VBG thrombosis/VBZ Atrial/NNP
hydrochloride/NN ingesting/VBG rats/NNS heart/NN involving/VBG thrombosis/VBZ
quinacrine/NN hydrochloride/NN treated/VBN Rats/NNS developed/VBD incidence/NN thrombosis/NNS atrial/JJ
quinacrine/NN hydrochloride/NN treated/VBN Rats/NNS developed/VBD incidence/NN thrombosis/NNS
hydrochloride/NN treated/VBN Rats/NNS developed/VBD incidence/NN thrombosis/NNS atrial/JJ
hydrochloride/NN treated/VBN Rats/NNS developed/VBD incidence/NN thrombosis/NNS
quinacrine/NN hydrochloride/NN nitrite/VBP rats/NNS percent/NN had/VBD have/VB thrombosis/NNS atrial/JJ
quinacrine/NN hydrochloride/NN nitrite/VBP rats/NNS percent/NN had/VBD have/VB thrombosis/NNS
hydrochloride/NN nitrite/VBP rats/NNS percent/NN had/VBD have/VB thrombosis/NNS atrial/JJ
hydrochloride/NN nitrite/VBP rats/NNS percent/NN had/VBD have/VB thrombosis/NNS
cyclosporine/NN reports/NNS precipitated/NNS thrombotic/JJ
cyclosporine/NN reports/NNS precipitated/NNS microangiopathy/NN
tacrolimus/JJ use/NN risk/NN call/VB patients/NNS SSc/NNP
CHP/NNP concentration/NN relationship/NN pain/NN
CHP/NNP cream/NN closest/JJS tolerance/NN pain/NN
lindane/NN effect/NN studied/VBD measuring/VBG onset/NN seizures/NNS
lindane/JJ administration/NN min/NN animals/NNS suffered/VBN convulsions/NNS
aminoglycoside/JJ antibiotics/NNS injection/NN failure/NN acute/JJ
aminoglycoside/JJ antibiotics/NNS injection/NN failure/NN renal/JJ
aminoglycoside/JJ antibiotics/NNS injection/NN failure/NN
tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN optic/JJ
tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN
FK/NNP tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN optic/JJ
FK/NNP tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN
506/CD FK/NNP tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN optic/JJ
506/CD FK/NNP tacrolimus/NNS patient/JJ therapy/NN case/NN neuropathy/NN
tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN optic/JJ
tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN
FK/NNP tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN optic/JJ
FK/NNP tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN
506/CD FK/NNP tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN optic/JJ
506/CD FK/NNP tacrolimus/NNS receiving/VBG patient/NN report/VB case/NN neuropathy/NN
Tacrolimus/NNPS agents/NNS associated/VBN toxicity/NN optic/JJ
Tacrolimus/NNPS agents/NNS associated/VBN toxicity/NN nerve/NN
Tacrolimus/NNPS agents/NNS associated/VBN toxicity/NN
nitric/JJ deficiency/NN induced/VBN hypertension/NN
oxide/NN deficiency/NN induced/VBN hypertension/NN
NO/RB deficiency/NN induced/VBN hypertension/NN
nitric/JJ oxide/NN derived/VBN hypertension/NN
oxide/NN derived/VBN hypertension/NN
NO/RB oxide/NN derived/VBN hypertension/NN
NO/RB removal/NN created/VBN hypertension/NN
NO/DT deficiency/NN increases/VBZ make/VB form/NN hypertension/NN
pilocarpine/NN produced/VBN seizures/NNS
Pilocarpine/NNP reproduces/VBZ provides/VBZ studying/VBG mechanisms/NNS buildup/NN activity/NN convulsive/JJ
Pilocarpine/NNP reproduces/VBZ provides/VBZ studying/VBG generalization/NN seizures/NNS
pilocarpine/NN produced/VBN seizures/NNS
pilocarpine/NN doses/NNS kg/NN activity/NN inhibitor/NN micrograms/NNS resulted/VBD seizures/NNS
pilocarpine/NN threshold/NN reduction/NN convulsions/NNS
pilocarpine/NN observed/VBN formation/NN related/VBN seizure/NN
pilocarpine/NN produced/VBN seizures/NNS
pilocarpine/JJ kg/NN produced/VBN seizures/NNS
pilocarpine/JJ kg/NN produced/VBN convulsions/NNS
pilocarpine/NN threshold/NN induced/VBN subjected/VBN seizures/NNS
doxorubicin/JJ kg/NN dose/NN resulted/VBD albuminuria/NN
isoproterenol/NN 832/CD CD/NNP induced/VBN ischemia/NN myocardial/JJ
isoproterenol/NN 832/CD CD/NNP induced/VBN ischemia/NN
isoproterenol/NN 832/CD Effects/NNPS induced/VBD studied/VBN ischemia/NN myocardial/JJ
isoproterenol/NN 832/CD Effects/NNPS induced/VBD studied/VBN ischemia/NN
ISO/NNP isoproterenol/NN 832/CD Effects/NNPS induced/VBD studied/VBN ischemia/NN myocardial/JJ
ISO/NNP isoproterenol/NN 832/CD Effects/NNPS induced/VBD studied/VBN ischemia/NN
ISO/NNP infusion/NNP improves/VBZ ischemia/NN myocardial/JJ
ISO/NNP infusion/NNP improves/VBZ ischemia/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD N/NNP herbicides/NNS embryolethality/NN
23121/CD N/NNP herbicides/NNS embryolethality/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS ventricular/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS septal/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS
23121/CD teratogenicity/NN defects/NNS ventricular/NN
23121/CD teratogenicity/NN defects/NNS septal/NN
23121/CD teratogenicity/NN defects/NNS
S/NNP BACKGROUND/NNP 23121/CD teratogenicity/NN
53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN
S/NNP BACKGROUND/NNP 23121/CD retardation/NN growth/NN
S/NNP BACKGROUND/NNP 23121/CD retardation/NN
53482/CD BACKGROUND/NNP 23121/CD retardation/NN growth/NN
53482/CD BACKGROUND/NNP 23121/CD retardation/NN
S/NNP BACKGROUND/NNP 23121/CD N/NNP herbicides/NNS embryolethality/NN
53482/CD BACKGROUND/NNP 23121/CD N/NNP herbicides/NNS embryolethality/NN
S/NNP BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS ventricular/NN
S/NNP BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS septal/NN
S/NNP BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS
53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS ventricular/NN
53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS septal/NN
53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN defects/NNS
S/NNP 53482/CD BACKGROUND/NNP 23121/CD teratogenicity/NN
23121/CD teratogenicity/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD retardation/NN growth/NN
S/NNP 53482/CD BACKGROUND/NNP 23121/CD retardation/NN
23121/CD retardation/NN growth/NN
23121/CD retardation/NN
S/NNP kg/NN administration/NN resulted/VBD incidence/NN death/NN embryonic/JJ
S/NNP kg/NN administration/NN resulted/VBD incidence/NN death/NN
23121/CD 800/CD mg/NNS kg/NN administration/NN resulted/VBD incidence/NN death/NN embryonic/JJ
23121/CD 800/CD mg/NNS kg/NN administration/NN resulted/VBD incidence/NN death/NN
S/NNP exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN embryonic/JJ
S/NNP exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN
23121/CD exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN embryonic/JJ
23121/CD exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN
S/NNP kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN ventricular/NN
S/NNP kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN septal/NN
S/NNP kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN
23121/CD 800/CD mg/NNS kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN ventricular/NN
23121/CD 800/CD mg/NNS kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN septal/NN
23121/CD 800/CD mg/NNS kg/NN administration/NN resulted/VBD incidence/NN death/NN defect/NN
S/NNP exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN ventricular/NN
S/NNP exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN septal/NN
S/NNP exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN
23121/CD exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN ventricular/NN
23121/CD exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN septal/NN
23121/CD exposure/NN following/VBG observed/JJ resulted/VBD incidence/NN death/NN defect/NN
S/NNP results/NNS CONCLUSIONS/NNS teratogenic/JJ
53482/CD S/NNP results/NNS CONCLUSIONS/NNS teratogenic/JJ
S/NNP 53482/CD S/NNP results/NNS CONCLUSIONS/NNS teratogenic/JJ
23121/RB teratogenic/JJ
calcium/NN therapy/NN Etiology/NNP hypercalcemia/NN
carbonate/NN therapy/NN Etiology/NNP hypercalcemia/NN
calcium/NN carbonate/NN switching/VBG hypercalcemic/JJ
carbonate/NN switching/VBG hypercalcemic/JJ
capsaicin/NN mastitis/NNS
Cocaine/NNP induced/VBN ischemia/NN myocardial/JJ
Cocaine/NNP induced/VBN ischemia/NN
cocaine/NN induced/VBN ischemia/NN myocardial/JJ
cocaine/NN induced/VBN ischemia/NN
Amlodipine/NNP effect/NN Rare/NN Going/VBG Dysguesia/NNP
amlodipine/NN dysguesia/JJ
amlodipine/NN cause/VB dysguesia/NN
amlodipine/NN dysguesia/NN
Penicillamine/NNP related/VBN dermatitis/NNS lichenoid/JJ
Penicillamine/NNP related/VBN dermatitis/NNS
penicillamine/NN interrupted/VBN appearance/NN dermatitis/NNS lichenoid/JJ
penicillamine/NN interrupted/VBN appearance/NN dermatitis/NNS
doxorubicin/NN cardiotoxicity/NN
Propylthiouracil/NNP induced/VBN damage/NN hepatic/JJ
Propylthiouracil/NNP induced/VBN damage/NN
propylthiouracil/NN cases/NNS observed/VBN damage/NN liver/NN
propylthiouracil/NN cases/NNS observed/VBN damage/NN
warfarin/NN users/NNS 0/CD MB/NNP TIA/NNP RESULTS/NNS analysis/NN ICH/NNP
warfarin/NN users/NNS 0/CD MB/NNP frequent/JJ TIA/NNP vs/NNP ICH/NNP
warfarin/NN MB/NNP excess/NN users/NNS nonusers/NNS ICH/NNP
warfarin/NN users/NNS none/NN 0/NNP nonusers/NNS ICH/NNP
warfarin/NN users/NNS ICH/NNP
warfarin/NN users/NNS MB/NNP excess/NN CONCLUSIONS/NNS suggests/VBZ increase/VB associated/JJ ICH/NNP
warfarin/NN risk/NN increase/VB suggests/VBZ CONCLUSIONS/NNS excess/NN MB/NNP users/NNS ICH/NNP
warfarin/NN risk/NN increase/VB associated/JJ ICH/NNP
remoxipride/JJ metabolites/NNS apoptosis/NNS Induction/NNP +/VBZ 19/CD induced/VBN anemia/NN aplastic/JJ
remoxipride/JJ metabolites/NNS apoptosis/NNS Induction/NNP +/VBZ 19/CD induced/VBN anemia/NN
remoxipride/NN relevance/NN cells/NNS 19/CD induced/VBN anemia/NN aplastic/JJ
remoxipride/NN relevance/NN cells/NNS 19/CD induced/VBN anemia/NN
remoxipride/JJ -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
remoxipride/JJ -LSB-/NNS agent/NN associated/VBN anemia/NN
S/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
S/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
3/CD -/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
3/CD -/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
bromo/NN -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
bromo/NN -LSB-/NNS agent/NN associated/VBN anemia/NN
N/NNP bromo/NN -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
N/NNP bromo/NN -LSB-/NNS agent/NN associated/VBN anemia/NN
-LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
-LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
ethyl/NN 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
ethyl/NN 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
2/CD 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
2/CD 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
pyrrolidinyl/NN 2/CD 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
pyrrolidinyl/NN 2/CD 1/CD -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
methyl/NN -RSB-/NNS -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
methyl/NN -RSB-/NNS -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
-RSB-/NNS -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
-RSB-/NNS -LSB-/NNP -LSB-/NNS agent/NN associated/VBN anemia/NN
2/CD -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
2/CD -LSB-/NNS agent/NN associated/VBN anemia/NN
6/CD 2/CD -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
6/CD 2/CD -LSB-/NNS agent/NN associated/VBN anemia/NN
dimethoxybenz/NN -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
dimethoxybenz/NN -LSB-/NNS agent/NN associated/VBN anemia/NN
amide/JJ -RSB-/NNS dimethoxybenz/NN -LSB-/NNS agent/NN associated/VBN anemia/NN aplastic/JJ
amide/JJ -RSB-/NNS dimethoxybenz/NN -LSB-/NNS agent/NN associated/VBN anemia/NN
remoxipride/NN induce/VB anemia/NN aplastic/JJ
remoxipride/NN induce/VB anemia/NN
remoxipride/NN induce/VB contribute/VB anemia/NN aplastic/JJ
remoxipride/NN induce/VB contribute/VB anemia/NN
remoxipride/NN associated/VBN anemia/NN contribute/VB induce/VB anemia/NN aplastic/JJ
remoxipride/NN associated/VBN anemia/NN contribute/VB induce/VB anemia/NN
remoxipride/NN associated/VBN anemia/NN aplastic/JJ
remoxipride/NN associated/VBN anemia/NN
benzene/NN remoxipride/NN induce/VB anemia/NN aplastic/JJ
benzene/NN remoxipride/NN induce/VB anemia/NN
benzene/NN remoxipride/NN induce/VB contribute/VB anemia/NN aplastic/JJ
benzene/NN remoxipride/NN induce/VB contribute/VB anemia/NN
bepridil/NN induced/VBN Studies/NNS bradycardia/NN
Bepridil/NNP induced/VBN bradycardia/NN
maleate/NN induced/VBN nephrotoxicity/RB
maleate/NN induced/VBN injury/NN renal/JJ
maleate/NN induced/VBN injury/NN
maleate/NN injection/NN induced/VBN proteinuria/NNP
Maleate/NNP induced/VBN included/VBD injury/NN renal/JJ
Maleate/NNP induced/VBN included/VBD injury/NN
Maleate/NNP induced/VBN included/VBD included/VBD' excretion/NN glucosaminidase/NN upregulation/NN molecule/NN kidney/NN
Maleate/NNP induced/VBN included/VBD included/VBD' excretion/NN glucosaminidase/NN upregulation/NN molecule/NN injury/NN
Maleate/NNP induced/VBN included/VBD included/VBD' excretion/NN besides/NNS necrosis/NNS
maleate/NN induced/VBN and/CC nephropathy/RB
Metronidazole/NNP induced/VBN encephalopathy/RB
metronidazole/NN intake/NN encephalopathy/NN
scopolamine/NN Reversal/NNP amnesia/NN
Scopolamine/JJ induced/VBN as/RB amnesia/NN
scopolamine/NN amnesia/NN
streptozotocin/NNS induced/VBN impairment/NN memory/NN
streptozotocin/NNS induced/VBN impairment/NN
streptozotocin/NN study/VB induced/VBN impairment/NN memory/NN
streptozotocin/NN study/VB induced/VBN impairment/NN
STZ/NNP streptozotocin/NN study/VB induced/VBN impairment/NN memory/NN
STZ/NNP streptozotocin/NN study/VB induced/VBN impairment/NN
flutamide/NN Administration/NNP impaired/VBN
flutamide/NN Administration/NNP impaired/VBN memory/NN the/DT
flutamide/NN Administration/NNP impaired/VBN memory/NN
flutamide/NN Administration/NNP impaired/VBN impairment/NN memory/NN
flutamide/NN Administration/NNP impaired/VBN impairment/NN
STZ/NNP improving/VBG attenuated/VBN impaired/VBN
STZ/NNP improving/VBG attenuated/VBN impaired/VBN memory/NN the/DT
STZ/NNP improving/VBG attenuated/VBN impaired/VBN memory/NN
STZ/NNP improving/VBG attenuated/VBN impaired/VBN impairment/NN memory/NN
STZ/NNP improving/VBG attenuated/VBN impaired/VBN impairment/NN
letrozole/NN flutamide/NN Administration/NNP impaired/VBN
letrozole/NN flutamide/NN Administration/NNP impaired/VBN memory/NN the/DT
letrozole/NN flutamide/NN Administration/NNP impaired/VBN memory/NN
letrozole/NN flutamide/NN Administration/NNP impaired/VBN impairment/NN memory/NN
letrozole/NN flutamide/NN Administration/NNP impaired/VBN impairment/NN
tamoxifen/NN flutamide/NN Administration/NNP impaired/VBN
tamoxifen/NN flutamide/NN Administration/NNP impaired/VBN memory/NN the/DT
tamoxifen/NN flutamide/NN Administration/NNP impaired/VBN memory/NN
tamoxifen/NN flutamide/NN Administration/NNP impaired/VBN impairment/NN memory/NN
tamoxifen/NN flutamide/NN Administration/NNP impaired/VBN impairment/NN
STZ/NNP ameliorates/NNS CONCLUSION/NNP impairment/NN memory/NN
STZ/NNP ameliorates/NNS CONCLUSION/NNP impairment/NN
amitriptyline/NNP fluoxetine/NN exacerbation/NN paranoid/JJ
fluoxetine/NN exacerbation/NN paranoid/JJ
sotalol/JJ dl/NN induced/VBN prolongation/NNP initiate/VB pointes/NNS torsade/JJ
sotalol/JJ dl/NN induced/VBN prolongation/NNP initiate/VB pointes/NNS de/NNP
sotalol/JJ dl/NN induced/VBN prolongation/NNP initiate/VB pointes/NNS
sotalol/JJ dl/NN induced/VBN prolongation/NNP initiate/VB pointes/NNS TdP/NNP
sotalol/JJ dl/NN induced/VBN prolongation/NNP QT/NNP
sotalol/JJ dl/NN induced/VBN prolongation/NNP
Sotalol/JJ duration/NN dl/NN dependently/NN prolongation/NN leading/JJ QT/NNP
Sotalol/JJ duration/NN dl/NN dependently/NN prolongation/NN
sotalol/JJ dl/NN EADs/VBZ produced/VBD rabbits/NNS seen/VBN prolongation/NNS QT/NNP
sotalol/JJ dl/NN EADs/VBZ produced/VBD rabbits/NNS seen/VBN prolongation/NNS
sotalol/JJ propagation/NN initiated/VBD episodes/NNS TdP/NNP
pentylenetetrazole/JJ investigates/VBZ anxiety/NN
caffeine/NN induced/VBN anxiety/NN
pentylenetetrazole/JJ caffeine/NN induced/VBN anxiety/NN
caffeine/NN induced/VBN anxiety/NN
caffeine/NN nicotine/NN anxiety/NN
caffeine/NN specific/JJ effect/NN nicotine/NN anxiety/NN
d/LS therapy/NN neuropathy/NN peripheral/JJ
d/LS therapy/NN neuropathy/NN
4/CD therapy/NN neuropathy/NN peripheral/JJ
4/CD therapy/NN neuropathy/NN
T/NNP therapy/NN neuropathy/NN peripheral/JJ
T/NNP therapy/NN neuropathy/NN
NVP/NNP therapy/NN associated/VBN rash/NN
GTN/NNP increased/VBN Headache/NNP
GTN/NNP using/VBG headache/NN
olanzapine/NNP risperidone/NNP difference/NN index/NN insulin/NN
olanzapine/NNP risperidone/NNP difference/NN index/NN sensitivity/NN
olanzapine/NNP risperidone/NNP difference/NN was/VBD subjects/NNS received/VBD exhibiting/VBG resistance/NN insulin/NN
olanzapine/NNP risperidone/NNP difference/NN was/VBD subjects/NNS received/VBD exhibiting/VBG resistance/NN
olanzapine/NN clozapine/NN received/VBD subjects/NNS was/VBD difference/NN index/NN insulin/NN
olanzapine/NN clozapine/NN received/VBD subjects/NNS was/VBD difference/NN index/NN sensitivity/NN
olanzapine/NN clozapine/NN received/VBD exhibiting/VBG resistance/NN insulin/NN
olanzapine/NN clozapine/NN received/VBD exhibiting/VBG resistance/NN
olanzapine/JJ risperidone/NN 001/NNP exhibiting/VBG received/VBD subjects/NNS was/VBD difference/NN index/NN insulin/NN
olanzapine/JJ risperidone/NN 001/NNP exhibiting/VBG received/VBD subjects/NNS was/VBD difference/NN index/NN sensitivity/NN
olanzapine/JJ risperidone/NN 001/NNP exhibiting/VBG resistance/NN insulin/NN
olanzapine/JJ risperidone/NN 001/NNP exhibiting/VBG resistance/NN
clozapine/JJ risperidone/NNP difference/NN index/NN insulin/NN
clozapine/JJ risperidone/NNP difference/NN index/NN sensitivity/NN
clozapine/JJ risperidone/NNP difference/NN was/VBD subjects/NNS received/VBD exhibiting/VBG resistance/NN insulin/NN
clozapine/JJ risperidone/NNP difference/NN was/VBD subjects/NNS received/VBD exhibiting/VBG resistance/NN
clozapine/NN received/VBD subjects/NNS was/VBD difference/NN index/NN insulin/NN
clozapine/NN received/VBD subjects/NNS was/VBD difference/NN index/NN sensitivity/NN
clozapine/NN received/VBD exhibiting/VBG resistance/NN insulin/NN
clozapine/NN received/VBD exhibiting/VBG resistance/NN
clozapine/JJ risperidone/NN risperidone/NN treated/VBN subjects/NNS resistance/NN exhibiting/VBG received/VBD subjects/NNS was/VBD difference/NN index/NN insulin/NN
clozapine/JJ risperidone/NN risperidone/NN treated/VBN subjects/NNS resistance/NN exhibiting/VBG received/VBD subjects/NNS was/VBD difference/NN index/NN sensitivity/NN
clozapine/JJ risperidone/NN risperidone/NN treated/VBN subjects/NNS resistance/NN insulin/NN
clozapine/JJ risperidone/NN risperidone/NN treated/VBN subjects/NNS resistance/NN
olanzapine/NNP risperidone/NNP 4/CD differed/VBD assessment/NN resistance/NN insulin/NN
olanzapine/NNP risperidone/NNP 4/CD differed/VBD assessment/NN resistance/NN
olanzapine/JJ risperidone/NN risperidone/NN clozapine/VB differed/VBD assessment/NN resistance/NN insulin/NN
olanzapine/JJ risperidone/NN risperidone/NN clozapine/VB differed/VBD assessment/NN resistance/NN
clozapine/JJ risperidone/NNP 4/CD differed/VBD assessment/NN resistance/NN insulin/NN
clozapine/JJ risperidone/NNP 4/CD differed/VBD assessment/NN resistance/NN
clozapine/VB differed/VBD assessment/NN resistance/NN insulin/NN
clozapine/VB differed/VBD assessment/NN resistance/NN
olanzapine/JJ clozapine/JJ nonobese/NN CONCLUSIONS/NNS treated/VBD displayed/VBD resistance/NN insulin/NN
olanzapine/JJ clozapine/JJ nonobese/NN CONCLUSIONS/NNS treated/VBD displayed/VBD resistance/NN
clozapine/JJ nonobese/NN CONCLUSIONS/NNS treated/VBD displayed/VBD resistance/NN insulin/NN
clozapine/JJ nonobese/NN CONCLUSIONS/NNS treated/VBD displayed/VBD resistance/NN
olanzapine/JJ clozapine/JJ taking/VBG Patients/NNS examined/VBN resistance/NN insulin/NN
olanzapine/JJ clozapine/JJ taking/VBG Patients/NNS examined/VBN resistance/NN
clozapine/JJ taking/VBG Patients/NNS examined/VBN resistance/NN insulin/NN
clozapine/JJ taking/VBG Patients/NNS examined/VBN resistance/NN
etomidate/NN Prevention/NNP myoclonus/NNS
etomidate/NN myoclonus/NNS
etomidate/NN myoclonus/NNS
Heparin/NNP induced/VBN thrombocytopenia/NN thromboembolism/NN
heparin/NN therapy/NN effects/NNS thrombocytopenia/NN thromboembolism/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
heparin/NN therapy/NN effects/NNS thrombocytopenia/NN
heparin/NN therapy/NN reactions/NNS osteoporosis/NNS
heparin/JJ reactions/NNS osteoporosis/NNS
heparin/NN thrombocytopenia/NN reactions/NNS osteoporosis/NNS
heparin/NN therapy/NN reactions/NNS eosinophilia/NN
heparin/JJ reactions/NNS eosinophilia/NN
heparin/NN thrombocytopenia/NN reactions/NNS eosinophilia/NN
heparin/NN therapy/NN reactions/NNS skin/NN
heparin/NN therapy/NN reactions/NNS reactions/NNS
heparin/JJ reactions/NNS skin/NN
heparin/JJ reactions/NNS reactions/NNS
heparin/NN thrombocytopenia/NN reactions/NNS skin/NN
heparin/NN thrombocytopenia/NN reactions/NNS reactions/NNS
heparin/NN therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN alopecia/NN
heparin/JJ reactions/NNS therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN alopecia/NN
heparin/NN thrombocytopenia/NN reactions/NNS therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN alopecia/NN
heparin/NN therapy/NN reactions/NNS thrombocytopenia/NN
heparin/NN therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN
heparin/JJ reactions/NNS thrombocytopenia/NN
heparin/JJ reactions/NNS therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN
heparin/NN thrombocytopenia/NN
heparin/NN thrombocytopenia/NN reactions/NNS therapy/NN effects/NNS discussed/VBN other/JJ thrombocytopenia/NN
heparin/NN therapy/NN reactions/NNS allergic/JJ
heparin/NN therapy/NN reactions/NNS
heparin/JJ reactions/NNS allergic/JJ
heparin/JJ reactions/NNS
heparin/NN thrombocytopenia/NN reactions/NNS allergic/JJ
heparin/NN thrombocytopenia/NN reactions/NNS
All/DT trans/NNS myositis/NNS
trans/NNS myositis/NNS
retinoic/JJ acid/NN trans/NNS myositis/NNS
acid/NN trans/NNS myositis/NNS
ATRA/NNP cases/NNS myositis/NNS
L/NNP bradykinesia/NNP February/NNP dyskinesias/NNS
DOPA/NNP February/NNP dyskinesias/NNS
propranolol/NN loading/NN induced/VBN failure/NN heart/NN
propranolol/NN loading/NN induced/VBN failure/NN
Disoprivan/NNP occurred/VBD Pain/NNP
Disoprivan/NNP occurred/VBD Pain/NNP 001/CD </NNS vs/NN thrombophlebitis/NNS
phosphorus/NN poisoning/NN presentation/NN Cholestatic/JJ
phosphorus/NN Poisoning/VBG manifests/VBZ hepatitis/NN acute/JJ
phosphorus/NN Poisoning/VBG manifests/VBZ hepatitis/NN
phosphorus/NN Poisoning/VBG leading/VBG failure/NN acute/JJ
phosphorus/NN Poisoning/VBG leading/VBG failure/NN liver/NN
phosphorus/NN Poisoning/VBG leading/VBG failure/NN
phosphorus/NN poisoning/NN presented/VBD features/NNS cholestasis/NNS
phosphorus/NN poisoning/NN presented/VBD highlighting/VBG feature/NN cholestasis/NNS
phosphorus/NN hepatotoxicity/NN feature/NN highlighting/VBG presented/VBD features/NNS cholestasis/NNS
phosphorus/NN hepatotoxicity/NN feature/NN cholestasis/NNS
spironolactone/NN inhibitor/NN converting/VBG caused/VBD hyperkalemia/NN
ramipril/NN doses/NNS considered/VBN cause/NN hyperkalemia/NN
spiranolactone/NN doses/NNS considered/VBN cause/NN hyperkalemia/NN
aspirin/NN taking/VBG prevention/NN infarctions/NNS strokes/NNS
aspirin/NN reviews/NNS SELECTION/NNP selected/VBN answer/VB questions/NNS decrease/VB events/NNS strokes/NNS
aspirin/NN reviews/NNS SELECTION/NNP selected/VBN answer/VB questions/NNS decrease/VB events/NNS stroke/NN
aspirin/NN decrease/VB events/NNS strokes/NNS
aspirin/NN decrease/VB events/NNS stroke/NN
aspirin/NN increase/VB bleeding/NN gastrointestinal/JJ
aspirin/NN increase/VB bleeding/NN
aspirin/NN use/NN increases/VBZ risk/NN events/NNS gastrointestinal/JJ
aspirin/NN use/NN increases/VBZ risk/NN events/NNS bleeding/VBG
Aspirin/NNP reduces/VBZ risk/NN infarction/NN men/NNS strokes/NNS
doxorubicin/NN enhanced/VBN disturbances/NNS cardiac/JJ
doxorubicin/NN enhanced/VBN disturbances/NNS
doxorubicin/JJ damage/NN provoked/VBN damage/NN heart/NN
doxorubicin/JJ damage/NN provoked/VBN damage/NN
amitriptyline/NNP therapy/NN Encephalopathy/RB
amitriptyline/NNP therapy/NN course/NN developed/VBN encephalopathy/NN
clarithromycin/NN Rhabdomyolysis/NNS
simvastatin/NN increment/NN Rhabdomyolysis/NNS
clarithromycin/NN dose/NN occurred/VBD rhabdomyolysis/NNS
statin/JJ rhabdomyolysis/NNS
glycopyrrolate/JJ patients/NNS headache/NN
glycopyrrolate/JJ patient/NN headache/NN
glycopyrrolate/JJ patients/NNS throat/NN sore/JJ
glycopyrrolate/JJ patients/NNS throat/NN
glycopyrrolate/JJ patient/NN headache/NN patients/NNS throat/NN sore/JJ
glycopyrrolate/JJ patient/NN headache/NN patients/NNS throat/NN
cocaine/NN dysfunction/NN cardiac/JJ
cocaine/NN dysfunction/NN
cocaine/NN model/NN function/NN dysfunction/NN cardiac/JJ
cocaine/NN model/NN function/NN dysfunction/NN
cocaine/NN demonstrate/VBP extend/VBP due/JJ dysfunction/NN cardiac/JJ
cocaine/NN demonstrate/VBP extend/VBP due/JJ dysfunction/NN
contrast/NN Incidence/NNP nephropathy/NN
contrast/NN related/VBN factors/NNS frequency/NN determine/VB induced/VBN nephropathy/NN
Contrast/NNP induced/VBN concern/NN nephropathy/NN
alcohol/NN consumption/NN depression/NN
alcohol/NN assessment/NN examination/NN measurement/NN symptoms/NNS depression/NN
alcohol/NN assessment/NN examination/NN using/VBG self/NN Scale/NNP Depression/NNP
alcohol/NN consumption/NN depression/NN
alcohol/NN consumption/NN has/VBZ association/NN depression/NN
isoproterenol/NN decreased/VBD induced/VBN tachycardia/NN
isoproterenol/NN decreased/VBD induced/VBN exercise/NN induced/VBN tachycardia/NN
rifampin/NN therapy/NN failure/NN hemolysis/JJ acute/JJ
rifampin/NN therapy/NN failure/NN renal/JJ
rifampin/NN therapy/NN failure/NN
rifampin/NN therapy/NN failure/NN hemolysis/JJ
rifampin/NN therapy/NN failure/NN acute/JJ
rifampin/NN therapy/NN failure/NN renal/JJ
rifampin/NN therapy/NN failure/NN
rifampin/NN therapy/NN failure/NN leading/VBG hemolysis/NNS
rifampin/NN failure/NN hemolysis/JJ acute/JJ
rifampin/NN failure/NN renal/JJ
rifampin/NN failure/NN
rifampin/NN failure/NN hemolysis/JJ
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN stroke/NN gallbladder/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN stroke/NN
trimethaphan/NN induced/VBN accompanied/VBN //NNP tachycardia/NN
trimethaphan/NN induced/VBN accompanied/VBN hypotension/JJ
carbamazepine/NN treated/VBN anemia/NN aplastic/JJ
carbamazepine/NN treated/VBN anemia/NN
carbamazepine/VB due/JJ anemia/NN aplastic/JJ
carbamazepine/VB due/JJ anemia/NN
cyclosporin/NN A/NN tablets/NNS Long/NNP hypertension/NN
A/NN tablets/NNS Long/NNP hypertension/NN
cyclosporin/NN course/NN hypertension/NN
A/DT therapy/NN treated/VBN cyclosporin/NN course/NN hypertension/NN
cyclosporin/JJ therapy/NN exhibited/VBN state/NN hypertensive/NN
A/DT therapy/NN exhibited/VBN state/NN hypertensive/NN
cyclosporin/NN A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN gingival/JJ
cyclosporin/NN A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN
A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN gingival/JJ
A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN
nifedipine/NN A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN gingival/JJ
nifedipine/NN A/NN therapy/NN events/NNS included/VBD 9/CD development/NN hyperplasia/NN
cyclosporin/NN A/NN treatment/NN sustained/VBD monitored/VBN hyperplasia/NN gingival/JJ
cyclosporin/NN A/NN treatment/NN sustained/VBD monitored/VBN hyperplasia/NN
A/NN treatment/NN sustained/VBD monitored/VBN hyperplasia/NN gingival/JJ
A/NN treatment/NN sustained/VBD monitored/VBN hyperplasia/NN
cyclosporin/NN A/NN treatment/NN sustained/VBD useful/JJ patients/NNS hypertensive/JJ
A/NN treatment/NN sustained/VBD useful/JJ patients/NNS hypertensive/JJ
nifedipine/NN useful/JJ sustained/VBD monitored/VBN hyperplasia/NN gingival/JJ
nifedipine/NN useful/JJ sustained/VBD monitored/VBN hyperplasia/NN
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN confusion/NN
//JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN confusion/NN
tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN confusion/NN
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN episodes/NNS tonic/NN
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN clonic/JJ
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN
//JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN episodes/NNS tonic/NN
//JJ tazobactam/NN doses/NNS seizure/NN clonic/JJ
//JJ tazobactam/NN doses/NNS seizure/NN
tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN episodes/NNS tonic/NN
tazobactam/NN doses/NNS seizure/NN clonic/JJ
tazobactam/NN doses/NNS seizure/NN
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN GTCS/NNP
//JJ tazobactam/NN doses/NNS seizure/NN GTCS/NNP
tazobactam/NN doses/NNS seizure/NN GTCS/NNP
piperacillin/JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN tremor/NN
//JJ tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN tremor/NN
tazobactam/NN doses/NNS seizure/NN given/VBN report/VBP receiving/VBG dialysis/NN developed/VBD speech/NN tremor/NN
piperacillin/JJ tazobactam/NN dose/NN recurred/VBD episode/NN GTCS/NNP
//JJ tazobactam/NN dose/NN recurred/VBD episode/NN GTCS/NNP
tazobactam/NN dose/NN recurred/VBD episode/NN GTCS/NNP
gentamicin/NN induced/VBN nephritis/NNS tubulointerstitial/NN
gentamicin/NN induced/VBN nephritis/NNS
gentamicin/NN induced/VBN nephritis/NNS tubulointerstitial/JJ
gentamicin/NN induced/VBN nephritis/NNS
sodium/NN nitroprusside/NN trimetaphan/NN hypotension/JJ
nitroprusside/NN trimetaphan/NN hypotension/JJ
SNP/NNP nitroprusside/NN trimetaphan/NN hypotension/JJ
trimetaphan/NN hypotension/JJ
TMP/NNP trimetaphan/NN hypotension/JJ
nitroprusside/JJ hypotension/NN used/VBN confirm/VB data/NNS flow/NN hypotension/NN
nitroprusside/JJ hypotension/NN
nitroprusside/JJ hypotension/NN used/VBN confirm/VB data/NNS flow/NN hypotension/NN effects/NNS Regarding/VBG mean/VBP hypotension/NN
trimetaphan/NN hypotension/NN mean/VBP Regarding/VBG effects/NNS hypotension/NN
trimetaphan/NN hypotension/NN mean/VBP Regarding/VBG effects/NNS hypotension/NN flow/NN data/NNS confirm/VB used/VBN hypotension/NN
trimetaphan/NN hypotension/NN
SNP/NNP hypotension/NN
epinephrine/NN clentiazem/NN effects/NNS induced/VBN cardiomyopathy/RB
Amiodarone/NNP induced/VBN pointes/NNS torsade/JJ
Amiodarone/NNP induced/VBN pointes/NNS de/NNP
Amiodarone/NNP induced/VBN pointes/NNS
amiodarone/NN therapy/NN associated/VBN pointes/NNS case/NN development/NN torsade/NN
amiodarone/NN therapy/NN associated/VBN pointes/NNS case/NN de/IN
amiodarone/NN therapy/NN associated/VBN pointes/NNS
amiodarone/NN therapy/NN associated/VBN pointes/NNS TdP/NNP
amiodarone/JJ therapy/NN absence/NN induce/VB TdP/NNP
xylometazoline/NN clonidine/NN effect/NN effect/NN' effect/NN cataleptic/JJ
codeine/JJ morphine/JJ induced/VBN analgesia/NN effect/NN effect/NN' effect/NN cataleptic/JJ
codine/NN morphine/NN effect/NN cataleptic/JJ
naphazoline/NN clonidine/NN effect/NN effect/NN' effect/NN cataleptic/JJ
clonidine/NN effect/NN effect/NN' effect/NN cataleptic/JJ
fentanyl/JJ morphine/JJ induced/VBN analgesia/NN effect/NN effect/NN' effect/NN cataleptic/JJ
fentanyl/NN morphine/NN effect/NN cataleptic/JJ
morphine/JJ induced/VBN analgesia/NN effect/NN effect/NN' effect/NN cataleptic/JJ
morphine/NN effect/NN cataleptic/JJ
fentanyl/NN morphine/NN induced/VBN catalepsy/RB
morphine/NN induced/VBN catalepsy/RB
xylometazoline/NN naphazoline/NN decreased/VBN increased/VBN catalepsy/RB
Codeine/NNP increased/VBN catalepsy/RB
naphazoline/NN decreased/VBN increased/VBN catalepsy/RB
clonidine/NN increased/VBN catalepsy/RB
methamphetamine/JJ abuse/NN associated/VBN brain/NN deficits/NNS structural/JJ
methamphetamine/JJ abuse/NN associated/VBN brain/NN deficits/NNS
methamphetamine/JJ abuse/NN associated/VBN brain/NN in/IN
methamphetamine/JJ abuse/NN associated/VBN brain/NN the/DT
methamphetamine/JJ abuse/NN associated/VBN brain/NN human/JJ
methamphetamine/JJ abuse/NN associated/VBN brain/NN
MA/NNP abuse/NN associated/VBN brain/NN deficits/NNS structural/JJ
MA/NNP abuse/NN associated/VBN brain/NN deficits/NNS
MA/NNP abuse/NN associated/VBN brain/NN in/IN
MA/NNP abuse/NN associated/VBN brain/NN the/DT
MA/NNP abuse/NN associated/VBN brain/NN human/JJ
MA/NNP abuse/NN associated/VBN brain/NN
MA/NNP used/VBD subjects/NNS map/VB abnormalities/NNS
MA/NNP used/VBD subjects/NNS map/VB cortex/NN in/IN
MA/NNP used/VBD subjects/NNS map/VB cortex/NN the/DT
MA/NNP used/VBD subjects/NNS map/VB cortex/NN
MA/NNP used/VBD subjects/NNS map/VB cortex/NN hippocampus/NNS
MA/NNP used/VBD subjects/NNS map/VB cortex/NN matter/NN white/JJ
MA/NNP used/VBD subjects/NNS map/VB cortex/NN matter/NN
MA/NNP used/VBD subjects/NNS map/VB cortex/NN and/CC
MA/NNP used/VBD subjects/NNS map/VB cortex/NN ventricles/NNS
methamphetamine/NN abuse/NN causes/VBZ pattern/NN contributes/VBZ performance/NN impaired/VBN
methamphetamine/NN abuse/NN causes/VBZ pattern/NN contributes/VBZ performance/NN memory/NN
methamphetamine/NN abuse/NN causes/VBZ pattern/NN contributes/VBZ performance/NN
MA/NNP abuse/NN symptoms/NNS help/VB providing/VBG targets/NNS injury/NN brain/NN
MA/NNP abuse/NN symptoms/NNS help/VB providing/VBG targets/NNS injury/NN
Ozone/NN Associations/NNS Concentrations/NNS Parkinson/NNP
Ozone/NN Associations/NNS Concentrations/NNS Parkinson/NNP '/POS
Ozone/NN Associations/NNS Disease/VBN s/VBZ
Ozone/NN Associations/NNS Disease/VBN
particulate/NN matter/NN disease/NN Parkinson/NNP
particulate/NN matter/NN disease/NN Parkinson/NNP '/POS
particulate/NN matter/NN disease/NN s/JJ
particulate/NN matter/NN disease/NN
matter/NN disease/NN Parkinson/NNP
matter/NN disease/NN Parkinson/NNP '/POS
matter/NN disease/NN s/JJ
matter/NN disease/NN
ozone/NN matter/NN disease/NN Parkinson/NNP
ozone/NN matter/NN disease/NN Parkinson/NNP '/POS
ozone/NN matter/NN disease/NN s/JJ
ozone/NN matter/NN disease/NN
particulate/NN matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP
particulate/NN matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP '/POS
particulate/NN matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN s/JJ
particulate/NN matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN
matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP
matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP '/POS
matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN s/JJ
matter/NN 0/CD odds/NNS ozone/NN observed/VBD associations/NNS disease/NN
ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP
ozone/NN observed/VBD associations/NNS disease/NN Parkinson/NNP '/POS
ozone/NN observed/VBD associations/NNS disease/NN s/JJ
ozone/NN observed/VBD associations/NNS disease/NN
ouabain/NN activity/NN tachycardia/NN ventricular/NN
ouabain/NN activity/NN tachycardia/NN
strophanthidin/NN activity/NN displayed/VBN sodium/NN arrhythmias/NNS
Citalopram/NNP Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP Torsade/NNP
Citalopram/NNP Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP de/IN
Citalopram/NNP Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP
Citalopram/NNP Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP TdP/NNP
Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP Torsade/NNP
Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP de/IN
Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP
Terfenadine/NNP blockers/NNS reported/VBN cause/VB Pointes/NNP TdP/NNP
pilocarpine/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN induced/VBN epilepticus/NNS
pilocarpine/JJ injection/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/JJ injection/NN induced/VBN epilepticus/NNS
pilocarpine/JJ injection/NN induced/VBN epilepticus/NNS SE/NNP
pilocarpine/JJ injection/NN induced/VBN SE/NNP
pilocarpine/NN regulated/VBN show/VB induced/VBN SE/RB
fluoxetine/JJ treatment/NN Delirium/VB
fluoxetine/NN concentration/NN hyperkinetic/JJ
fluoxetine/NNS desmethylfluoxetine/NN concentration/NN hyperkinetic/JJ
fluoxetine/NN concentration/NN delirium/JJ
fluoxetine/NNS desmethylfluoxetine/NN concentration/NN delirium/JJ
L/NNP induced/VBN changes/NNS spasm/NN
norepinephrine/NN L/NNP induced/VBN changes/NNS spasm/NN
ecstasy/NN observations/NNS line/NN increases/NNS anxiety/NN depression/NN
Mefenamic/JJ acid/NN induced/VBN failure/NN neutropenia/NN
acid/NN induced/VBN failure/NN neutropenia/NN
Mefenamic/JJ acid/NN induced/VBN failure/NN neutropenia/NN renal/JJ
Mefenamic/JJ acid/NN induced/VBN failure/NN
acid/NN induced/VBN failure/NN neutropenia/NN renal/JJ
acid/NN induced/VBN failure/NN
mefenamic/JJ acid/NN neutropenia/NN
acid/NN neutropenia/NN
mefenamic/JJ acid/NN failure/NN renal/JJ
mefenamic/JJ acid/NN failure/NN
acid/NN failure/NN renal/JJ
acid/NN failure/NN
cocaine/NN patients/NNS associated/JJ pain/NN chest/NN
cocaine/NN patients/NNS associated/JJ pain/NN
cocaine/NN presenting/VBG admitted/VBN pain/NN chest/NN
cocaine/NN presenting/VBG admitted/VBN pain/NN
cocaine/NN efficacious/NNS associated/JJ pain/NN chest/NN
cocaine/NN efficacious/NNS associated/JJ pain/NN
cocaine/NN patients/NNS pain/NN chest/NN
cocaine/NN patients/NNS pain/NN
cocaine/NN patients/NNS total/NN RESULTS/NNS evaluated/VBN pain/NN chest/NN
cocaine/NN patients/NNS total/NN RESULTS/NNS evaluated/VBN pain/NN
cocaine/NN result/VB discharged/VBN patients/NNS cocaine/NN associated/VBN pain/NN chest/NN
cocaine/NN result/VB discharged/VBN patients/NNS cocaine/NN associated/VBN pain/NN
cocaine/NN associated/VBN pain/NN chest/NN
cocaine/NN associated/VBN pain/NN
cocaine/NN ischemia/NN myocardial/JJ
cocaine/NN ischemia/NN
cocaine/NN patients/NNS discharged/VBN result/VB cocaine/NN ischemia/NN myocardial/JJ
cocaine/NN patients/NNS discharged/VBN result/VB cocaine/NN ischemia/NN
morphine/NN administration/NN achieved/VBN OIH/NNP
tetracycline/NN induced/VBN liver/NN Fatty/JJ
tetracycline/NN induced/VBN liver/NN
tetracycline/NN induced/VBN liver/NN fatty/NN
tetracycline/NN induced/VBN liver/NN
tetracycline/VB accounted/VBD liver/NN fatty/NN
tetracycline/VB accounted/VBD liver/NN
cyclophosphamide/NN investigations/NNS lesions/NNS
cyclophosphamide/NN investigations/NNS lesions/NNS bladder/NN of/IN
cyclophosphamide/NN investigations/NNS lesions/NNS bladder/NN the/DT
cyclophosphamide/NN investigations/NNS lesions/NNS bladder/NN urinary/JJ
cyclophosphamide/NN investigations/NNS lesions/NNS bladder/NN
cocaine/NN use/NN alcohol/NN pallidus/VBZ case/NN 31/CD man/NN ischemia/NN
cocaine/NN use/NN alcohol/NN pallidus/VBZ case/NN 31/CD man/NN ischemia/NN globus/NNS of/IN
cocaine/NN use/NN alcohol/NN pallidus/VBZ case/NN 31/CD man/NN ischemia/NN globus/NNS the/DT
cocaine/NN use/NN alcohol/NN pallidus/VBZ case/NN 31/CD man/NN ischemia/NN globus/NNS
cocaine/NN use/NN alcohol/NN pallidus/VBZ
heroin/NN associated/VBN infarctions/NNS globus/NN
heroin/NN associated/VBN infarctions/NNS pallidus/NNS
heroin/NN associated/VBN infarctions/NNS
heroin/NN use/NN reported/VBN infarcts/NNS basal/JJ
heroin/NN use/NN reported/VBN infarcts/NNS ganglia/NN
heroin/NN use/NN reported/VBN infarcts/NNS
5/CD infusion/NN FU/NNP occurred/VBD pain/NN block/NN right/JJ
5/CD infusion/NN FU/NNP occurred/VBD pain/NN block/NN bundle/NN
5/CD infusion/NN FU/NNP occurred/VBD pain/NN block/NN branch/NN
5/CD infusion/NN FU/NNP occurred/VBD pain/NN block/NN
FU/NNP occurred/VBD pain/NN block/NN right/JJ
FU/NNP occurred/VBD pain/NN block/NN bundle/NN
FU/NNP occurred/VBD pain/NN block/NN branch/NN
FU/NNP occurred/VBD pain/NN block/NN
5/CD infusion/NN FU/NNP occurred/VBD pain/NN precordial/JJ
5/CD infusion/NN FU/NNP occurred/VBD pain/NN
FU/NNP occurred/VBD pain/NN precordial/JJ
FU/NNP occurred/VBD pain/NN
5/CD discontinuation/NN disappeared/VBD pain/NN precordial/JJ
5/CD discontinuation/NN disappeared/VBD pain/NN
FU/NNP discontinuation/NN disappeared/VBD pain/NN precordial/JJ
FU/NNP discontinuation/NN disappeared/VBD pain/NN
5/CD due/JJ considered/VBN pain/NN precordial/JJ
5/CD due/JJ considered/VBN pain/NN
FU/NNP 5/CD due/JJ considered/VBN pain/NN precordial/JJ
FU/NNP 5/CD due/JJ considered/VBN pain/NN
5/CD administration/NN induced/VBN 5/CD due/JJ considered/VBN pain/NN precordial/JJ
5/CD administration/NN induced/VBN 5/CD due/JJ considered/VBN pain/NN
FU/NNP abandoned/VBN considered/VBN pain/NN precordial/JJ
FU/NNP abandoned/VBN considered/VBN pain/NN
isoproterenol/VB hypertrophy/NN cardiac/JJ
isoproterenol/VB hypertrophy/NN
risperidone/NN administration/NN developed/VBD syndrome/NN malignant/JJ neuroleptic/JJ
risperidone/NN administration/NN developed/VBD syndrome/NN malignant/JJ
risperidone/NN administration/NN developed/VBD syndrome/NN
risperidone/NN administration/NN developed/VBD syndrome/NN NMS/NNP
levomepromazine/NN risperidone/NN administration/NN developed/VBD syndrome/NN malignant/JJ neuroleptic/JJ
levomepromazine/NN risperidone/NN administration/NN developed/VBD syndrome/NN malignant/JJ
levomepromazine/NN risperidone/NN administration/NN developed/VBD syndrome/NN
levomepromazine/NN risperidone/NN administration/NN developed/VBD syndrome/NN NMS/NNP
cocaine/NN exposure/NN infants/NNS preterm/NN
cocaine/NN exposure/NN infants/NNS
cocaine/NN exposure/NN linked/VBN hemorrhage/NN formation/NN cysts/NNS
cocaine/NN exposure/NN increases/VBZ incidence/NN cysts/NNS infants/NNS preterm/NN
cocaine/NN exposure/NN increases/VBZ incidence/NN cysts/NNS infants/NNS
cocaine/NN prenatally/NN exposed/VBN incidence/NN formation/NN infants/NNS preterm/NN
cocaine/NN prenatally/NN exposed/VBN incidence/NN formation/NN infants/NNS
Tacrolimus/NNS seizure/NN
TAC/NN level/NN gender/NN included/VBD factors/NNS associated/VBN seizures/NNS
TAC/NN level/NN factor/NN associated/VBN seizures/NNS
TAC/NN level/NN factor/NN contributed/VBD seizures/NNS
TAC/NNP factors/NNS serum/NN PELD/NNP seizures/NNS
oestrogen/NN therapy/NN associated/VBN hyperplasia/NNP
oestrogen/NN therapy/NN problems/NNS difficulty/NN hyperplasia/NN
cocaine/NN patients/NNS Clinical/VB associated/JJ infarction/NN myocardial/JJ
cocaine/NN patients/NNS Clinical/VB associated/JJ infarction/NN
cocaine/NN setting/NN evaluate/VB induced/VBN infarction/NN myocardial/JJ
cocaine/NN setting/NN evaluate/VB induced/VBN infarction/NN
cocaine/NN setting/NN evaluate/VB induced/VBN infarction/NN MI/NNP
cocaine/NN Patients/NNS PARTICIPANTS/NNS associated/VBN MI/NNP
cocaine/NN setting/NN lidocaine/VB associated/JJ MI/NNP
cocaine/NN toxicity/NN enhance/VB associated/VBN MI/NNP
cocaine/NN patients/NNS enhance/VB associated/VBN MI/NNP
Ethambutol/NN optic/NN
Ethambutol/NN neuropathy/VBZ
ethambutol/JJ optic/JJ
ethambutol/JJ neuropathy/NN
ethambutol/NN treated/VBN developed/VBD neuropathy/NN optic/JJ
ethambutol/NN treated/VBN developed/VBD neuropathy/NN
ethambutol/JJ therapy/NN starting/VBG had/VBD neuropathy/NN optic/JJ
ethambutol/JJ therapy/NN starting/VBG had/VBD neuropathy/NN
ethambutol/JJ therapy/NN patients/NNS considered/VBN recognition/NN neuropathy/NN optic/JJ
ethambutol/JJ therapy/NN patients/NNS considered/VBN recognition/NN neuropathy/NN
cocaine/NN evaluation/NN assess/VB study/VB associated/JJ pain/NN chest/NN
cocaine/NN evaluation/NN assess/VB study/VB associated/JJ pain/NN
cocaine/NN use/NN setting/NN pain/NN Chest/JJ
cocaine/NN use/NN setting/NN pain/NN
cocaine/NN use/NN setting/NN dobutamine/NN administration/NN concern/NN conducted/VBD study/VB associated/JJ pain/NN chest/NN
cocaine/NN use/NN setting/NN dobutamine/NN administration/NN concern/NN conducted/VBD study/VB associated/JJ pain/NN
cocaine/NN assess/VB study/VB associated/JJ pain/NN chest/NN
cocaine/NN assess/VB study/VB associated/JJ pain/NN
cocaine/NN used/VBN hours/NNS preceding/VBG onset/NN pain/NN chest/NN
cocaine/NN used/VBN hours/NNS preceding/VBG onset/NN pain/NN
cocaine/NN patients/NNS pain/NN chest/NN
cocaine/NN patients/NNS pain/NN
dobutamine/NN treatment/NN pointes/VBZ de/NNP Torsade/NNP
dobutamine/NN treatment/NN pointes/VBZ de/NNP
dobutamine/NN treatment/NN pointes/VBZ
dobutamine/JJ dose/NN cycle/NN tachycardia/NN torsade/VB
dobutamine/JJ dose/NN cycle/NN tachycardia/NN de/IN
dobutamine/JJ dose/NN cycle/NN tachycardia/NN pointes/JJ
dobutamine/NN tachycardia/NN torsade/NN
dobutamine/NN tachycardia/NN torsade/NN de/IN
dobutamine/NN tachycardia/NN pointes/JJ
Amiodarone/NNP risk/NN bradyarrhythmia/NN
amiodarone/NN use/NN increases/VBZ risk/NN bradyarrhythmia/NN
amiodarone/JJ therapy/NN bradyarrhythmia/NN
amiodarone/NN use/NN increases/VBZ risk/NN bradyarrhythmia/NN
bupivacaine/JJ production/NN effects/NNS expression/NN increases/VBZ pain/NN postoperative/JJ
bupivacaine/JJ production/NN effects/NNS expression/NN increases/VBZ pain/NN
Penicillin/NNP anaphylaxis/VBZ
penicillin/NN anaphylaxis/NNS
penicillin/NN anaphylaxis/NNS case/NN described/VBN reviewed/VBN terminology/NN treatment/NN anaphylaxis/NNS
penicillin/NN anaphylaxis/NNS
cyclophosphamide/NN neurons/NNS induced/VBN cystitis/NNS
cyclophosphamide/NN induced/VBN inflammation/NN bladder/NN
cyclophosphamide/NN induced/VBN inflammation/NN
CYP/NNP cyclophosphamide/NN induced/VBN inflammation/NN bladder/NN
CYP/NNP cyclophosphamide/NN induced/VBN inflammation/NN
CYP/NNP induced/VBN increased/VBD cystitis/NNS
CYP/NNP increased/VBN immunoreactive/NN number/NN cystitis/NNS
CYP/NN demonstrated/VBN reaction/NN real/JJ induced/VBZ cystitis/NNS
isoproterenol/NN severity/NN exercise/NN Effects/NNPS infarction/NN myocardial/JJ
isoproterenol/NN severity/NN exercise/NN Effects/NNPS infarction/NN
isoproterenol/NN severity/NN infarction/NN myocardial/JJ
isoproterenol/NN severity/NN infarction/NN
flecainide/NN concentrations/NNS patient/NN Delirium/NNP
paroxetine/NN interaction/NN role/NN Delirium/NNP
flecainide/NN case/NN describe/VB induced/VBN delirium/NN
paroxetine/NN interaction/NN associated/VBN delirium/NN
Flecainide/NNP agents/NNS cause/VB delirium/NN
flecainide/NN delirium/NN
flecainide/NN reports/NNS paroxetine/NN flecainide/NN delirium/NN
paroxetine/NN flecainide/NN delirium/NN
flecainide/NN cause/NN delirium/NN
flecainide/NN interaction/NN indicates/VBZ cause/NN delirium/NN
paroxetine/NN flecainide/NN interaction/NN indicates/VBZ cause/NN delirium/NN
flecainide/JJ concentrations/NNS cause/VB delirium/NN
trimethoprim/NN alone/RB SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN liver/NN
trimethoprim/NN alone/RB SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN
TMP/NNP SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN liver/NN
TMP/NNP SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN
SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN liver/NN
SMZ/NNP prescribed/VBN persons/NNS similar/JJ risk/NN disease/NN
TMP/NNP exposed/VBN disorders/NNS experienced/VBD SMZ/VBP SMZ/NNP seven/CD Stevens/NNP
TMP/NNP exposed/VBN disorders/NNS experienced/VBD SMZ/VBP SMZ/NNP seven/CD Stevens/NNP Johnson/NNP
TMP/NNP exposed/VBN disorders/NNS experienced/VBD SMZ/VBP SMZ/NNP seven/CD Stevens/NNP Johnson/NNP syndrome/CD
SMZ/NNP seven/CD Stevens/NNP
SMZ/NNP seven/CD Stevens/NNP Johnson/NNP
SMZ/NNP seven/CD Stevens/NNP Johnson/NNP syndrome/CD
TMP/NNP exposed/VBN Johnson/NNP Stevens/NNP
TMP/NNP exposed/VBN Johnson/NNP
TMP/NNP exposed/VBN Johnson/NNP syndrome/CD
SMZ/VBP SMZ/NNP seven/CD Stevens/NNP
SMZ/VBP SMZ/NNP seven/CD Stevens/NNP Johnson/NNP
SMZ/VBP SMZ/NNP seven/CD Stevens/NNP Johnson/NNP syndrome/CD
cephalexin/NN took/VBD patient/NN occurred/VBD case/NN necrolysis/NNS toxic/JJ
cephalexin/NN took/VBD patient/NN occurred/VBD case/NN necrolysis/NNS epidermal/JJ
cephalexin/NN took/VBD patient/NN occurred/VBD case/NN necrolysis/NNS
BCNU/NNP model/NN cortex/NN induced/VBN dysplasia/NN cortical/JJ
BCNU/NNP model/NN cortex/NN induced/VBN dysplasia/NN
carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
1/CD -LSB-/NNP carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
1/CD -LSB-/NNP carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
3/CD -LSB-/NNP carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
3/CD -LSB-/NNP carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
2/CD bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
2/CD bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
chloroethyl/NN 2/CD bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
chloroethyl/NN 2/CD bis/NN carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
1/CD carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
1/CD carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
nitrosoure/JJ -RSB-/NNS carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
nitrosoure/JJ -RSB-/NNS carmustine/NN induced/VBN cerebellum/NN evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
BCNU/NNP evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
BCNU/NNP evaluate/VB investigate/VB BCNU/NNS induced/VBN dysplasia/NN
BCNU/NNS induced/VBN dysplasia/NN cortical/JJ
BCNU/NNS induced/VBN dysplasia/NN
BCNU/NNP noted/VBN group/NN cortical/JJ
BCNU/NNP noted/VBN group/NN dysplasia/NN
Linezolid/NNP induced/VBN neuropathy/NN optic/JJ
Linezolid/NNP induced/VBN neuropathy/NN
veralipride/NN use/NN Worsening/VBG Parkinsonism/NNP
veralipride/NN symptoms/NNS therapy/NN marked/JJ shown/VBN patient/NN disease/NN Parkinson/NNP
veralipride/NN symptoms/NNS therapy/NN marked/JJ shown/VBN patient/NN disease/NN Parkinson/NNP '/POS
veralipride/NN symptoms/NNS therapy/NN marked/JJ shown/VBN patient/NN disease/NN s/JJ
veralipride/NN symptoms/NNS therapy/NN marked/JJ shown/VBN patient/NN disease/NN
levodopa/NN characterize/VB was/VBD induced/VBN dyskinesia/NN
levodopa/NN dose/NN basis/NN explained/VBN function/NN swallowing/VBG performed/VBD patients/NNS dyskinetic/JJ
imipramine/NN induced/VBN Hypertension/NNP
Imipramine/NNP given/VBN occurrence/NN hypertension/NN
Imipramine/NNP discontinuation/NN diagnosis/NN elevation/NN had/VBD believe/VBP caused/VBD hypertension/NN
Doxorubicin/NNP induced/VBN monitored/VBN cardiotoxicity/RB
doxorubicin/NN induced/VBN cardiotoxicity/RB
doxorubicin/NN protectors/NNS testing/NN allows/VBZ model/NN result/NN induced/VBN cardiotoxicity/RB
bupivacaine/JJ AD/NNP determining/VBG concentration/NN bupivacaine/NN caused/VBD myocyte/VBP become/VB arrhythmic/JJ
bupivacaine/NN caused/VBD myocyte/VBP become/VB arrhythmic/JJ
progesterone/NN exposure/NN effect/NN determined/VBD determining/VBG concentration/NN bupivacaine/NN caused/VBD myocyte/VBP become/VB arrhythmic/JJ
bupivacaine/JJ arrhythmia/NN
doxorubicin/NN cardiotoxicity/NN
doxorubicin/NN cardiotoxicity/NN
DOX/NNP doxorubicin/NN cardiotoxicity/NN
DOX/NN received/VBD animals/NNS observed/VBN deaths/NNS related/VBN cardiotoxicity/NN
DOX/NN received/VBD animals/NNS observed/VBN revealed/VBD heart/NN consistent/JJ cardiotoxicity/JJ
DOX/NN copolymer/NNP mixture/NN DOX/NN received/VBD animals/NNS observed/VBN deaths/NNS related/VBN cardiotoxicity/NN
DOX/NN copolymer/NNP mixture/NN DOX/NN received/VBD animals/NNS observed/VBN revealed/VBD heart/NN consistent/JJ cardiotoxicity/JJ
DOX/NNP consistent/JJ heart/NN revealed/VBD observed/VBN deaths/NNS related/VBN cardiotoxicity/NN
DOX/NNP consistent/JJ cardiotoxicity/JJ
Gentamicin/NNP OAT/NNP AQP/NNP ATPase/NNP K/NNP induced/VBN Nephropathy/RB
gentamicin/NN transporters/NNS regulation/NN is/VBZ induced/VBN nephropathy/RB
Gentamicin/NNP related/VBN nephropathy/RB
amino/JJ compounds/NNS effect/NN Hyperglycemic/JJ
amino/JJ derivatives/NNS amounts/NNS feeding/NN resulted/VBD hyperglycemia/NN
Levodopa/NNP induced/VBN dyskinesias/NNS ocular/NN
Levodopa/NNP induced/VBN dyskinesias/NNS
Levodopa/NNP induced/VBN uncommon/JJ dyskinesias/NNS ocular/NN
Levodopa/NNP induced/VBN uncommon/JJ dyskinesias/NNS
levodopa/NN effect/NN report/VB hypothesize/VB induce/VB dyskinesias/NNS ocular/NN
levodopa/NN effect/NN report/VB hypothesize/VB induce/VB dyskinesias/NNS
levodopa/NN appearance/NN needed/VBN hypothesize/VB induce/VB dyskinesias/NNS ocular/NN
levodopa/NN appearance/NN needed/VBN hypothesize/VB induce/VB dyskinesias/NNS
tiapride/NN tetrabenazine/NN therapy/NN induced/VBN syndrome/NN Neuroleptic/JJ
tiapride/NN tetrabenazine/NN therapy/NN induced/VBN syndrome/NN malignant/JJ
tiapride/NN tetrabenazine/NN therapy/NN induced/VBN syndrome/NN
tetrabenazine/NN therapy/NN induced/VBN syndrome/NN Neuroleptic/JJ
tetrabenazine/NN therapy/NN induced/VBN syndrome/NN malignant/JJ
tetrabenazine/NN therapy/NN induced/VBN syndrome/NN
tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN neuroleptic/JJ
tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN malignant/JJ
tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN
tetrabenazine/NN tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN neuroleptic/JJ
tetrabenazine/NN tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN malignant/JJ
tetrabenazine/NN tiapride/NN therapy/NN initiation/NN occurred/VBD case/NN 81/CD woman/NN syndrome/NN
tiapride/NN tetrabenazine/NN therapy/NN due/JJ syndrome/NN neuroleptic/JJ
tiapride/NN tetrabenazine/NN therapy/NN due/JJ syndrome/NN malignant/JJ
tiapride/NN tetrabenazine/NN therapy/NN due/JJ syndrome/NN
tetrabenazine/NN therapy/NN due/JJ syndrome/NN neuroleptic/JJ
tetrabenazine/NN therapy/NN due/JJ syndrome/NN malignant/JJ
tetrabenazine/NN therapy/NN due/JJ syndrome/NN
vancomycin/NN pathogenesis/NNS suggesting/VBG induced/VBZ nephrotoxicity/RB
vancomycin/NN examine/VB investigate/VB role/NN erdosteine/NN antioxidant/VBN tissue/NN VCM/NN induced/VBN impairment/NN renal/JJ
vancomycin/NN examine/VB investigate/VB role/NN erdosteine/NN antioxidant/VBN tissue/NN VCM/NN induced/VBN impairment/NN
VCM/NNP vancomycin/NN examine/VB investigate/VB role/NN erdosteine/NN antioxidant/VBN tissue/NN VCM/NN induced/VBN impairment/NN renal/JJ
VCM/NNP vancomycin/NN examine/VB investigate/VB role/NN erdosteine/NN antioxidant/VBN tissue/NN VCM/NN induced/VBN impairment/NN
VCM/NN induced/VBN impairment/NN renal/JJ
VCM/NN induced/VBN impairment/NN
VCM/NNP administration/NN increased/VBD excretion/NNS NAG/NNP marker/NN injury/NN renal/JJ
VCM/NNP administration/NN increased/VBD excretion/NNS NAG/NNP marker/NN injury/NN tubular/JJ
VCM/NNP administration/NN increased/VBD excretion/NNS NAG/NNP marker/NN injury/NN
VCM/NNP showed/VBD induced/VBN nephrotoxicity/RB
VCM/NNP role/NN plays/VBZ concluded/VBN reduces/VBZ induced/VBN nephrotoxicity/RB
VCM/NNP role/NN plays/VBZ concluded/VBN reduces/VBZ VCM/NNP induced/VBN damage/NN kidney/NN
VCM/NNP role/NN plays/VBZ concluded/VBN reduces/VBZ VCM/NNP induced/VBN damage/NN
VCM/NNP reduces/VBZ induced/VBN nephrotoxicity/RB
VCM/NNP induced/VBN damage/NN kidney/NN
VCM/NNP induced/VBN damage/NN
halothane/NN anaesthetized/VBN cats/NNS induced/VBN arrhythmias/NNS cardiac/JJ
halothane/NN anaesthetized/VBN cats/NNS induced/VBN arrhythmias/NNS
adrenaline/NN induced/VBN arrhythmias/NNS cardiac/JJ
adrenaline/NN induced/VBN arrhythmias/NNS
adrenaline/NNP dose/NN increasing/VBG surmountable/JJ Blockade/NNP arrhythmias/NNS
ouabain/NN caused/VBN tachycardia/NN ventricular/NN
ouabain/NN caused/VBN tachycardia/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
Heparin/NNP induced/VBN remains/VBZ thrombocytopenia/NN
Heparin/NNP induced/VBN remains/VBZ thrombocytopenia/NN HIT/NNP
heparin/NN exposure/NN occurs/VBZ suspected/VBN acknowledged/VBN predilection/NN thrombosis/NNS
heparin/NN exposure/NN occurs/VBZ thrombosis/NNS
heparin/NN exposure/NN occurs/VBZ suspected/VBN acknowledged/VBN HIT/NNP
heparin/NN exposure/NN cessation/NN mandates/VBZ treatment/NN HIT/NNP
heparin/VB patients/NNS history/NN HIT/NNP
heparin/NN remains/VBZ one/CD most/JJS used/VBN potential/NN HIT/NNP
heparin/NN exposure/NN used/VBN potential/NN HIT/NNP
heparin/NN initiated/VBN practiced/VBN remains/VBZ one/CD most/JJS used/VBN potential/NN HIT/NNP
busulfan/NN course/NN days/NNS developed/VBD seizures/NNS
everolimus/NNS treated/VBN amyloidosis/VBZ AL/NNP
everolimus/NNS treated/VBN amyloidosis/VBZ
everolimus/NNS treated/VBN diagnosis/NN proteinuria/NN
everolimus/NNS tacrolimus/NNS developed/VBD amyloidosis/NNS
everolimus/NNS tacrolimus/NNS developed/VBD proteinuria/NN
isoproterenol/NN 76/CD induced/VBN hypertrophy/NN heart/NN
isoproterenol/NN 76/CD induced/VBN hypertrophy/NN
isoproterenol/NN model/NN hypertrophy/NN heart/NN
isoproterenol/NN model/NN hypertrophy/NN
isoproterenol/NN prevent/VB producing/VBG hypertrophy/NN heart/NN
isoproterenol/NN prevent/VB producing/VBG hypertrophy/NN
lidocaine/JJ group/NN hypotension/NN
lidocaine/JJ received/VBN nine/CD hypotension/NN
lidocaine/NN had/VBN asystole/NN died/VBN patients/NNS hypotension/NN
dexmedetomidine/JJ receive/VBP prevalence/NN occur/VBP hypotension/NN
propofol/JJ dexmedetomidine/JJ receive/VBP prevalence/NN occur/VBP hypotension/NN bradycardia/NN
dexmedetomidine/JJ receive/VBP prevalence/NN occur/VBP hypotension/NN bradycardia/NN
propofol/JJ dexmedetomidine/JJ receive/VBP prevalence/NN occur/VBP hypotension/NN
pilocarpine/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN induced/VBN epilepticus/NNS
pilocarpine/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN induced/VBN epilepticus/NNS
pilocarpine/JJ model/NN epilepsy/NN temporal/JJ
pilocarpine/JJ model/NN epilepsy/NN lobe/NN
pilocarpine/JJ model/NN epilepsy/NN
methylprednisolone/NN therapy/NN dose/NN Bradycardia/NNP
verapamil/JJ therapy/NN rhythms/VBZ junctional/NNP Accelerated/NNP
verapamil/JJ therapy/NN rhythms/VBZ junctional/NNP
verapamil/JJ therapy/NN rhythms/VBZ
verapamil/NN receiving/VBG patients/NNS examined/VBD frequency/NN dissociation/NN rhythms/NNS accelerated/VBN
verapamil/NN receiving/VBG patients/NNS examined/VBD frequency/NN dissociation/NN rhythms/NNS junctional/JJ
verapamil/NN receiving/VBG patients/NNS examined/VBD frequency/NN dissociation/NN rhythms/NNS
streptozotocin/NN development/NN induced/VBN nephropathy/NN diabetic/JJ
streptozotocin/NN development/NN induced/VBN nephropathy/NN
STZ/NNP nephropathy/NN diabetic/JJ
STZ/NNP nephropathy/NN
STZ/NNP induced/VBN nephropathy/NN diabetic/JJ
STZ/NNP induced/VBN nephropathy/NN
droperidol/NN due/JJ anxiety/NN
droperidol/NN induced/VBN disturbance/NN psychological/JJ
droperidol/NN induced/VBN disturbance/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN anorexia/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN anorexia/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN anorexia/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN dizziness/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN dizziness/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN dizziness/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN nausea/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN nausea/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN edema/NN nausea/NN
calcium/NN blockers/NNS tolerated/JJ effects/NNS headache/NN flushing/NN
channel/NN blockers/NNS tolerated/JJ effects/NNS headache/NN flushing/NN
blockers/NNS tolerated/JJ effects/NNS headache/NN flushing/NN
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN red/JJ
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN cell/NN
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN lymphadenopathy/NN
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN dermatitis/NNS toxic/JJ
diphenylhydantoin/NN taking/VBG patient/NN Pure/VB aplasia/NN dermatitis/NNS
diphenylhydantoin/NN taking/VBG patient/NN developed/VBD rash/NN aplasia/NN pure/JJ
diphenylhydantoin/NN taking/VBG patient/NN developed/VBD rash/NN aplasia/NN red/JJ
diphenylhydantoin/NN taking/VBG patient/NN developed/VBD rash/NN aplasia/NN cell/NN
diphenylhydantoin/NN taking/VBG patient/NN developed/VBD rash/NN aplasia/NN
diphenylhydantoin/NN taking/VBG patient/NN developed/VBD rash/NN lymphadenopathy/NN
diphenylhydantoin/NN treatment/NN complication/NN known/VBN benign/JJ lymphadenopathy/RB
diphenylhydantoin/NN medication/NN associated/VBN aplasia/NN Pure/JJ
diphenylhydantoin/NN medication/NN associated/VBN aplasia/NN red/JJ
diphenylhydantoin/NN medication/NN associated/VBN aplasia/NN cell/NN
diphenylhydantoin/NN medication/NN associated/VBN aplasia/NN
diphenylhydantoin/NN ingestion/NN relation/NN suggestive/JJ aplasia/NNS lymphadenopathy/NN pure/JJ
diphenylhydantoin/NN ingestion/NN relation/NN suggestive/JJ aplasia/NNS red/JJ
diphenylhydantoin/NN ingestion/NN relation/NN suggestive/JJ aplasia/NNS cell/NN
diphenylhydantoin/NN ingestion/NN relation/NN suggestive/JJ aplasia/NNS
diphenylhydantoin/NN ingestion/NN relation/NN suggestive/JJ aplasia/NNS lymphadenopathy/NN
cyclophosphamide/NN receptor/NN induced/VBN cystitis/NNS
cyclophosphamide/NN NK/VB explore/VB is/VBZ study/NN purpose/NN PURPOSE/NNP cystitis/NNS
CYP/NNP cyclophosphamide/NN NK/VB explore/VB is/VBZ study/NN purpose/NN PURPOSE/NNP cystitis/NNS
CYP/NNP administration/NN behaviors/NNS pain/NN
Cyclophosphamide/NNP treatment/NN increased/VBD behaviors/VBZ pain/NN
CYP/NNP CONCLUSIONS/NNS induced/VBN cystitis/NNS
methamphetamine/NN dose/NN induces/VBZ behaviour/NN depressive/JJ
Methamphetamine/NNP triggers/VBZ leads/VBZ states/NNS symptoms/NNS depressive/JJ
Methamphetamine/NNP triggers/VBZ leads/VBZ states/NNS symptoms/NNS
METH/NNP Methamphetamine/NNP triggers/VBZ leads/VBZ states/NNS symptoms/NNS depressive/JJ
METH/NNP Methamphetamine/NNP triggers/VBZ leads/VBZ states/NNS symptoms/NNS
METH/NNS abuse/NN system/NN disruption/NN leads/VBZ states/NNS symptoms/NNS depressive/JJ
METH/NNS abuse/NN system/NN disruption/NN leads/VBZ states/NNS symptoms/NNS
METH/NNP dosage/NN causes/VBZ long/JJ phenotype/NN depressive/NN
METH/NNS dose/NN periods/NNS assessed/VBD term/NN depressive/JJ
METH/NNP induced/VBN profile/NN accompanied/VBN depressive/NN
METH/NNP dose/NN induces/VBZ demonstrate/VBP mice/NNS depressive/NN
streptozotocin/NN inflammation/NN paw/NN carrageenan/NN induced/VBN neuropathy/NN diabetic/JJ
streptozotocin/NN inflammation/NN paw/NN carrageenan/NN induced/VBN neuropathy/NN
STZ/NNP inflammation/NN paw/NN carrageenan/NN induced/VBN neuropathy/NN diabetic/JJ
STZ/NNP inflammation/NN paw/NN carrageenan/NN induced/VBN neuropathy/NN
carrageenan/NN paw/NN inflammation/NN
STZ/NNP 1/CD 14/CD doses/NNS calculated/VBN cause/VB 7/CD reversal/NN hyperalgesia/NN
carrageenan/NN model/NN 1/CD 83/CD doses/NNS calculated/VBN cause/VB 7/CD reversal/NN hyperalgesia/NN
CPA/NNP therapy/NN caused/VBN mediated/VBN %/NN coronary/NNP
CPA/NNP therapy/NN caused/VBN mediated/VBN %/NN coronary/NNP arteriosclerosis/VBZ
CPA/NNP therapy/NN caused/VBN mediated/VBN %/NN coronary/NNP A/NNP known/VBN effect/NN hyperglyceridemic/JJ
CPA/NNP therapy/NN caused/VBN mediated/VBN %/NN coronary/NNP A/NNP known/VBN effect/NN
lithium/NN drugs/NNS used/VBN consider/VBP asterixis/NNS
clozapine/NN lithium/NN drugs/NNS used/VBN consider/VBP asterixis/NNS
pilocarpine/JJ timolol/JJ drops/NNS associated/VBN bradycardia/NN
timolol/JJ drops/NNS associated/VBN bradycardia/NN hypotension/NN
pilocarpine/JJ timolol/JJ drops/NNS associated/VBN bradycardia/NN hypotension/NN
timolol/JJ drops/NNS associated/VBN bradycardia/NN
pilocarpine/JJ nitrate/NN treated/VBN man/NN developed/VBD bradycardia/NN
nitrate/NN treated/VBN man/NN developed/VBD bradycardia/NN
timolol/JJ drops/NNS nitrate/NN treated/VBN man/NN developed/VBD became/VBD hypotensive/NN
maleate/NN drops/NNS nitrate/NN treated/VBN man/NN developed/VBD became/VBD hypotensive/NN
pilocarpine/JJ nitrate/NN treated/VBN man/NN developed/VBD became/VBD hypotensive/NN
nitrate/NN treated/VBN man/NN developed/VBD became/VBD hypotensive/NN
timolol/JJ drops/NNS nitrate/NN treated/VBN man/NN developed/VBD bradycardia/NN
maleate/NN drops/NNS nitrate/NN treated/VBN man/NN developed/VBD bradycardia/NN
methotrexate/NN therapy/NN failure/NN Acute/JJ
methotrexate/NN therapy/NN failure/NN renal/JJ
methotrexate/NN therapy/NN failure/NN
MTX/NNP therapy/NN HD/NNP report/VBP case/NN failure/NN acute/JJ
MTX/NNP therapy/NN HD/NNP report/VBP case/NN failure/NN renal/JJ
MTX/NNP therapy/NN HD/NNP report/VBP case/NN failure/NN
MTX/NNP therapy/NN caused/VBD failure/NN acute/JJ
MTX/NNP therapy/NN caused/VBD failure/NN renal/JJ
MTX/NNP therapy/NN caused/VBD failure/NN
olanzapine/NN treated/VBN had/VBD gain/NN weight/NN
olanzapine/NN treated/VBN had/VBD gain/NN
olanzapine/NN treated/VBD patients/NNS treatment/NN somnolence/NN
haloperidol/NN induced/VBN Hyperprolactinemia/NNP
haloperidol/JJ month/NN hyperprolactinemia/JJ
carbachol/NN potentiated/VBD inhibited/VBD enlargement/NN
carbachol/NN potentiated/VBD inhibited/VBD enlargement/NN pulse/NN of/IN
carbachol/NN potentiated/VBD inhibited/VBD enlargement/NN pulse/NN
carbachol/NN potentiated/VBD inhibited/VBD pressure/NN
desmethylimipramine/JJ mg/NN i/FW inhibited/VBD enlargement/NN
desmethylimipramine/JJ mg/NN i/FW inhibited/VBD enlargement/NN pulse/NN of/IN
desmethylimipramine/JJ mg/NN i/FW inhibited/VBD enlargement/NN pulse/NN
desmethylimipramine/JJ mg/NN i/FW inhibited/VBD pressure/NN
carbachol/NN potentiated/VBD inhibited/VBD pressure/NN tachycardia/NN
cyclosporine/NN Conversion/NNP induced/VBN nephropathy/RB
cyclosporin/NN A/NN conversion/NN Protocols/NNS used/VBN prevent/VB CsA/NNP induced/VBN nephropathy/RB
A/NN conversion/NN Protocols/NNS used/VBN prevent/VB CsA/NNP induced/VBN nephropathy/RB
CsA/NNP A/NN conversion/NN Protocols/NNS used/VBN prevent/VB CsA/NNP induced/VBN nephropathy/RB
CsA/NNP induced/VBN nephropathy/RB
SRL/NNP treated/VBN rats/NNS presented/VBN proteinuria/NNP
CsA/NN treatment/NN presented/VBD lesions/NNS kidney/NN
CsA/NN treatment/NN presented/VBD lesions/NNS
CsA/NNP exposure/NN aggravated/VBN damage/NN renal/JJ
CsA/NNP exposure/NN aggravated/VBN damage/NN
CsA/NNP induced/VBN evolution/NN renal/JJ
CsA/NNP induced/VBN evolution/NN damage/NN
CsA/NNP replacement/NN biomarker/NN seems/VBZ induced/VBN evolution/NN renal/JJ
CsA/NNP replacement/NN biomarker/NN seems/VBZ induced/VBN evolution/NN damage/NN
Amiodarone/NNP reported/VBN cause/VB hepatotoxicity/RB
Amiodarone/RB induced/VBN hepatomegaly/NN
amiodarone/NN effects/NNS dependent/JJ indicated/VBD hepatomegaly/VBP
amiodarone/NN effects/NNS hepatotoxic/JJ
amiodarone/NN effects/NNS information/NN provide/VBP indicate/VBP protects/VBZ amiodarone/NN induced/VBN hepatotoxicity/RB
amiodarone/NN protects/VBZ indicate/VBP provide/VBP information/NN effects/NNS hepatotoxic/JJ
amiodarone/NN induced/VBN hepatotoxicity/RB
cocaine/NN users/NNS recognition/NN fear/VBP Impaired/NNP
cocaine/NN users/NNS recognition/NN fear/VBP
cocaine/NN users/NNS recognition/NN
cocaine/NN effects/NNS explained/VBN manifested/VBD deficit/NN
cocaine/NN effects/NNS explained/VBN manifested/VBD deficit/NN accuracy/NN in/IN
cocaine/NN effects/NNS explained/VBN manifested/VBD deficit/NN accuracy/NN fear/NN
cocaine/NN effects/NNS explained/VBN manifested/VBD deficit/NN accuracy/NN recognition/NN
apomorphine/NN dexamphetamine/NN trazodone/NN effect/NN METHODS/NNP induced/VBN catalepsy/NN
apomorphine/JJ haloperidol/JJ behavior/NN induced/VBN catalepsy/NN
haloperidol/JJ behavior/NN induced/VBN catalepsy/NN
apomorphine/NN antagonize/VB induce/VB catalepsy/RB
apomorphine/NN antagonize/VB induce/VB RESULTS/NNS induced/VBN catalepsy/RB
apomorphine/JJ stereotypy/JJ apomorphine/NN antagonize/VB induce/VB catalepsy/RB
apomorphine/JJ stereotypy/JJ apomorphine/NN antagonize/VB induce/VB RESULTS/NNS induced/VBN catalepsy/RB
haloperidol/JJ catalepsy/NN
apomorphine/JJ stereotypies/NNS antagonized/VBN induced/VBN catalepsy/RB
haloperidol/JJ catalepsy/NN
dexamethasone/NN mice/NNS Treatment/NNP led/VBD elevation/NN pressure/NN degeneration/NN axonal/JJ
dexamethasone/NN mice/NNS Treatment/NNP led/VBD elevation/NN pressure/NN degeneration/NN
dexamethasone/NN mice/NNS Treatment/NNP led/VBD resembling/VBG glucocorticoid/JJ glaucoma/NN
dexamethasone/NN hypertension/NN ocular/NN
dexamethasone/NN hypertension/NN
Dexamethasone/NNP induced/VBN reduced/VBD prevented/VBD dexamethasone/NN hypertension/NN ocular/NN
Dexamethasone/NNP induced/VBN reduced/VBD prevented/VBD dexamethasone/NN hypertension/NN
dexamethasone/NN hypertension/NN ocular/NN
dexamethasone/NN hypertension/NN
dexamethasone/JJ prevented/VBN phenylbutyrate/NN TM/NNP induced/VBN hypertension/NN ocular/NN
dexamethasone/JJ prevented/VBN phenylbutyrate/NN TM/NNP induced/VBN hypertension/NN
disulfiram/NN induced/VBN hepatitis/NN Toxic/JJ
disulfiram/NN induced/VBN hepatitis/NN
disulfiram/NN treated/VBN woman/NN non/NN observed/VBN damage/NN toxic/JJ
disulfiram/NN treated/VBN woman/NN non/NN observed/VBN damage/NN liver/NN
disulfiram/NN treated/VBN woman/NN non/NN observed/VBN damage/NN
Levodopa/NNP therapy/NN lead/VB outcomes/NNS fluctuations/NNS hallucinations/NNS visual/JJ
Levodopa/NNP therapy/NN lead/VB outcomes/NNS fluctuations/NNS hallucinations/NNS
Levodopa/NNP therapy/NN lead/VB outcomes/NNS fluctuations/NNS dyskinesia/NN
doxorubicin/NN cardiomyopathy/NN
DOX/NNP doxorubicin/NN cardiomyopathy/NN
Trimethoprim/NNP induced/VBN anemia/NN hemolytic/JJ
Trimethoprim/NNP induced/VBN anemia/NN
nicergoline/VB due/JJ nephritis/VBZ interstitial/NNP
nicergoline/VB due/JJ nephritis/VBZ
Sermion/NNP nicergoline/VB due/JJ nephritis/VBZ interstitial/NNP
Sermion/NNP nicergoline/VB due/JJ nephritis/VBZ
nicergoline/JJ nephritis/NNS interstitial/JJ
nicergoline/JJ nephritis/NNS
nicergoline/JJ nephritis/NNS AIN/NNP
Sermion/NNP nephritis/NNS interstitial/JJ
Sermion/NNP nephritis/NNS
Sermion/NNP nephritis/NNS AIN/NNP
nicergoline/NN associated/VBN AIN/NNP
acetaminophen/NN failure/NN acute/JJ
acetaminophen/NN failure/NN liver/NN
acetaminophen/NN failure/NN
Acetaminophen/NNP BACKGROUND/NNP cause/NN hepatotoxicity/RB
Acetaminophen/NNP BACKGROUND/NNP cause/NN failure/NN acute/JJ
Acetaminophen/NNP BACKGROUND/NNP cause/NN failure/NN liver/NN
Acetaminophen/NNP BACKGROUND/NNP cause/NN failure/NN
Acetaminophen/NNP BACKGROUND/NNP cause/NN failure/NN ALF/NNP
acetaminophen/NN 2004/CD undergone/VBN patients/NNS outcomes/NNS severity/NN ALF/NNP
acetaminophen/NN 2004/CD undergone/VBN patients/NNS outcomes/NNS severity/NN acetaminophen/NN ALF/NNP
acetaminophen/NN severity/NN ALF/NNP
acetaminophen/NN ALF/NNP
Acetaminophen/NNP undergoing/VBG patients/NNS ALF/NNP
acetaminophen/VBZ had/VBD patients/NNS ALF/NNP
acetaminophen/VBZ had/VBD had/VBD LT/NNP non/NN 01/NNP 0/NNP ALF/NNP
acetaminophen/NNP 01/NNP non/NN LT/NNP had/VBD had/VBD patients/NNS ALF/NNP
acetaminophen/NNP 01/NNP 0/NNP ALF/NNP
acetaminophen/NNP ALF/NNP
acetaminophen/NNP ALF/NNP years/NNS ALF/NNP
acetaminophen/NN non/NN years/NNS ALF/NNP
acetaminophen/NN non/NN years/NNS ALF/NNP
acetaminophen/NN induced/VBN patients/NNS ALF/NNP
acetaminophen/NN transplanted/VBD comparable/JJ ALF/NNP
acetaminophen/NN transplanted/VBD comparable/JJ transplanted/NN ALF/NNP
acetaminophen/NN transplanted/NN comparable/JJ ALF/NNP
acetaminophen/NN transplanted/NN ALF/NNP
d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS torsades/JJ
d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS de/NNP
d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS
l/NN d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS torsades/JJ
l/NN d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS de/NNP
l/NN d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN incidence/NN pointes/NNS
sotalol/NN study/NN evaluated/VBN efficacy/NN incidence/NN pointes/NNS torsades/JJ
sotalol/NN study/NN evaluated/VBN efficacy/NN incidence/NN pointes/NNS de/NNP
sotalol/NN study/NN evaluated/VBN efficacy/NN incidence/NN pointes/NNS
d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN factors/NNS torsades/NNS
d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN de/IN
d/SYM treated/VBN patients/NNS pointes/NNS
l/NN d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN factors/NNS torsades/NNS
l/NN d/SYM treated/VBN patients/NNS pointes/NNS efficacy/NN de/IN
l/NN d/SYM treated/VBN patients/NNS pointes/NNS
sotalol/NN study/NN evaluated/VBN efficacy/NN factors/NNS torsades/NNS
sotalol/NN study/NN evaluated/VBN efficacy/NN de/IN
sotalol/NN study/NN evaluated/VBN efficacy/NN pointes/NNS
d/SYM treatment/NN pointes/NNS torsades/NNS
d/SYM treatment/NN pointes/NNS torsades/NNS de/IN
d/SYM treatment/NN pointes/NNS
l/NN torsades/NNS
l/NN torsades/NNS de/IN
l/NN torsades/NNS pointes/NNS
sotalol/NN torsades/NNS
sotalol/NN torsades/NNS de/IN
sotalol/NN torsades/NNS pointes/NNS
d/SYM dose/NN lower/JJR patients/NNS pointes/NNS torsades/JJ
d/SYM dose/NN lower/JJR patients/NNS pointes/NNS de/NNP
d/SYM dose/NN lower/JJR patients/NNS pointes/NNS
l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS torsades/JJ
l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS de/NNP
l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS
sotalol/NN l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS torsades/JJ
sotalol/NN l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS de/NNP
sotalol/NN l/NN d/SYM dose/NN lower/JJR patients/NNS pointes/NNS
d/SYM treatment/NN years/NNS had/VBD torsades/NNS
d/SYM treatment/NN years/NNS had/VBD torsades/NNS de/IN
d/SYM treatment/NN years/NNS had/VBD torsades/NNS pointes/NNS
l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS
l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS de/IN
l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS pointes/NNS
sotalol/NN l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS
sotalol/NN l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS de/IN
sotalol/NN l/NN d/SYM treatment/NN years/NNS had/VBD torsades/NNS pointes/NNS
d/NNS doses/NNS occurred/VBD pointes/NNS Torsades/NNP
d/NNS doses/NNS occurred/VBD pointes/NNS de/NNP
d/NNS doses/NNS occurred/VBD pointes/NNS
l/JJ occurred/VBD pointes/NNS Torsades/NNP
l/JJ occurred/VBD pointes/NNS de/NNP
l/JJ occurred/VBD pointes/NNS
sotalol/JJ l/JJ occurred/VBD pointes/NNS Torsades/NNP
sotalol/JJ l/JJ occurred/VBD pointes/NNS de/NNP
sotalol/JJ l/JJ occurred/VBD pointes/NNS
d/NNS dose/NN relation/NN ECG/NN changes/VBZ identify/VB risk/NN pointes/NNS torsades/JJ
d/NNS dose/NN relation/NN ECG/NN changes/VBZ identify/VB risk/NN pointes/NNS de/NNP
d/NNS dose/NN relation/NN ECG/NN changes/VBZ identify/VB risk/NN pointes/NNS
l/NN changes/VBZ identify/VB risk/NN pointes/NNS torsades/JJ
l/NN changes/VBZ identify/VB risk/NN pointes/NNS de/NNP
l/NN changes/VBZ identify/VB risk/NN pointes/NNS
sotalol/NN identify/VB risk/NN pointes/NNS torsades/JJ
sotalol/NN identify/VB risk/NN pointes/NNS de/NNP
sotalol/NN identify/VB risk/NN pointes/NNS
d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS torsades/JJ
d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS de/NNP
d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS
l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS torsades/JJ
l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS de/NNP
l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS
sotalol/NN l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS torsades/JJ
sotalol/NN l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS de/NNP
sotalol/NN l/NN d/SYM application/NN parameters/NNS identify/VB risk/NN pointes/NNS
acetaminophen/NN female/NN year/NN induced/VBN failure/NN fulminant/JJ
acetaminophen/NN female/NN year/NN induced/VBN failure/NN liver/NN
acetaminophen/NN female/NN year/NN induced/VBN failure/NN
acetaminophen/NN female/NN year/NN induced/VBN AKI/NNP
clopidogrel/NN associated/VBN hepatitis/NNP
clopidogrel/NN case/NN describe/VBP hepatitis/NN
clopidogrel/JJ hepatotoxicity/NN
clopidogrel/NN prescribed/VBN injury/NN hepatic/JJ
clopidogrel/NN prescribed/VBN injury/NN
steroid/JJ injection/NN occurred/VBN woman/NN presented/VBN sensation/NN paresthesia/NN
steroid/JJ injection/NN occurred/VBN paresthesia/NN
isotretinoin/VB report/VBP anomalies/NNS anotia/NNP Taussig/NNP
isotretinoin/VB report/VBP anomalies/NNS anotia/NNP malformation/NN Bing/NNP
isotretinoin/VB report/VBP anomalies/NNS anotia/NNP malformation/NN
isotretinoin/VB report/VBP anomalies/NNS anotia/NNP
isoproterenol/NN induced/VBN hypertrophy/NN cardiac/JJ
isoproterenol/NN induced/VBN hypertrophy/NN
Iso/NNP treatment/NN induced/VBN LV/NNP
Iso/NNP treatment/NN induced/VBN hypertrophy/RB
nicotine/NN Relationship/NNP seizures/NNS
nicotine/NN relationship/NN induced/VBN seizures/NN
nicotine/NN effects/NNS sensitive/JJ Mice/NNS had/VBD alpha/NNS bungarotoxin/NN hippocampus/NNS mice/NNS seizure/NN
quinine/JJ amblyopia/NN
quinine/JJ sulfate/NN use/NN man/NN blindness/NN
sulfate/NN use/NN man/NN blindness/NN
quinine/JJ sulfate/NN use/NN man/NN blindness/NN response/NN tonic/NN
quinine/JJ sulfate/NN use/NN man/NN blindness/NN response/NN pupillary/NN
sulfate/NN use/NN man/NN blindness/NN response/NN tonic/NN
sulfate/NN use/NN man/NN blindness/NN response/NN pupillary/NN
quinine/JJ toxicity/NN potentials/NNS supersensitivity/JJ denervation/VBN response/NN tonic/NN
quinine/JJ toxicity/NN potentials/NNS supersensitivity/JJ denervation/VBN response/NN pupillary/NN
beclomethasone/JJ dipropionate/NN developed/VBD candidiasis/NNS hoarseness/NNS
dipropionate/NN developed/VBD candidiasis/NNS hoarseness/NNS
beclomethasone/JJ dipropionate/NN developed/VBD candidiasis/NNS oral/JJ
beclomethasone/JJ dipropionate/NN developed/VBD candidiasis/NNS
dipropionate/NN developed/VBD candidiasis/NNS oral/JJ
dipropionate/NN developed/VBD candidiasis/NNS
beclomethasone/NN placed/VBN patients/NNS developed/VBD hoarseness/NNS
beclomethasone/NN placed/VBN patients/NNS developed/VBD hoarseness/NNS thrush/NN
beclomethasone/NN restarted/VBN conclude/VBP challenged/VBD because/RB patients/NNS develop/VBP re/VBN hoarseness/NNS
beclomethasone/NN prednisone/NN use/NN increase/VB risk/NN developing/VBG hoarseness/NNS
methadone/JJ therapy/NN male/NN Rhabdomyolysis/NNS
heroin/NN stroke/NN Rhabdomyolysis/NNS
heroin/NN presented/VBN rhabdomyolysis/NNS
methadone/NN using/VBG Those/DT CONCLUSION/NNP increase/VB risk/NN rhabdomyolysis/NNS
heroin/NN methadone/NN using/VBG Those/DT CONCLUSION/NNP increase/VB risk/NN rhabdomyolysis/NNS
heroin/NN rhabdomyolysis/NNS stroke/NN
heroin/NN abusers/NNS rhabdomyolysis/NNS stroke/NN
heroin/NN rhabdomyolysis/NNS
heroin/NN abusers/NNS rhabdomyolysis/NNS
Tacrolimus/NNP ointment/NNP used/VBN indicate/VBP effective/JJ aggravated/VBN dermatitis/NNS rosacea/NN
CY/NNP toxicity/NNP caused/VBD cystitis/NNS haemorrhagic/JJ
CY/NNP toxicity/NNP caused/VBD cystitis/NNS
CY/NNP ulcerous/NNS days/NNS appeared/VBD forms/NNS cystitis/NNS
procaterol/NN effects/NNS asthmatic/JJ tremorgenic/JJ
Chinese/JJ pill/NN use/NN failure/NN acute/JJ
Chinese/JJ pill/NN use/NN failure/NN renal/JJ
Chinese/JJ pill/NN use/NN failure/NN
herbal/JJ pill/NN use/NN failure/NN acute/JJ
herbal/JJ pill/NN use/NN failure/NN renal/JJ
herbal/JJ pill/NN use/NN failure/NN
diclofenac/JJ intake/NN aggravated/VBN injury/NN renal/JJ
diclofenac/JJ intake/NN aggravated/VBN injury/NN
Methoxamine/NNP evoked/VBD caused/VBD rise/NN a/DT
Methoxamine/NNP evoked/VBD caused/VBD rise/NN significant/JJ
Methoxamine/NNP evoked/VBD caused/VBD rise/NN
Methoxamine/NNP evoked/VBD caused/VBD pressure/NN in/IN
Methoxamine/NNP evoked/VBD caused/VBD pressure/NN systolic/JJ
Methoxamine/NNP evoked/VBD caused/VBD pressure/NN blood/NN
Methoxamine/NNP evoked/VBD caused/VBD pressure/NN
isoproterenol/JJ placebo/JJ tachycardia/NN
isoproterenol/JJ tachycardia/NN
isoproterenol/NN activates/VBZ blocked/VBN activation/NN results/NNS tachycardia/NN
TNA/NNP dose/NN hours/NNS had/VBD episode/NN convulsions/NNS tonic/NN
TNA/NNP dose/NN hours/NNS had/VBD episode/NN convulsions/NNS clonic/NN
TNA/NNP dose/NN hours/NNS had/VBD episode/NN convulsions/NNS
crack/NN cocaine/NN smokers/NNS seroconversion/NN HIV/NN
crack/NN cocaine/NN smokers/NNS seroconversion/NN
cocaine/NN smokers/NNS seroconversion/NN HIV/NN
cocaine/NN smokers/NNS seroconversion/NN
crack/NN cocaine/NN smokers/NNS participants/NNS seroconversion/NN HIV/NN
crack/NN cocaine/NN smokers/NNS participants/NNS seroconversion/NN
cocaine/NN smokers/NNS participants/NNS seroconversion/NN HIV/NN
cocaine/NN smokers/NNS participants/NNS seroconversion/NN
crack/NN cocaine/NN Smoking/NN found/VBN factor/NN seroconversion/NN HIV/NN
crack/NN cocaine/NN Smoking/NN found/VBN factor/NN seroconversion/NN
cocaine/NN Smoking/NN found/VBN factor/NN seroconversion/NN HIV/NN
cocaine/NN Smoking/NN found/VBN factor/NN seroconversion/NN
ritodrin/NN decreased/VBD amplitudes/NNS tremor/NN
HCl/NNP infusion/NNP ritodrin/NN decreased/VBD amplitudes/NNS tremor/NN
fenoterol/NN end/NN infusion/NN decreased/VBD amplitudes/NNS tremor/NN
hydrobromide/NN infusion/NN decreased/VBD amplitudes/NNS tremor/NN
succinylcholine/JJ administration/NN dose/NN rocuronium/NN fasciculation/NN myalgia/NN
succinylcholine/JJ administration/NN dose/NN rocuronium/NN fasciculation/NN
Succinylcholine/NNP produces/VBZ effects/NNS fasciculation/NN myalgia/NN
Succinylcholine/NNP produces/VBZ effects/NNS fasciculation/NN muscle/NN
Succinylcholine/NNP produces/VBZ effects/NNS fasciculation/NN
succinylcholine/NN prevent/VB identified/VBN induced/VBN fasciculation/NN myalgia/NN
succinylcholine/NN produced/VBD study/NN identified/VBN induced/VBN fasciculation/NN myalgia/NN
succinylcholine/NN prevent/VB identified/VBN induced/VBN fasciculation/NN
succinylcholine/NN produced/VBD study/NN identified/VBN induced/VBN fasciculation/NN
succinylcholine/JJ kg/NN received/VBD assessed/VBN assessed/VBN myalgia/NN
succinylcholine/JJ kg/NN received/VBD assessed/VBN incidence/NN fasciculations/NNS
ribavirin/NNP Interferon/NNP produces/VBZ anemia/NN hemolytic/JJ
ribavirin/NNP Interferon/NNP produces/VBZ anemia/NN
Interferon/NNP produces/VBZ anemia/NN hemolytic/JJ
Interferon/NNP produces/VBZ anemia/NN
ifosfamide/JJ nephropathy/NN
ifosfamide/NN anti/NNS responsible/JJ damage/NN renal/JJ
ifosfamide/NN anti/NNS responsible/JJ damage/NN
IFO/NNP ifosfamide/NN anti/NNS responsible/JJ damage/NN renal/JJ
IFO/NNP ifosfamide/NN anti/NNS responsible/JJ damage/NN
IFO/NNP therapy/NN anti/NNS responsible/JJ damage/NN renal/JJ
IFO/NNP therapy/NN anti/NNS responsible/JJ damage/NN
IFO/NNP prevent/VB nephropathy/RB
CTX/NNP treatment/NN neutropenia/NN frequency/NN %/NN effect/NN Neutropenia/NNP
CTX/NNP treatment/NN neutropenia/NN
CCNU/NNP CTX/NNP treatment/NN neutropenia/NN frequency/NN %/NN effect/NN Neutropenia/NNP
CCNU/NNP CTX/NNP treatment/NN neutropenia/NN
17/CD alpha/NN shows/VBZ associated/VBN cholestasis/NNS intrahepatic/JJ
17/CD alpha/NN shows/VBZ associated/VBN cholestasis/NNS
alpha/NN shows/VBZ associated/VBN cholestasis/NNS intrahepatic/JJ
alpha/NN shows/VBZ associated/VBN cholestasis/NNS
ethinylestradiol/JJ alpha/NN shows/VBZ associated/VBN cholestasis/NNS intrahepatic/JJ
ethinylestradiol/JJ alpha/NN shows/VBZ associated/VBN cholestasis/NNS
EE/NNP ethinylestradiol/JJ alpha/NN shows/VBZ associated/VBN cholestasis/NNS intrahepatic/JJ
EE/NNP ethinylestradiol/JJ alpha/NN shows/VBZ associated/VBN cholestasis/NNS
morphine/NN CCK/NNP induced/VBN decreases/NNS amnesia/JJ
morphine/NN hippocampus/NNS region/NN induced/VBN decreases/NNS amnesia/JJ
Carbimazole/NNP ANCA/NNP
Carbimazole/NNP ANCA/NNP vasculitis/NNS positive/JJ
Carbimazole/NNP ANCA/NNP vasculitis/NNS
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS antibody/NN Antineutrophil/JJ
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS antibody/NN cytoplasmic/JJ
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS antibody/NN
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS antibody/NN ANCA/NNP
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS associated/JJ
antithyroidmedications/NNS effect/NN threatening/VBG life/NN vasculitis/NNS
indomethacin/NN misoprostol/NN effect/NN dose/NN dysfunction/NN renal/JJ
indomethacin/NN misoprostol/NN effect/NN dose/NN dysfunction/NN
indomethacin/NN induced/VBN dysfunction/NN renal/JJ
indomethacin/NN induced/VBN dysfunction/NN
adenosine/JJ triphosphate/NN induced/VBN effects/NNS hypotension/NN
triphosphate/NN induced/VBN effects/NNS hypotension/NN
sodium/NN nitroprusside/NN triphosphate/NN induced/VBN effects/NNS hypotension/NN
nitroprusside/NN triphosphate/NN induced/VBN effects/NNS hypotension/NN
Adenosine/JJ triphosphate/NN administered/VBN induce/VB hypotension/NN
triphosphate/NN administered/VBN induce/VB hypotension/NN
ATP/NNP triphosphate/NN administered/VBN induce/VB hypotension/NN
sodium/NN nitroprusside/NN triphosphate/NN administered/VBN induce/VB hypotension/NN
nitroprusside/NN triphosphate/NN administered/VBN induce/VB hypotension/NN
SNP/NNP nitroprusside/NN triphosphate/NN administered/VBN induce/VB hypotension/NN
ATP/NNP induced/VBN Hypotension/NNP
ATP/NNP stopped/VBN returned/VBD accompanied/VBN Hypotension/NNP
SNP/NNP decreases/NNS produced/VBN hypotension/NN
Bisphenol/NNP A/NNP exposure/NN increases/VBZ anxiety/NN
A/NNP exposure/NN increases/VBZ anxiety/NN
BPA/NNP exposed/VBN mice/NNS increased/VBN indicated/VBD anxiety/NN
BPA/NN exposure/NN increased/VBD anxiety/NN
sulfadiazine/JJ nephrotoxicity/NN acute/JJ
sulfadiazine/JJ nephrotoxicity/NN
Sulfadiazine/NNP acute/NNP
Sulfadiazine/NNP acute/NNP reviving/VBG nephrotoxicity/RB
sulfadiazine/NN treatment/NN developed/VBD showed/VBD calculi/NNS renal/JJ
sulfadiazine/NN treatment/NN developed/VBD showed/VBD calculi/NNS
helodermin/NN produced/VBN hypotension/NN
Helodermin/NNP produced/VBD hypotension/NN
levcromakalim/NN abolished/VBD glibenclamide/NN attenuated/VBN Hypotension/NNP
acetylcholine/NN duration/NN shortened/VBN induced/VBN hypotension/NN
acetylcholine/NN duration/NN shortened/VBN induced/VBN helodermin/NN produced/VBN hypotension/NN
ACh/NNP acetylcholine/NN duration/NN shortened/VBN induced/VBN hypotension/NN
ACh/NNP acetylcholine/NN duration/NN shortened/VBN induced/VBN helodermin/NN produced/VBN hypotension/NN
helodermin/NN induced/VBN hypotension/NN
helodermin/NN produced/VBN hypotension/NN
helodermin/NN suggest/VBP attributable/JJ hypotension/NN
Streptozotocin/NNP induced/VBN impairment/NN memory/NN
Streptozotocin/NNP induced/VBN impairment/NN
Streptozotocin/NNP activation/NN role/NN rats/NNS memory/NN
Streptozotocin/NNP activation/NN role/NN rats/NNS impaired/VBN
STZ/NNP role/NN rats/NNS memory/NN
STZ/NNP role/NN rats/NNS impaired/VBN
STZ/NNP administration/NN days/NNS found/VBN deficit/NN Memory/NN
STZ/NNP administration/NN days/NNS found/VBN deficit/NN
STZ/NNP causes/VBZ expression/NN CD/NNP neuroinflammation/NN
STZ/NNP impairment/NN memory/NN
STZ/NNP impairment/NN
propranolol/NN induced/VBN hypertension/NN
pilocarpine/NN animals/NNS epilepsy/NNP
Indomethacin/NNP hypotension/NNP
adrenaline/NN Support/NN hypertension/NN
adrenaline/JJ infusion/NN effect/NN Support/NN hypertension/NN
adrenaline/NN support/NN hypothesis/NNS hypertension/NN
levodopa/NN prior/RB neuropsychiatric/JJ evaluated/JJ time/NN disability/NN dyskinesia/NN
levodopa/NN increase/NN induced/VBN fluctuations/NNS dyskinesia/NN
levodopa/NN therapy/NN duration/NN correlated/VBN increase/NN induced/VBN fluctuations/NNS dyskinesia/NN
tobramycin/NN concentration/NN duration/NN related/VBN Azotemia/NNP
doxorubicin/NN cardiomyopathy/NN
Indomethacin/NNP typical/JJ cystitis/NNS interstitial/JJ
Indomethacin/NNP typical/JJ cystitis/NNS
Indomethacin/NNP epithelium/NN mastocytosis/NNS
L/NNP reduced/VBD dyskinesias/NNS
DOPA/NNP dyskinesias/NNS
L/NNP development/NN lesion/NN dyskinesias/NNS
DOPA/NNP lesion/NN dyskinesias/NNS
Contrast/VB nephrotoxicity/NN
medium/NN nephrotoxicity/NN
contrast/NN medium/NN induced/VBN dysfunction/NNP Renal/NNP
contrast/NN medium/NN induced/VBN dysfunction/NNP
medium/NN induced/VBN dysfunction/NNP Renal/NNP
medium/NN induced/VBN dysfunction/NNP
CM/NNP medium/NN induced/VBN dysfunction/NNP Renal/NNP
CM/NNP medium/NN induced/VBN dysfunction/NNP
CM/NNP effect/NN nephrotoxic/JJ
CM/NNP administration/NN induced/VBN damage/NN renal/JJ
CM/NNP administration/NN induced/VBN damage/NN
all/DT complications/NNS Thrombotic/JJ
trans/NNS complications/NNS Thrombotic/JJ
retinoic/JJ therapy/NN trans/NNS complications/NNS Thrombotic/JJ
acid/JJ therapy/NN trans/NNS complications/NNS Thrombotic/JJ
all/DT treated/VBN occlusion/NN due/JJ failure/NN acute/JJ
all/DT treated/VBN occlusion/NN due/JJ failure/NN renal/JJ
all/DT treated/VBN occlusion/NN due/JJ failure/NN
trans/NNS all/DT treated/VBN occlusion/NN due/JJ failure/NN acute/JJ
trans/NNS all/DT treated/VBN occlusion/NN due/JJ failure/NN renal/JJ
trans/NNS all/DT treated/VBN occlusion/NN due/JJ failure/NN
retinoic/JJ acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN acute/JJ
retinoic/JJ acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN renal/JJ
retinoic/JJ acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN
acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN acute/JJ
acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN renal/JJ
acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN
ATRA/NNP acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN acute/JJ
ATRA/NNP acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN renal/JJ
ATRA/NNP acid/NN all/DT treated/VBN occlusion/NN due/JJ failure/NN
ATRA/NNP treated/VBN patient/NN report/VBP case/NN failure/NN acute/JJ
ATRA/NNP treated/VBN patient/NN report/VBP case/NN failure/NN renal/JJ
ATRA/NNP treated/VBN patient/NN report/VBP case/NN failure/NN
aminophylline/NN infusions/NNS received/VBD onset/NN seizures/NNS
lithium/NN therapy/NN leading/VBG hyperparathyroidism/VB
lithium/NN treated/VBN patient/NN had/VBD hypercalcemia/NN
lithium/NN %/NN IMPLICATIONS/NNP treated/VBD become/VBP hypercalcemic/JJ
methamphetamine/JJ psychosis/NNS
methamphetamine/NN factors/NNS psychosis/NNS
methamphetamine/NN risk/NN determine/VB was/VBD study/NN objective/NN OBJECTIVE/NNP psychosis/NNS
methamphetamine/JJ dependence/NN patients/NNS psychosis/NNS
methamphetamine/NN morbidity/NN association/NN induced/VBD studied/VBN psychosis/NNS
methamphetamine/NN diagnosis/NN Patients/NNS based/VBN interviewed/VBN using/VBG Interview/NNP disorders/NNS methamphetamine/JJ psychosis/NNS
methamphetamine/JJ psychosis/NNS
methamphetamine/NN uses/NNS =/NNP associated/VBN psychosis/VBZ
methamphetamine/NN associated/VBN psychosis/VBZ
methamphetamine/JJ dependence/NN patients/NNS psychosis/NNS
methamphetamine/NN use/NN co/NN personality/NN antisocial/JJ
methamphetamine/NN use/NN co/NN personality/NN
methamphetamine/JJ dependence/NN cases/NNS screened/VBN symptoms/NNS psychotic/JJ
methamphetamine/JJ dependence/NN cases/NNS screened/VBN symptoms/NNS
Aconitine/NNP induced/VBN Ca/JJ causes/VBZ apoptosis/NNS arrhythmia/NN
aconitine/NN cardiotoxicity/NN
aconitine/JJ poisoning/NN
aconitine/JJ poisoning/NN
aconitine/NN aggravates/VBZ causes/VBZ arrhythmia/NN
cromakalim/NN induced/VBN hypotension/NN
pinacidil/NN cromakalim/NN induced/VBN hypotension/NN
cromakalim/NN induced/VBN hypotension/NN vessels/NNS Vasodilation/NNP affected/VBN abolished/VBN tachycardia/NNP
pinacidil/NN cromakalim/NN induced/VBN hypotension/NN vessels/NNS Vasodilation/NNP affected/VBN abolished/VBN tachycardia/NNP
Caffeine/JJ challenge/NN test/VBP disorder/NN panic/NN
Caffeine/JJ challenge/NN test/VBP disorder/NN
Caffeine/JJ challenge/NN test/VBP attacks/NNS panic/NN
Caffeine/JJ challenge/NN test/VBP attacks/NNS
caffeine/NN test/NN respond/VB patients/NNS disorder/NN panic/NN
caffeine/NN test/NN respond/VB patients/NNS disorder/NN
caffeine/NN test/NN respond/VB patients/NNS disorder/NN PD/NNP
caffeine/NN test/NN respond/VB patients/NNS disorder/NN patients/NNS depression/NN attacks/NNS panic/NN
caffeine/NN test/NN respond/VB patients/NNS disorder/NN patients/NNS depression/NN attacks/NNS
caffeine/NN test/NN respond/VB induction/NN attacks/NNS panic/NN
caffeine/NN test/NN respond/VB induction/NN attacks/NNS
caffeine/NN sensitive/JJ patients/NNS PD/NNP
caffeine/NN observed/VBN attack/NN panic/NN
caffeine/NN observed/VBN attack/NN
caffeine/NN test/NN associated/VBN' associated/VBN is/VBZ association/NN attacks/NNS panic/NN
caffeine/NN test/NN associated/VBN' associated/VBN is/VBZ association/NN attacks/NNS
caffeine/NN test/NN associated/VBN' associated/VBN PD/NNP
trimethoprim/NN induced/VBN crisis/NN hemolytic/JJ
trimethoprim/NN induced/VBN crisis/NN anemia/NN
sulfomethoxazole/VBD year/NN girl/NN had/VBD crisis/NN hemolytic/JJ
sulfomethoxazole/VBD year/NN girl/NN had/VBD crisis/NN anemia/NN
isoproterenol/NN extract/VB investigate/VB was/VBD induced/VBN cardiotoxicity/RB
dobutamine/NN occurs/VBZ left/VBD
dobutamine/NN occurs/VBZ dysfunction/NN ventricular/NN
dobutamine/NN occurs/VBZ dysfunction/NN
dobutamine/JJ results/NNS left/VBD
dobutamine/JJ results/NNS left/VBD dysfunction/NN ventricular/NN
dobutamine/JJ results/NNS left/VBD dysfunction/NN
dobutamine/JJ results/NNS left/VBD dysfunction/NN presumed/VBN stunning/JJ myocardial/JJ
dobutamine/JJ results/NNS left/VBD dysfunction/NN presumed/VBN stunning/JJ
paracetamol/NNP due/JJ failure/NN acute/JJ
paracetamol/NNP due/JJ failure/NN liver/NN
paracetamol/NNP due/JJ failure/NN
paracetamol/NNP overdose/NNP greater/JJR patients/NNS failure/NN acute/JJ
paracetamol/NNP overdose/NNP greater/JJR patients/NNS failure/NN liver/NN
paracetamol/NNP overdose/NNP greater/JJR patients/NNS failure/NN
ibuprofen/NN hypertension/NN Pulmonary/JJ
ibuprofen/NN hypertension/NN
ibuprofen/NN administration/NN arteriosus/VBZ report/VBP cases/NNS hypoxaemia/NN
ibuprofen/NN arteriosus/VBZ report/VBP cases/NNS hypoxaemia/NN
ibuprofen/NN administration/NN occurs/VBZ hypoxaemia/NN
Neuroleptic/NNP associated/VBN hyperprolactinemia/NN
neuroleptic/JJ medications/NNS associated/VBN oligomenorrhea/NN
medications/NNS associated/VBN oligomenorrhea/NN
neuroleptic/JJ medications/NNS associated/VBN oligomenorrhea/NN treated/VBN outpatients/NNS hyperprolactinemia/NN
medications/NNS associated/VBN oligomenorrhea/NN treated/VBN outpatients/NNS hyperprolactinemia/NN
neuroleptic/JJ medications/NNS associated/VBN oligomenorrhea/NN treated/VBN outpatients/NNS hyperprolactinemia/NN amenorrhea/NN
medications/NNS associated/VBN oligomenorrhea/NN treated/VBN outpatients/NNS hyperprolactinemia/NN amenorrhea/NN
bromocriptine/NN taking/VBG developed/VBD symptoms/NNS psychiatric/JJ
bromocriptine/NN taking/VBG developed/VBD symptoms/NNS
neuroleptic/JJ galactorrhea/NNS hyperprolactinemia/NN
neuroleptic/JJ galactorrhea/NNS hyperprolactinemia/NN amenorrhea/NN
rifampicin/NN due/JJ Acute/VB
rifampicin/NN due/JJ failure/NN renal/JJ
rifampicin/NN due/JJ failure/NN
Metolachlor/NNP UNASSIGNED/NNP classified/VBN based/VBN neoplasms/NNS liver/NN
Metolachlor/NNP UNASSIGNED/NNP classified/VBN based/VBN neoplasms/NNS
metolachlor/NN liver/NN
metolachlor/NN cancer/NN
metolachlor/NN cancer/NN association/NN suggestion/NN finding/NN neoplasms/NNS liver/NN
metolachlor/NN cancer/NN association/NN suggestion/NN finding/NN neoplasms/NNS
metolachlor/NN use/NN effects/NNS up/RB follow/VB warrant/VBP findings/NNS cancer/NN liver/NN
metolachlor/NN use/NN effects/NNS up/RB follow/VB warrant/VBP findings/NNS cancer/NN
epinephrine/NN appeared/VBD VT/NNP
epinephrine/VBP dogs/NNS susceptible/JJ VT/NNP
Vigabatrin/NNP history/NN associated/JJ defects/NNS visual/JJ
Vigabatrin/NNP history/NN associated/JJ defects/NNS field/NN
Vigabatrin/NNP history/NN associated/JJ defects/NNS
Vigabatrin/NNP have/VB known/VBN patients/NNS group/NN determine/VB history/NN defects/NNS visual/JJ
Vigabatrin/NNP have/VB known/VBN patients/NNS group/NN determine/VB history/NN defects/NNS field/NN
Vigabatrin/NNP have/VB known/VBN patients/NNS group/NN determine/VB history/NN defects/NNS
Vigabatrin/NNP therapy/NN due/JJ presumed/VBN defects/NNS visual/JJ
Vigabatrin/NNP therapy/NN due/JJ presumed/VBN defects/NNS field/NN
Vigabatrin/NNP therapy/NN due/JJ presumed/VBN defects/NNS
Vigabatrin/NNP associated/VBN defects/NNS visual/JJ
Vigabatrin/NNP associated/VBN defects/NNS field/NN
Vigabatrin/NNP associated/VBN defects/NNS
dipyridamole/NN ischemia/NN myocardial/JJ
dipyridamole/NN ischemia/NN
picrotoxin/NN microperfusion/NN induced/VBN effect/NN acetate/NN seizures/NNS
picrotoxin/NN doses/NNS treated/VBN animals/NNS s/NN number/NN seizures/NNS
picrotoxin/NN doses/NNS treated/VBN animals/NNS s/NN +/VBD was/VBD duration/NN seizure/NN
picrotoxin/NN microperfusion/NN h/NN prevented/VBD seizures/NNS
Rifampicin/NNP glomerulonephritis/NNS
rifampicin/NN therapy/NN complication/NN reported/VBN glomerulonephritis/NNS
rifampicin/NN treated/VBN failure/NN acute/JJ
rifampicin/NN treated/VBN failure/NN renal/JJ
rifampicin/NN treated/VBN failure/NN
rifampicin/NN therapy/NN complication/NN literature/NN review/VB treated/VBN failure/NN acute/JJ
rifampicin/NN therapy/NN complication/NN literature/NN review/VB treated/VBN failure/NN renal/JJ
rifampicin/NN therapy/NN complication/NN literature/NN review/VB treated/VBN failure/NN
rifampicin/NN treated/VBN secondary/JJ glomerulonephritis/NNS
rifampicin/NN therapy/NN complication/NN literature/NN review/VB treated/VBN secondary/JJ glomerulonephritis/NNS
cyclophosphamide/NN induced/VBN cystitis/NNS
CYP/NNP cyclophosphamide/NN induced/VBN cystitis/NNS
puromycin/NN administration/NN developed/VBN model/NN sclerosis/NN focal/JJ
puromycin/NN administration/NN developed/VBN model/NN sclerosis/NN segmental/JJ
puromycin/NN administration/NN developed/VBN model/NN sclerosis/NN glomerular/NN
puromycin/NN administration/NN developed/VBN model/NN sclerosis/NN
aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN focal/JJ
aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN segmental/JJ
aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN glomerular/NN
aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN
puromycin/NN administration/NN developed/VBN model/NN sclerosis/NN FSGS/NNP
aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN FSGS/NNP
AMNS/NNP aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN focal/JJ
AMNS/NNP aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN segmental/JJ
AMNS/NNP aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN glomerular/NN
AMNS/NNP aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN
AMNS/NNP aminonucleoside/NN administration/NN developed/VBN model/NN sclerosis/NN FSGS/NNP
AMNS/NNS toxicity/NN enhances/VBZ produces/VBZ FSGS/NNS
AMNS/NNS toxicity/NN enhances/VBZ produces/VBZ rats/NNS resulting/VBG end/NN
AMNS/NNS toxicity/NN enhances/VBZ produces/VBZ rats/NNS disease/NN stage/NN
AMNS/NNS toxicity/NN enhances/VBZ produces/VBZ rats/NNS disease/NN renal/JJ
AMNS/NNS toxicity/NN enhances/VBZ produces/VBZ rats/NNS disease/NN
Ethambutol/NNP known/VBN cause/VB neuropathy/NN polyneuropathy/NN
Ethambutol/NNP known/VBN cause/VB neuropathy/NN optic/JJ
Ethambutol/NNP known/VBN cause/VB neuropathy/NN
ethambutol/NN dose/NN developed/VBD loss/NN paresthesias/NNS
ethambutol/NN dose/NN developed/VBD loss/NN visual/JJ
ethambutol/NN dose/NN developed/VBD loss/NN
Thalidomide/JJ sensory/JJ
Thalidomide/JJ neurotoxicity/NN
thalidomide/NN doses/NNS treated/VBN patients/NNS confirmed/VBD incidence/NN neuropathy/NN sensory/JJ
thalidomide/NN doses/NNS treated/VBN patients/NNS confirmed/VBD incidence/NN neuropathy/NN axonal/JJ
thalidomide/NN doses/NNS treated/VBN patients/NNS confirmed/VBD incidence/NN neuropathy/NN
vincristine/NN Effect/NN sulfate/VBP infections/NNS Pseudomonas/NNP
vincristine/NN Effect/NN sulfate/VBP infections/NNS
sulfate/VBP infections/NNS Pseudomonas/NNP
sulfate/VBP infections/NNS
vincristine/JJ sulfate/NN mg/NN inoculation/NN Intravenous/NNS followed/VBN leukopenia/NN
sulfate/NN mg/NN inoculation/NN Intravenous/NNS followed/VBN leukopenia/NN
methylprednisolone/JJ acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN retinal/JJ
methylprednisolone/JJ acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN
methylprednisolone/JJ acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN and/CC
methylprednisolone/JJ acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN choriocapillaris/NNS
methylprednisolone/JJ acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ
acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN retinal/JJ
acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN
acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN and/CC
acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ cases/NNS artery/NN choriocapillaris/NNS
acetate/NN injection/NN reported/VBN Two/CD occlusions/VBZ
PTU/NNP therapy/NN stopping/VBG weeks/NNS resolved/VBN symptoms/NNS fever/NN polyarthralgia/NN
PTU/NNP discontinuing/VBG increased/VBD developed/VBD fever/NN polyarthralgia/NN
PTU/NNP therapy/NN stopping/VBG weeks/NNS resolved/VBN symptoms/NNS fever/NN ulcers/NNS oral/JJ
PTU/NNP therapy/NN stopping/VBG weeks/NNS resolved/VBN symptoms/NNS fever/NN ulcers/NNS
PTU/NNP discontinuing/VBG increased/VBD developed/VBD fever/NN ulcers/NNS oral/JJ
PTU/NNP discontinuing/VBG increased/VBD developed/VBD fever/NN ulcers/NNS
PTU/NNP therapy/NN stopping/VBG weeks/NNS resolved/VBN symptoms/NNS fever/NN
PTU/NNP discontinuing/VBG increased/VBD developed/VBD fever/NN
amphetamine/NN dehydroepiandrosterone/NN Effects/NNPS models/NNS schizophrenia/NN
haloperidol/NN induced/VBN used/VBN tests/NNS catalepsy/JJ
apomorphine/NN haloperidol/NN induced/VBN used/VBN models/NNS schizophrenia/NN
Amphetamine/NNP induced/VBN apomorphine/NN haloperidol/NN induced/VBN used/VBN models/NNS schizophrenia/NN
haloperidol/NN induced/VBN used/VBN models/NNS schizophrenia/NN
haloperidol/NN groups/NNS difference/NN test/NN catalepsy/JJ
Lithium/NNP implicated/VBN changed/VBD induced/VBN DI/NNP nephrogenic/JJ
Lithium/NNP implicated/VBN changed/VBD induced/VBN DI/NNP
Lithium/NNP implicated/VBN changed/VBD focus/VB DI/NNP nephrogenic/JJ
Lithium/NNP implicated/VBN changed/VBD focus/VB DI/NNP
lithium/NN received/VBN DI/NNP nephrogenic/JJ
lithium/NN received/VBN DI/NNP
lithium/NN received/VBN DI/NNP induced/VBN changed/VBD focus/VB DI/NNP nephrogenic/JJ
lithium/NN received/VBN DI/NNP induced/VBN changed/VBD focus/VB DI/NNP
lithium/NN treating/VBG induced/VBN DI/NN nephrogenic/JJ
lithium/NN treating/VBG induced/VBN DI/NN
lithium/NN treating/VBG induced/VBN developed/VBN secondary/JJ DI/NNP neurogenic/JJ
lithium/NN treating/VBG induced/VBN developed/VBN secondary/JJ DI/NNP
isoniazid/NN induced/VBN convulsions/NNS
strophantine/JJ G/NNP used/JJ types/NNS arrhythmia/NN
G/NNP used/JJ types/NNS arrhythmia/NN
BaCl/NNP used/JJ types/NNS arrhythmia/NN
2/CD BaCl/NNP used/JJ types/NNS arrhythmia/NN
chloroform/NN BaCl/NNP used/JJ types/NNS arrhythmia/NN
adrenaline/JJ used/JJ types/NNS arrhythmia/NN
aconitine/NN used/JJ' used/JJ types/NNS arrhythmia/NN
BaCl/NNP induced/VBN' induced/VBN arrhythmia/NN inhibition/NNS causing/VBG manifests/VBZ models/NNS arrhythmia/NN
2/CD BaCl/NNP induced/VBN' induced/VBN arrhythmia/NN inhibition/NNS causing/VBG manifests/VBZ models/NNS arrhythmia/NN
BaCl/NNP induced/VBN' induced/VBN arrhythmia/NN
2/CD BaCl/NNP induced/VBN' induced/VBN arrhythmia/NN
chloroform/NN induced/VBN arrhythmia/NN inhibition/NNS causing/VBG manifests/VBZ models/NNS arrhythmia/NN
chloroform/NN induced/VBN arrhythmia/NN
adrenaline/NN chloroform/NN induced/VBN arrhythmia/NN inhibition/NNS causing/VBG manifests/VBZ models/NNS arrhythmia/NN
adrenaline/NN chloroform/NN induced/VBN arrhythmia/NN
Suxamethonium/NNP induced/VBN stiffness/NNS jaw/NN
Suxamethonium/NNP induced/VBN stiffness/NNS
Suxamethonium/NNP induced/VBN stiffness/NNS myalgia/NN
suxamethonium/NN occur/VB rigidity/NN prolonged/JJ
suxamethonium/NN occur/VB rigidity/NN jaw/NN
suxamethonium/NN occur/VB rigidity/NN
suxamethonium/NN occur/VB rigidity/NN myalgia/NN
diethylpropion/NN efficacy/NN evaluating/VBG study/NN subject/NN man/NN became/VBD manic/JJ
DEP/NNP man/NN became/VBD manic/JJ
DEP/NNP different/JJ observed/VBD subjects/NNS become/VB manic/JJ
1/CD induced/VBN syndrome/NN Milk/NN
1/CD induced/VBN syndrome/NN alkali/JJ
1/CD induced/VBN syndrome/NN
25/CD 1/CD induced/VBN syndrome/NN Milk/NN
25/CD 1/CD induced/VBN syndrome/NN alkali/JJ
25/CD 1/CD induced/VBN syndrome/NN
OH/NNP 1/CD induced/VBN syndrome/NN Milk/NN
OH/NNP 1/CD induced/VBN syndrome/NN alkali/JJ
OH/NNP 1/CD induced/VBN syndrome/NN
2/CD D/NNS 1/CD induced/VBN syndrome/NN Milk/NN
2/CD D/NNS 1/CD induced/VBN syndrome/NN alkali/JJ
2/CD D/NNS 1/CD induced/VBN syndrome/NN
D/NNS 1/CD induced/VBN syndrome/NN Milk/NN
D/NNS 1/CD induced/VBN syndrome/NN alkali/JJ
D/NNS 1/CD induced/VBN syndrome/NN
calcium/NN amounts/NNS described/VBN Milk/NN
calcium/NN amounts/NNS described/VBN syndrome/NN alkali/NN
calcium/NN amounts/NNS described/VBN syndrome/NN
alkali/NN calcium/NN amounts/NNS described/VBN Milk/NN
alkali/NN calcium/NN amounts/NNS described/VBN syndrome/NN alkali/NN
alkali/NN calcium/NN amounts/NNS described/VBN syndrome/NN
calcitriol/NN carbonate/NN treated/VBN resulting/VBG hospital/NN milk/NN
calcitriol/NN carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN alkali/JJ
calcitriol/NN carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN
calcium/NN carbonate/NN treated/VBN resulting/VBG hospital/NN milk/NN
calcium/NN carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN alkali/JJ
calcium/NN carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN
carbonate/NN treated/VBN resulting/VBG hospital/NN milk/NN
carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN alkali/JJ
carbonate/NN treated/VBN hypoparathyroidism/NN syndrome/NN
epirubicine/NN cardiotoxicity/NN
streptozotocin/JJ rats/NNS diabetic/JJ
isoproterenol/NN study/NN induced/VBN fibrosis/NN
streptozotocin/NN diabetes/NN
ISO/NNP given/VBN appeared/VBD analyzed/VBN fibrosis/NNP
ISO/NNP fibrosis/NNP
streptozotocin/NN causes/VBZ points/VBZ effect/NN sensitivity/NN rats/NNS diabetic/JJ
puromycin/NN nephropathy/NN
aminonucleoside/NN nephropathy/NN
puromycin/NN aminonucleoside/NN nephropathy/RB
aminonucleoside/NN nephropathy/RB
puromycin/NN aminonucleoside/NN exacerbates/VBZ model/NN disease/NN glomerular/NN
puromycin/NN aminonucleoside/NN exacerbates/VBZ model/NN disease/NN
aminonucleoside/NN exacerbates/VBZ model/NN disease/NN glomerular/NN
aminonucleoside/NN exacerbates/VBZ model/NN disease/NN
PAN/NNP aminonucleoside/NN nephropathy/RB
PAN/NNP aminonucleoside/NN exacerbates/VBZ model/NN disease/NN glomerular/NN
PAN/NNP aminonucleoside/NN exacerbates/VBZ model/NN disease/NN
PAN/NNP nephropathy/NN
PAN/NNP injections/NNS induced/VBN glomerulopathy/NN
PAN/NNP nephropathy/NN
PAN/NNP animals/NNS nephropathy/NN
PAN/NNP nephropathy/NN
PAN/NN nephropathy/NN
fluorescein/NN injection/NN followed/VBD Tonic/NNP
fluorescein/NN injection/NN followed/VBD seizures/NNS clonic/JJ
fluorescein/NN injection/NN followed/VBD seizures/NNS
quinine/JJ infusion/NN getting/VBG reported/VBN presented/VBD arrhythmia/NN contraction/NN premature/JJ
quinine/JJ infusion/NN getting/VBG reported/VBN presented/VBD arrhythmia/NN contraction/NN ventricular/NN
quinine/JJ infusion/NN getting/VBG reported/VBN presented/VBD arrhythmia/NN contraction/NN
quinine/JJ infusion/NN hours/NNS felt/VBD showed/VBD >/VBD contraction/NN premature/JJ
quinine/JJ infusion/NN hours/NNS felt/VBD showed/VBD >/VBD contraction/NN ventricular/NN
quinine/JJ infusion/NN hours/NNS felt/VBD showed/VBD >/VBD contraction/NN
quinine/JJ infusion/NN hours/NNS felt/VBD showed/VBD >/VBD contraction/NN PVC/NNP
Quinine/RB alkaloid/NN arrhythmia/NN PVC/NNP
suxamethonium/NN pains/NNS
scoline/JJ pain/NN
scoline/JJ pain/NN
scoline/JJ pain/NN
scoline/JJ pain/NN occurrence/NN influence/VB abolition/NN fasciculations/NNS
suxamethonium/NN preparation/NN type/NN used/VBD affected/VBD incidence/NN pain/NN
scoline/JJ pain/NN
iAs/NN exposure/NN development/NN relationship/NN cancer/NN
iAs/NN exposure/NN life/NN OBJECTIVES/NNS research/NN underlie/VB risk/NN development/NN cancer/NN
iAs/NN elicits/NNS DISCUSSION/NNP Epigenetic/NNP reprogramming/VBG plausible/JJ changes/NNS expression/NN development/NN cells/NNS cancer/NN
iAs/NN exposure/NN development/NN cancer/NN
phenylpropanolamine/NN antagonism/NN hypertension/NN
Phenylpropanolamine/NNP cause/VB hypertension/NN
PPA/NNP Phenylpropanolamine/NNP cause/VB hypertension/NN
PPA/NNP treatment/NN hypertension/NN
hepatitis/NN carriers/NNS DNA/NN hepatitis/NNP
hepatitis/NN carriers/NNS DNA/NN B/NNP
B/NN carriers/NNS DNA/NN hepatitis/NNP
B/NN carriers/NNS DNA/NN B/NNP
surface/NN carriers/NNS DNA/NN hepatitis/NNP
surface/NN carriers/NNS DNA/NN B/NNP
antigen/NN carriers/NNS DNA/NN hepatitis/NNP
antigen/NN carriers/NNS DNA/NN B/NNP
methimazole/NN case/NN hepatitis/NN cases/NNS necrosis/NNS hepatocellular/NN
methimazole/NN case/NN hepatitis/NN cases/NNS necrosis/NNS
propylthiouracil/NN cases/NNS hepatitis/NN
propylthiouracil/NN case/NN necrosis/NNS cases/NNS hepatitis/NN
propylthiouracil/NN cases/NNS associated/VBN lupus/NNS
propylthiouracil/NN cases/NNS described/VBN syndrome/NN like/IN
propylthiouracil/NN cases/NNS described/VBN syndrome/NN
propylthiouracil/NN case/NN necrosis/NNS cases/NNS associated/VBN lupus/NNS
propylthiouracil/NN case/NN necrosis/NNS cases/NNS described/VBN syndrome/NN like/IN
propylthiouracil/NN case/NN necrosis/NNS cases/NNS described/VBN syndrome/NN
Fluconazole/VB agranulocytosis/NNS
Fluconazole/VB agranulocytosis/NNS thrombocytopenia/NN
fluconazole/JJ agranulocytosis/NNS
fluconazole/JJ agranulocytosis/NNS thrombocytopenia/NN
fluconazole/NN therapy/NN result/NN probable/JJ occurred/VBD algorithm/VBP agranulocytosis/VBZ
fluconazole/NN therapy/NN result/NN probable/JJ occurred/VBD thrombocytopenia/NN
Indomethacin/NNP induced/VBN hyperkalemia/NN
indomethacin/NN developed/VBD severe/JJ life/NN hyperkalemia/NN
indomethacin/NN developed/VBD severe/JJ life/NN hyperkalemia/NN insufficiency/NN renal/JJ
indomethacin/NN developed/VBD severe/JJ life/NN hyperkalemia/NN insufficiency/NN
Cephalothin/NNP induced/VBN anemia/NN hemolytic/JJ
Cephalothin/NNP induced/VBN anemia/NN
cephalothin/NN therapy/NN receiving/VBG anemia/NN hemolytic/JJ
cephalothin/NN therapy/NN receiving/VBG anemia/NN
levodopa/NN dyskinesias/NNS
levodopa/NN dyskinesias/NNS LIDs/NNP
acetaminophen/NN celecoxib/JJ patients/NNS reactions/NNS skin/NN
acetaminophen/NN celecoxib/JJ patients/NNS reactions/NNS
paracetamol/NNP acetaminophen/NN celecoxib/JJ patients/NNS reactions/NNS skin/NN
paracetamol/NNP acetaminophen/NN celecoxib/JJ patients/NNS reactions/NNS
nimesulide/NN celecoxib/JJ patients/NNS reactions/NNS skin/NN
nimesulide/NN celecoxib/JJ patients/NNS reactions/NNS
P/NNP reactions/NNS cutaneous/NNS
P/NNP reactions/NNS
N/NNP P/NNP reactions/NNS cutaneous/NNS
N/NNP P/NNP reactions/NNS
P/NNP diagnosis/NN based/VBN reactions/NNS skin/NN
P/NNP diagnosis/NN based/VBN reactions/NNS
N/NNP P/NNP diagnosis/NN based/VBN reactions/NNS skin/NN
N/NNP P/NNP diagnosis/NN based/VBN reactions/NNS
ibuprofen/NN administration/NN followed/VBN pain/NN
ibuprofen/NN administration/NN followed/VBN pain/NN increase/NN correlates/NNS pain/NN
ibuprofen/NN administration/NN followed/VBN indicating/VBG interaction/NN stimuli/NNS pain/NN
ibuprofen/NN effect/NN indicating/VBG followed/VBN pain/NN
ibuprofen/NN effect/NN indicating/VBG followed/VBN pain/NN increase/NN correlates/NNS pain/NN
ibuprofen/NN effect/NN indicating/VBG interaction/NN stimuli/NNS pain/NN
risperidone/NN 0/CD 8/CD induced/NNP N/NNP hyperprolactinemia/NNP
risperidone/NN pseudoprolactinoma/NN associated/VBN 0/CD hyperprolactinemia/NN
adriamycin/NN induced/VBN injury/NN mitochondrial/JJ
adriamycin/NN induced/VBN injury/NN
ADR/NNP HNE/NNP showed/VBD point/NN appeared/VBD injury/NN mitochondrial/JJ
ADR/NNP HNE/NNP showed/VBD point/NN appeared/VBD injury/NN
Vincristine/NNP use/NN reported/VBN hormone/NN Hyponatremia/NN
Vincristine/NNP use/NN reported/VBN hormone/NN Hyponatremia/NN syndrome/NN
Vincristine/NNP use/NN reported/VBN hormone/NN Hyponatremia/NN anti/NNS of/IN
Vincristine/NNP use/NN reported/VBN hormone/NN Hyponatremia/NN anti/NNS inappropriate/JJ
Vincristine/NNP use/NN reported/VBN hormone/NN Hyponatremia/NN anti/NNS
Vincristine/NNP use/NN reported/VBN hormone/NN diuretic/JJ
Vincristine/NNP use/NN reported/VBN hormone/NN
vincristine/NN hormone/NN secretion/NN syndrome/NN rate/NN hyponatremia/NN
vincristine/NN hormone/NN secretion/NN syndrome/NN
vincristine/NN hormone/NN secretion/NN of/IN
vincristine/NN hormone/NN secretion/NN inappropriate/JJ
vincristine/NN hormone/NN secretion/NN
vincristine/NN hormone/NN secretion/NN anti/NNS of/IN
vincristine/NN hormone/NN secretion/NN anti/NNS
vincristine/NN hormone/NN diuretic/JJ
vincristine/NN hormone/NN
vincristine/NN hormone/NN SIADH/NNP
vincristine/NN use/NN reported/VBN reported/VBD cases/NNS hyponatremia/NN
vincristine/NN use/NN reported/VBN reported/VBD cases/NNS SIADH/NNP
vincristine/JJ use/NN associated/VBN SIADH/NNP cases/NNS hyponatremia/NN
vincristine/JJ use/NN associated/VBN SIADH/NNP
vincristine/JJ use/NN associated/VBN suggest/VBP risk/NN hyponatremia/NN
vincristine/JJ use/NN associated/VBN suggest/VBP SIADH/RB
vincristine/NN associated/VBN SIADH/NNP
desvenlafaxine/NN associated/VBN Syndrome/NNP
desvenlafaxine/NN associated/VBN Syndrome/NNP secretion/NN of/IN
desvenlafaxine/NN associated/VBN Syndrome/NNP secretion/NN inappropriate/JJ
desvenlafaxine/NN associated/VBN Syndrome/NNP secretion/NN antidiuretic/JJ
desvenlafaxine/NN associated/VBN Syndrome/NNP secretion/NN hormone/NN
desvenlafaxine/NN associated/VBN secretion/NNS case/NN syndrome/NN
desvenlafaxine/NN associated/VBN secretion/NNS case/NN syndrome/NN anti/NNS of/IN
desvenlafaxine/NN associated/VBN secretion/NNS case/NN syndrome/NN anti/NNS inappropriate/JJ
desvenlafaxine/NN associated/VBN secretion/NNS case/NN syndrome/NN anti/NNS
desvenlafaxine/NN associated/VBN secretion/NNS diuretic/JJ
desvenlafaxine/NN associated/VBN secretion/NNS hormone/NN
desvenlafaxine/NN associated/VBN secretion/NNS SIADH/NNP
desvenlafaxine/JJ included/VBD included/VBD nausea/NN confusion/NN
desvenlafaxine/JJ included/VBD included/VBD nausea/NN anxiety/NN
desvenlafaxine/JJ included/VBD included/VBD nausea/NN
desvenlafaxine/NN cause/VB hyponatremia/NN
kanamycin/NN protects/NNS zinc/NN induced/VBN hearing/VBG
kanamycin/NN protects/NNS zinc/NN induced/VBN hearing/VBG loss/NN
paclitaxel/JJ combination/NN dosed/VBN appear/VB add/VB toxicities/NNS hematologic/JJ
paclitaxel/JJ combination/NN dosed/VBN appear/VB add/VB toxicities/NNS
doxorubicin/NN demonstrated/VBN agent/NN limiting/VBG erythrodysesthesia/NN
doxorubicin/NN demonstrated/VBN hand/VB
doxorubicin/NN demonstrated/VBN hand/VB foot/NN -/JJ
doxorubicin/NN demonstrated/VBN hand/VB foot/NN
doxorubicin/NN demonstrated/VBN hand/VB syndrome/NN
Doxil/NNP doxorubicin/NN demonstrated/VBN agent/NN limiting/VBG erythrodysesthesia/NN
Doxil/NNP doxorubicin/NN demonstrated/VBN hand/VB
Doxil/NNP doxorubicin/NN demonstrated/VBN hand/VB foot/NN -/JJ
Doxil/NNP doxorubicin/NN demonstrated/VBN hand/VB foot/NN
Doxil/NNP doxorubicin/NN demonstrated/VBN hand/VB syndrome/NN
doxorubicin/NN demonstrated/VBN stomatitis/VBZ
Doxil/NNP doxorubicin/NN demonstrated/VBN stomatitis/VBZ
doxorubicin/NN results/NNS toxicity/NN stomatitis/NNS hand/NN
doxorubicin/NN results/NNS toxicity/NN stomatitis/NNS syndrome/NN foot/NN
doxorubicin/NN results/NNS toxicity/NN stomatitis/NNS syndrome/NN
doxorubicin/NN results/NNS toxicity/NN stomatitis/NNS
tropicamide/NN dilation/VBN effect/NN pupil/NN
tropicamide/NN dilation/VBN
tropicamide/VBP dilation/NN pupil/NN
tropicamide/VBP dilation/NN
Zidovudine/NNP induced/VBN hepatitis/NN
zidovudine/NNP patient/NN induced/VBN hepatitis/NN
caffeine/NN exposure/NN induce/VB retardation/NN intrauterine/JJ
caffeine/NN exposure/NN induce/VB retardation/NN growth/NN
caffeine/NN exposure/NN induce/VB retardation/NN
caffeine/NN exposure/NN induce/VB retardation/NN IUGR/NNP
Sotalol/NNP induced/VBN spasm/NN coronary/JJ
Sotalol/NNP induced/VBN spasm/NN
sotalol/NN properties/NNS blocking/VBG induced/VBN vasospasm/NNP Coronary/NNP
sotalol/NN properties/NNS blocking/VBG induced/VBN vasospasm/NNP
GTN/NNP administration/NN pressure/NN drop/NN
GTN/NNP administration/NN pressure/NN drop/NN blood/NN in/IN
GTN/NNP administration/NN pressure/NN drop/NN blood/NN
GTN/NNP administration/NN pressure/NN
GTN/NNP minutes/NNS experienced/VBD drop/NN
GTN/NNP minutes/NNS experienced/VBD pressure/NN in/IN
GTN/NNP minutes/NNS experienced/VBD pressure/NN blood/NN
GTN/NNP minutes/NNS experienced/VBD pressure/NN
isradipine/NN reported/VBD frequent/JJ headache/NN
isradipine/NN reported/VBD frequent/JJ headache/NN flushing/NN
isradipine/NN reported/VBD frequent/JJ headache/NN dizziness/NN
bupivacaine/NN doses/NNS increase/VB shown/VBN Pre/VBN induced/VBN cardiotoxicity/RB
bupivacaine/NN alleviate/VB shown/VBN Pre/VBN induced/VBN cardiotoxicity/RB
bupivacaine/NN induced/VBN cardiotoxicity/RB
bupivacaine/JJ consumption/NN amount/NN asystole/VB
bupivacaine/NN onset/NN delayed/VBN treatment/NN pre/NN induced/VBN effects/NNS cardiotoxic/JJ
bupivacaine/NN levels/NNS effects/NNS cardiotoxic/JJ
suxamethonium/NN apnea/NN
suxamethonium/VB characterized/VBN apnea/NN
mivacurium/VB suxamethonium/VB characterized/VBN deficiency/NN Butyrylcholinesterase/JJ
mivacurium/VB suxamethonium/VB characterized/VBN deficiency/NN
mivacurium/VB suxamethonium/VB characterized/VBN apnea/NN
suxamethonium/VB characterized/VBN deficiency/NN Butyrylcholinesterase/JJ
suxamethonium/VB characterized/VBN deficiency/NN
phenylephrine/NN effect/NN ischemia/NN hypertension/NN
phenylephrine/NN effect/NN determined/VBN min/NN occlusion/NN rats/NNS hypertensive/NN
phenylephrine/NN effect/NN induced/VBN hypertension/NN
phenobarbital/JJ administration/NN linked/VBD proliferation/NN hepatomegaly/NN
thalidomide/NN completed/VBD men/NNS found/VBN evidence/NN neuropathy/NN peripheral/JJ
thalidomide/NN completed/VBD men/NNS found/VBN evidence/NN neuropathy/NN
thalidomide/NN option/NN patients/NNS failed/VBN maintained/VBN development/NN neuropathy/NN peripheral/JJ
thalidomide/NN option/NN patients/NNS failed/VBN maintained/VBN development/NN neuropathy/NN
bortezomib/NN fasciitis/NNS Necrotising/VBG
bortezomib/NN fasciitis/NNS
dexamethasone/NN bortezomib/NN fasciitis/NNS Necrotising/VBG
dexamethasone/NN bortezomib/NN fasciitis/NNS
bortezomib/JJ dose/NN treatment/NN suffered/VBD fasciitis/NNS necrotising/JJ
bortezomib/JJ dose/NN treatment/NN suffered/VBD fasciitis/NNS
dexamethasone/JJ dose/NN treatment/NN suffered/VBD fasciitis/NNS necrotising/JJ
dexamethasone/JJ dose/NN treatment/NN suffered/VBD fasciitis/NNS
argatroban/NN bleeding/NN
5/CD cisplatin/NN receiving/VBG patients/NNS Hypotension/NNP
fluorouracil/VBP Hypotension/NNP
cisplatin/NN receiving/VBG patients/NNS Hypotension/NNP
5/CD cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
fluorouracil/NN 5/CD cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
5/CD fluorouracil/NN 5/CD cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
FU/NNP 5/CD fluorouracil/NN 5/CD cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
CDDP/NNP cisplatin/NN treated/VBN developed/VBD symptoms/NNS hypotension/NN
vincristine/NN Syndrome/NNP
vincristine/NN Syndrome/NNP secretion/NN of/IN
vincristine/NN Syndrome/NNP secretion/NN inappropriate/JJ
vincristine/NN Syndrome/NNP secretion/NN
vincristine/NN Syndrome/NNP hormone/NN of/IN
vincristine/NN Syndrome/NNP hormone/NN antidiuretic/JJ
vincristine/NN Syndrome/NNP hormone/NN
vincristine/JJ infusion/NN attributed/VBN hormone/NN secretion/NN syndrome/NN
vincristine/JJ infusion/NN attributed/VBN hormone/NN secretion/NN of/IN
vincristine/JJ infusion/NN attributed/VBN hormone/NN secretion/NN inappropriate/JJ
vincristine/JJ infusion/NN attributed/VBN hormone/NN secretion/NN
vincristine/JJ infusion/NN attributed/VBN hormone/NN of/IN
vincristine/JJ infusion/NN attributed/VBN hormone/NN antidiuretic/JJ
vincristine/JJ infusion/NN attributed/VBN hormone/NN
methylphenidate/NN syndrome/NN Neuroleptic/VB
methylphenidate/NN syndrome/NN malignant/JJ
methylphenidate/NN syndrome/NN
methylphenidate/NN caused/VBN syndrome/NN neuroleptic/JJ
methylphenidate/NN caused/VBN syndrome/NN malignant/JJ
methylphenidate/NN caused/VBN syndrome/NN
methylphenidate/NN caused/VBN syndrome/NN neuroleptic/JJ
methylphenidate/NN caused/VBN syndrome/NN malignant/JJ
methylphenidate/NN caused/VBN syndrome/NN
Minocycline/NNP induced/VBN fulfilling/VBG criteria/NNS nodosa/NN polyarteritis/JJ
Minocycline/NNP induced/VBN fulfilling/VBG criteria/NNS nodosa/NN
fluoxetine/JJ treatment/NN associated/VBN Mania/NNP
fluoxetine/NN reported/VBN induce/VB mania/NN
fluoxetine/NN developed/VBD mania/NN
fluoxetine/JJ pharmacotherapy/NN mania/NN
fluoxetine/JJ pharmacotherapy/NN mania/NN hypomania/NN
fluoxetine/JJ pharmacotherapy/NN mania/NN development/NN factors/NNS combination/NN disorder/NN bipolar/JJ
fluoxetine/JJ pharmacotherapy/NN mania/NN development/NN factors/NNS combination/NN disorder/NN
fluoxetine/JJ pharmacotherapy/NN mania/NN development/NN factors/NNS combination/NN diagnosis/NN disorder/NNP bipolar/NNP
fluoxetine/JJ pharmacotherapy/NN mania/NN development/NN factors/NNS combination/NN diagnosis/NN disorder/NNP
fluoxetine/VB mania/NN
sumatriptan/NN Transmural/VB infarction/NN myocardial/JJ
sumatriptan/NN Transmural/VB infarction/NN
sumatriptan/NN subcutaneously/NN administration/NN describe/VBP 47/CD woman/NN infarction/NN myocardial/JJ
sumatriptan/NN subcutaneously/NN administration/NN describe/VBP 47/CD woman/NN infarction/NN
warfarin/NN induced/VBN epiphyses/NNS hypoplasia/JJ stippled/JJ
warfarin/NN induced/VBN epiphyses/NNS
warfarin/NN induced/VBN epiphyses/NNS punctata/NN chondrodysplasia/NN
warfarin/NN induced/VBN epiphyses/NNS punctata/NN
warfarin/NN treated/VBN mothers/NNS born/VBN infants/NNS reported/VBN hypoplasia/NN epiphyses/NNS stippled/JJ
warfarin/NN treated/VBN mothers/NNS born/VBN infants/NNS reported/VBN hypoplasia/NN epiphyses/NNS
d/SYM antagonists/NNS induced/VBN hypotension/NN
tubocurarine/NN antagonists/NNS induced/VBN hypotension/NN
carmustine/NN explore/VB aimed/VBN study/NN dysfunction/NN cognitive/NN
carmustine/NN explore/VB aimed/VBN study/NN dysfunction/NN
BCNU/NNP carmustine/NN explore/VB aimed/VBN study/NN dysfunction/NN cognitive/NN
BCNU/NNP carmustine/NN explore/VB aimed/VBN study/NN dysfunction/NN
biperiden/VB due/JJ Bradycardia/NNP
biperiden/NN induced/VBN Bradycardia/NNP
verapamil/RB resulting/VBG block/NN atrioventricular/JJ
verapamil/RB resulting/VBG block/NN AV/NNP
verapamil/RB resulting/VBG block/NN
clonidine/NN interaction/NN cases/NNS report/VB resulting/VBG block/NN hypotension/NN
clonidine/NN interaction/NN cases/NNS report/VB resulting/VBG block/NN atrioventricular/JJ
clonidine/NN interaction/NN cases/NNS report/VB resulting/VBG block/NN AV/NNP
clonidine/NN interaction/NN cases/NNS report/VB resulting/VBG block/NN
verapamil/RB resulting/VBG block/NN hypotension/NN
clonidine/NN dose/NN addition/NN developed/VBD block/NN hypotension/NN
clonidine/NN dose/NN addition/NN developed/VBD block/NN AV/NNP
clonidine/NN dose/NN addition/NN developed/VBD block/NN
clonidine/NN bid/NN addition/NN developed/VBD block/NN AV/NN
clonidine/NN bid/NN addition/NN developed/VBD block/NN
melphalan/VBN dose/NN Acute/VB
melphalan/VBN dose/NN Acute/VB insufficiency/NN renal/JJ
melphalan/VBN dose/NN Acute/VB insufficiency/NN
melphalan/NN conditioning/NN noted/VBN development/NN insufficiency/NN acute/JJ
melphalan/NN conditioning/NN noted/VBN development/NN insufficiency/NN renal/JJ
melphalan/NN conditioning/NN noted/VBN development/NN insufficiency/NN
melphalan/NN defined/VBN high/NN insufficiency/NN Acute/JJ
melphalan/NN defined/VBN high/NN insufficiency/NN renal/JJ
melphalan/NN defined/VBN high/NN insufficiency/NN
melphalan/NN defined/VBN high/NN insufficiency/NN ARI/NNP
melphalan/NN dose/NN RESULTS/NNS developed/VBD ARI/NNP
melphalan/NN underwent/VBD Patients/NNS had/VBD ARI/NNP
melphalan/NN suggests/VBZ timing/NN injury/NN renal/JJ
melphalan/NN suggests/VBZ timing/NN injury/NN
melphalan/NN injury/NN renal/JJ
melphalan/NN injury/NN
Acetaminophen/NNP produces/VBZ necrosis/NNS tubular/JJ
Acetaminophen/NNP produces/VBZ necrosis/NNS
APAP/NNP Acetaminophen/NNP produces/VBZ necrosis/NNS tubular/JJ
APAP/NNP Acetaminophen/NNP produces/VBZ necrosis/NNS
APAP/NNP induced/VBN necrosis/NNS renal/JJ
APAP/NNP induced/VBN necrosis/NNS tubular/JJ
APAP/NNP induced/VBN necrosis/NNS
PAP/NNP formation/NN accounts/VBZ APAP/NNP induced/VBN necrosis/NNS renal/JJ
PAP/NNP formation/NN accounts/VBZ APAP/NNP induced/VBN necrosis/NNS tubular/JJ
PAP/NNP formation/NN accounts/VBZ APAP/NNP induced/VBN necrosis/NNS
Epsilon/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN subarachnoid/JJ
Epsilon/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN
aminocaproic/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN subarachnoid/JJ
aminocaproic/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN
acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN subarachnoid/JJ
acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN
Epsilon/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN SAH/NNP
aminocaproic/JJ acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN SAH/NNP
acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN SAH/NNP
EACA/NNP acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN subarachnoid/JJ
EACA/NNP acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN
EACA/NNP acid/NN used/VBN prevent/VB rebleeding/VBG patients/NNS hemorrhage/NN SAH/NNP
EACA/NNP therapy/NN complications/NNS thrombotic/JJ
EACA/NNP treated/VBN syndromes/NNS included/VBN thrombi/NNS
EACA/NNP treated/VBN syndromes/NNS included/VBN deterioration/NN thrombosis/NNS intracranial/JJ
EACA/NNP treated/VBN syndromes/NNS included/VBN deterioration/NN thrombosis/NNS vascular/NN
EACA/NNP treated/VBN syndromes/NNS included/VBN deterioration/NN thrombosis/NNS
EACA/NNP treated/VBN syndromes/NNS included/VBN thrombi/NNS arteriolar/NN SAH/NN
EACA/NNP implicated/VBN observed/VBN thrombi/NNS
EACA/NNP implicated/VBN pathogenesis/NNS thrombi/NNS
EACA/NNP therapy/NN occurred/VBD patient/NN SAH/NNP
EACA/NNP therapy/NN occurred/VBD patient/NN documentation/NN SAH/NNP
acetaminophen/NN edema/NN cerebral/JJ
acetaminophen/NN edema/NN
acetaminophen/NN edema/NN based/VBN unit/NN facility/NN 27/CD female/NN FHF/NNP
acetaminophen/NN edema/NN cerebral/JJ
acetaminophen/NN edema/NN
acetaminophen/NN confirmed/VBD FHF/NNP
acetaminophen/NN overdose/NN edema/NN cerebral/JJ
acetaminophen/NN overdose/NN edema/NN
acetaminophen/NN overdose/NN edema/NN patients/NNS FHF/NNP
ketoconazole/NN using/VBG presented/VBN eruption/NN maculopapular/NN
ketoconazole/NN using/VBG presented/VBN eruption/NN
heparin/NN Incidence/NNP II/NNP thrombocytopenia/NN
heparin/NN Incidence/NNP II/NNP type/NN
heparin/NN Incidence/NNP II/NNP
heparin/NN impact/NN induced/VBN II/NNP thrombocytopenia/NNP
heparin/NN impact/NN induced/VBN II/NNP type/NN
heparin/NN impact/NN induced/VBN II/NNP
heparin/NN impact/NN induced/VBN II/NNP II/NNP HIT/NNP
heparin/NN impact/NN induced/VBN II/NNP II/NNP type/NNP
heparin/NN impact/NN induced/VBN II/NNP II/NNP
heparin/NN impact/NN induced/VBN cause/NN thrombocytopenia/NN
heparin/NN use/NN avoided/VBN reduction/NN II/NNP HIT/NNP
heparin/NN use/NN avoided/VBN reduction/NN II/NNP type/NN
heparin/NN use/NN avoided/VBN reduction/NN II/NNP
heparin/VBN weight/NN performed/VBN avoided/VBN reduction/NN II/NNP HIT/NNP
heparin/VBN weight/NN performed/VBN avoided/VBN reduction/NN II/NNP type/NN
heparin/VBN weight/NN performed/VBN avoided/VBN reduction/NN II/NNP
morphine/NN administration/NN nystagmus/NNS Downbeat/JJ
morphine/NN administration/NN nystagmus/NNS
morphine/NN controlled/VBD IMPLICATIONS/NNS case/NN documents/VBZ patient/NN developed/VBD downbeating/VBG
morphine/NN controlled/VBD IMPLICATIONS/NNS case/NN documents/VBZ patient/NN developed/VBD downbeating/VBG nystagmus/NNS
morphine/NN controlled/VBD IMPLICATIONS/NNS case/NN documents/VBZ patient/NN developed/VBD dizziness/NN
cyclosporine/NN recipients/VBZ infections/NNS
cyclosporine/JJ patients/NNS had/VBD infections/NNS
cyclosporine/JJ patients/NNS had/VBD infections/NNS infections/NNS
Aza/NNP patients/NNS had/VBD infections/NNS
Aza/NNP patients/NNS had/VBD infections/NNS infections/NNS
cyclosporine/JJ patients/NNS infections/JJ
cyclosporine/JJ patients/NNS infections/JJ infections/NNS
Aza/JJ patients/NNS had/VBD infections/NNS infections/JJ
Aza/JJ patients/NNS had/VBD infections/NNS
cyclosporine/NN patients/NNS deaths/NNS were/VBD played/VBD infection/NN
Aza/NN cyclosporine/NN patients/NNS deaths/NNS were/VBD played/VBD infection/NN
cyclosporine/NN common/JJ infections/NNS
Aza/NNP treated/VBN cyclosporine/NN common/JJ infections/NNS
Flurothyl/JJ ether/NN produced/VBD hypothermia/NN
Flurothyl/JJ ether/NN produced/VBD unclear/JJ relationship/NN hypothermia/NN
flurothyl/JJ exposure/NN duration/NN correlated/VBN hypothermia/NN
flurothyl/JJ exposure/NN duration/NN correlated/VBN hypothermia/NN produced/VBD unclear/JJ relationship/NN hypothermia/NN
aspirin/NN analgesic/NN use/NN Studies/NNS drugs/NNS end/NN
aspirin/NN analgesic/NN use/NN Studies/NNS BACKGROUND/NNP stage/VBP
aspirin/NN analgesic/NN use/NN Studies/NNS BACKGROUND/NNP stage/VBP given/VBN disease/NN renal/JJ
aspirin/NN analgesic/NN use/NN Studies/NNS BACKGROUND/NNP stage/VBP given/VBN disease/NN
aspirin/NN analgesic/NN use/NN Studies/NNS BACKGROUND/NNP stage/VBP given/VBN disease/NN ESRD/NNP
aspirin/NN associated/VBN ESRD/NNP
aspirin/NN use/NN increase/VB risk/NN ESRD/NNP
sirolimus/NNS role/NN anemia/NN
Sirolimus/NNS implicated/VBN playing/VBG anemia/NN
rapamycin/NN inhibitor/NN target/NN Sirolimus/NNS implicated/VBN playing/VBG anemia/NN
sirolimus/NNS associated/VBN anemia/NN
clonidine/NN brain/NN pathway/NN Participation/NNP hypotension/NN
clonidine/NN brain/NN pathway/NN Participation/NNP hypotension/NN bradycardia/NN
clonidine/NN induced/VBN antagonized/VBN hypotension/NN
clonidine/NN bradycardia/NN
clonidine/VB reduced/VBD magnitude/NN vasodepressor/NN responses/NNS bradycardiac/JJ
clonidine/NN development/NN involved/VBN hypotension/NN
clonidine/NN development/NN involved/VBN hypotension/NN bradycardia/NN
heparin/NN aspects/NNS thrombocytopenia/NN
heparin/NN therapy/NN thrombocytopenia/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN hypoaldosteronism/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN hypoaldosteronism/NN
heparin/JJ osteoporosis/NNS alopecia/NN hypoaldosteronism/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS
heparin/JJ osteoporosis/NNS
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS eosinophilia/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS eosinophilia/NN
heparin/JJ osteoporosis/NNS eosinophilia/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS skin/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS skin/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS
heparin/JJ osteoporosis/NNS reactions/NNS skin/NN
heparin/JJ osteoporosis/NNS reactions/NNS
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN hyperkalemia/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN hyperkalemia/NN
heparin/JJ osteoporosis/NNS alopecia/NN hyperkalemia/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN
heparin/JJ osteoporosis/NNS alopecia/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN thrombocytopenia/JJ
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS thrombocytopenia/NN
heparin/NN induced/VBN thrombocytopenia/JJ
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS thrombocytopenia/NN
heparin/JJ induced/VBN thrombocytopenia/JJ
heparin/JJ osteoporosis/NNS reactions/NNS thrombocytopenia/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN priapism/NN
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS alopecia/NN priapism/NN
heparin/JJ osteoporosis/NNS alopecia/NN priapism/NN
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS allergic/JJ
heparin/NN therapy/NN effects/NNS include/VBP heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS allergic/JJ
heparin/NN induced/VBN heparin/JJ osteoporosis/NNS reactions/NNS
heparin/JJ osteoporosis/NNS reactions/NNS allergic/JJ
heparin/JJ osteoporosis/NNS reactions/NNS
heparin/NN use/NN common/JJ osteoporosis/JJ
dobutamine/NN response/NN Hypertensive/JJ
dobutamine/NN studies/NNS occurred/VBD response/NN hypertensive/JJ
dobutamine/JJ infusion/NN had/VBD had/VBD history/NN hypertension/NN
cocaine/NN amount/NN causes/VBZ deterioration/NN
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN of/IN
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN left/JJ
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN LV/NNP
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN function/NN systolic/JJ
cocaine/NN amount/NN causes/VBZ deterioration/NN ventricular/NN function/NN
cocaine/NN infusion/NN causes/VBZ performance/NN deterioration/NN
cocaine/NN infusion/NN causes/VBZ performance/NN deterioration/NN LV/NNP of/IN
cocaine/NN infusion/NN causes/VBZ performance/NN deterioration/NN LV/NNP
cocaine/NN infusion/NN causes/VBZ performance/NN systolic/JJ
cocaine/NN infusion/NN causes/VBZ performance/NN systolic/JJ and/CC
cocaine/NN infusion/NN causes/VBZ performance/NN systolic/JJ diastolic/JJ
cocaine/NN infusion/NN causes/VBZ performance/NN
digoxin/NN has/VBZ effects/NNS increasing/VBG causing/VBG arrhythmias/NNS
indomethacin/NN induced/VBN Hyperkalemia/NNP
naproxen/NN indomethacin/NN induced/VBN Hyperkalemia/NNP
indomethacin/NN caused/VBN hypoaldosteronism/NN
mefenamic/JJ nephropathy/NN
acid/JJ nephropathy/NN
indomethacin/NN caused/VBN hypoaldosteronism/NN hyperkalemia/JJ
naproxen/NN indomethacin/NN caused/VBN hypoaldosteronism/NN
naproxen/NN indomethacin/NN caused/VBN hypoaldosteronism/NN hyperkalemia/JJ
indomethacin/NN therapy/NN allowing/VBG correcting/VBG hyperkalemia/NN
etomidate/NN prove/VB hypnotic/NN choice/NN technique/NN adults/NNS incidence/NN myoclonia/NN
amisulpride/JJ overdose/NN cases/NNS cause/NN syndrome/NN prolonged/VBN
amisulpride/JJ overdose/NN cases/NNS cause/NN syndrome/NN QT/NNP
amisulpride/JJ overdose/NN cases/NNS cause/NN syndrome/NN
Caffeine/NNP produced/VBD subject/JJ anxiety/NN tremors/NNS
Caffeine/NNP produced/VBD subject/JJ anxiety/NN
Caffeine/NNP produced/VBD subject/JJ anxiety/NN nausea/NN
caffeine/NN avoiding/VBG benefit/VB Patients/NNS disorders/NNS anxiety/NN
caffeine/NN avoiding/VBG benefit/VB Patients/NNS disorders/NNS
levodopa/NN factors/NNS dyskinesia/NN
levodopa/NN therapy/NN leads/VBZ development/NN fluctuations/NNS dyskinesia/NNS
levodopa/NN predictors/NNS dyskinesia/NN
levodopa/NN therapy/NN present/JJ Dyskinesia/NNP
levodopa/NN therapy/NN duration/NN age/NN had/VBD Patients/NNS dyskinesia/NN
levodopa/NN therapy/NN duration/NN age/NN had/VBD dyskinesia/NN
levodopa/NN dose/NN total/NN age/NN had/VBD Patients/NNS dyskinesia/NN
levodopa/NN dose/NN total/NN age/NN had/VBD dyskinesia/NN
levodopa/NN therapy/NN duration/NN predictors/NNS dyskinesia/NN
levodopa/NN dose/NN therapy/NN duration/NN predictors/NNS dyskinesia/NN
levodopa/NN prevalence/NN CONCLUSIONS/NNS %/NN dyskinesia/NN
tranexamic/JJ acid/NN seizures/NNS convulsive/NN
acid/NN seizures/NNS convulsive/NN
tranexamic/JJ acid/NN seizures/NNS
acid/NN seizures/NNS
tranexamic/JJ acid/NN aorta/NN ascending/VBG calcification/NN surgery/NN redo/VB included/VBD predictors/NNS seizures/NNS
acid/NN aorta/NN ascending/VBG calcification/NN surgery/NN redo/VB included/VBD predictors/NNS seizures/NNS
tranexamic/JJ acid/NN predictor/NN seizures/NNS
acid/NN predictor/NN seizures/NNS
tranexamic/JJ acid/NN factor/NN weighed/VBN risk/NN seizures/NNS
acid/NN factor/NN weighed/VBN risk/NN seizures/NNS
cimetidine/NN caused/VBN hypotension/NN
cimetidine/NN activity/NN mediated/VBN useful/JJ preventing/VBG hypotension/NN
DOX/NNP induced/VBN failure/NN heart/NN
DOX/NNP induced/VBN failure/NN
Methyldopa/NNP induced/VBN anemia/NN hemolytic/JJ
Methyldopa/NNP induced/VBN anemia/NN
methyldopa/NN case/NN report/VBP syncope/VBP anemia/NN hemolytic/JJ
methyldopa/NN case/NN report/VBP syncope/VBP anemia/NN
DOCA/NNP pathogenesis/NNS plays/VBZ hypertension/NN
DOCA/NNP treated/VBN hypertension/NN
lithium/NN rats/NNS substantial/JJ hypertension/NN treated/VBN insipidus/NNS diabetes/NN
lithium/NN rats/NNS substantial/JJ hypertension/NN treated/VBN insipidus/NNS
warfarin/NN anticoagulant/NN causing/VBG hemorrhage/NN intracerebral/JJ
warfarin/NN anticoagulant/NN causing/VBG hemorrhage/NN
haloperidol/NN releasing/VBG induced/VBN hyperprolactinemia/NN
haloperidol/JJ infusions/NNS course/NN found/VBN hyperprolactinemia/NN
levobupivacaine/NN injection/NN seizures/NNS grand/JJ
levobupivacaine/NN injection/NN seizures/NNS mal/NN
levobupivacaine/NN injection/NN seizures/NNS
levobupivacaine/NN %/NN microgram/NN mL/NN administration/NN developed/VBD seizures/NNS grand/JJ
levobupivacaine/NN %/NN microgram/NN mL/NN administration/NN developed/VBD seizures/NNS mal/NN
levobupivacaine/NN %/NN microgram/NN mL/NN administration/NN developed/VBD seizures/NNS
morphine/NN induced/VBN hyperactivity/NN
morphine/JJ prevented/VBN blockers/NNS K/NNP induced/VBN morphine/NN induced/VBN hyperactivity/NN
morphine/NN prevent/VB sufficient/JJ suggested/VBN induced/VBN morphine/JJ seems/VBZ hyperactivity/RB
morphine/JJ seems/VBZ hyperactivity/RB
temsirolimus/VBZ patchy/NN limited/VBN found/VBN areas/NNS compatible/JJ post/NN repair/NN necrotic/JJ
Adrenaline/NNP induced/VBN used/VBN hypertension/NN
adrenaline/NN giving/VBG using/VBG evaluated/VBN BBB/NNP destroy/VB used/VBN hypertension/NN
levobupivacaine/JJ received/VBD occurred/VBD collapse/NN cardiovascular/JJ
levobupivacaine/JJ received/VBD occurred/VBD collapse/NN
apomorphine/JJ amnesia/NN
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN learning/VBG
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN and/CC
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN post/NN
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN training/VBG
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN training/VBG deficits/NNS consolidation/NN
scopolamine/JJ attenuates/VBZ derivative/NN induced/VBN training/VBG deficits/NNS
apomorphine/NN inhibits/VBZ evaluated/VBN amnesia/NN
apomorphine/NN induced/VBN amnesia/NN
suxamethonium/NN injection/NN spasm/NN muscle/NN
suxamethonium/NN injection/NN spasm/NN
Dimer/NNP had/VBD incidence/NN nausea/NN dizziness/NN
X/NNP group/NN had/VBD incidence/NN nausea/NN dizziness/NN
Dimer/NNP had/VBD incidence/NN nausea/NN
X/NNP group/NN had/VBD incidence/NN nausea/NN
Endografine/NNP group/NN had/VBD incidence/NN pain/NN abdominal/JJ
Endografine/NNP group/NN had/VBD incidence/NN pain/NN
Quetiapine/NNP induced/VBN neutropenia/NN
Quetiapine/NNP derivative/NN has/VBZ risk/NN causing/VBG dyscrasias/NNS neutropenia/NN
quetiapine/NN developed/VBD neutropenia/NN
quetiapine/NN treated/VBN developed/VBD leucopenia/NN
quetiapine/NN effect/NN neutropenia/NN
quetiapine/VB marker/NN fever/NN
capsaicin/NN injections/NNS glutamate/NN variability/NN hyperalgesia/NN
capsaicin/NN injections/NNS glutamate/NN variability/NN hyperalgesia/NN allodynia/NN
capsaicin/NN glutamate/NN injections/NNS attractive/JJ use/VB mimic/VBP hyperalgesia/NN
capsaicin/NN glutamate/NN injections/NNS attractive/JJ use/VB mimic/VBP hyperalgesia/NN allodynia/NN
capsaicin/NN detected/VBN hyperalgesia/NN
Capsaicin/NN injection/NN reproducible/JJ hyperalgesia/NN secondary/JJ
Capsaicin/NN injection/NN reproducible/JJ hyperalgesia/NN
Capsaicin/NN injection/NN reproducible/JJ hyperalgesia/NN allodynia/NN
capsaicin/NN conclusion/NN yield/VB hyperalgesic/JJ
capsaicin/NN conclusion/NN yield/VB hyperalgesic/JJ responses/NNS allodynic/JJ
corticosteroid/VBD treated/VBN carcinoma/NNP Hepatocellular/NNP
corticosteroid/VBD treated/VBN carcinoma/NNP
androgen/NN treated/VBN carcinoma/NNP Hepatocellular/NNP
androgen/NN treated/VBN carcinoma/NNP
corticosteroid/VBD non/VBP metastasizing/VBG develop/VB neoplasms/NNS peliosis/NNS
androgen/NN patients/NNS develop/VB neoplasms/NNS peliosis/NNS
vigabatrin/VB specific/JJ defects/NNS Binasal/JJ
vigabatrin/VB specific/JJ defects/NNS visual/JJ
vigabatrin/VB specific/JJ defects/NNS field/NN
vigabatrin/VB specific/JJ defects/NNS
vigabatrin/NN associated/VBN defects/NNS visual/JJ
vigabatrin/NN associated/VBN defects/NNS
VGB/NNP vigabatrin/NN associated/VBN defects/NNS visual/JJ
VGB/NNP vigabatrin/NN associated/VBN defects/NNS
VGB/NNP associated/VBN toxicity/NN retinal/JJ
VGB/NNP associated/VBN toxicity/NN
pilocarpine/NN seizures/NNS
pilocarpine/NN installation/NN frequency/NN epilepticus/NNS status/NN
pilocarpine/NN installation/NN frequency/NN epilepticus/NNS
pilocarpine/NN installation/NN frequency/NN epilepticus/NNS demonstrated/VBD seizure/NN
non/NN inhibitors/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
non/NN inhibitors/NNS risk/NN infarction/NN myocardial/JJ
non/NN inhibitors/NNS risk/NN infarction/NN
steroidal/JJ anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
steroidal/JJ anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ
steroidal/JJ anti/NNS OBJECTIVES/NNS risk/NN infarction/NN
anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ
anti/NNS OBJECTIVES/NNS risk/NN infarction/NN
inflammatory/JJ drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
inflammatory/JJ drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ
inflammatory/JJ drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN
drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN myocardial/JJ
drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN
non/NN inhibitors/NNS risk/NN infarction/NN AMI/NNP
steroidal/JJ anti/NNS OBJECTIVES/NNS risk/NN infarction/NN AMI/NNP
anti/NNS OBJECTIVES/NNS risk/NN infarction/NN AMI/NNP
inflammatory/JJ drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN AMI/NNP
drugs/NNS anti/NNS OBJECTIVES/NNS risk/NN infarction/NN AMI/NNP
COX/NNP risk/NN infarction/NN myocardial/JJ acute/JJ
COX/NNP risk/NN infarction/NN myocardial/JJ
COX/NNP risk/NN infarction/NN
2/CD inhibitors/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
2/CD inhibitors/NNS risk/NN infarction/NN myocardial/JJ
2/CD inhibitors/NNS risk/NN infarction/NN
inhibitors/NNS risk/NN infarction/NN myocardial/JJ acute/JJ
inhibitors/NNS risk/NN infarction/NN myocardial/JJ
inhibitors/NNS risk/NN infarction/NN
COX/NNP risk/NN infarction/NN AMI/NNP
2/CD inhibitors/NNS risk/NN infarction/NN AMI/NNP
inhibitors/NNS risk/NN infarction/NN AMI/NNP
COX/NNP NSAIDs/NNP using/VBG bleeding/VBG risks/NNS hospitalization/NN AMI/NNP
2/CD inhibitors/NNS NSAIDs/NNP using/VBG bleeding/VBG risks/NNS hospitalization/NN AMI/NNP
inhibitors/NNS NSAIDs/NNP using/VBG bleeding/VBG risks/NNS hospitalization/NN AMI/NNP
rofecoxib/NN group/NN acetaminophen/NN GI/VBP non/NN users/NNS aspirin/NN ratios/NNS hospitalization/NN AMI/NNP
naproxen/NNP 1/CD 27/CD group/NN acetaminophen/NN GI/VBP non/NN users/NNS aspirin/NN ratios/NNS hospitalization/NN AMI/NNP
naproxen/NN seemed/VBN carry/VB risk/NN GI/NNP
naproxen/NN seemed/VBN carry/VB risk/NN GI/NNP bleeding/VBG
naproxen/NN seemed/VBN carry/VB risk/NN GI/NNP AMI/NNP
rofecoxib/NNP those/DT better/JJR seemed/VBD similar/JJ AMI/NNP
methotrexate/NN Paraplegia/NNP
methotrexate/NN instillation/NN paraplegia/NN
5/CD doses/NNS receiving/VBG patients/NNS patients/NNS' patients/NNS seen/VBN levels/NNS onset/NN hyperammonemia/NN
FU/NNP doses/NNS receiving/VBG patients/NNS patients/NNS' patients/NNS seen/VBN levels/NNS onset/NN hyperammonemia/NN
levodopa/NN rigidity/NN induced/VBN underwent/VBD dyskinesias/NNS
levodopa/NN dose/NN reduction/NN useful/JJ drug/NN
levodopa/NN dose/NN reduction/NN useful/JJ dyskinesias/JJ induced/RB
levodopa/NN dose/NN reduction/NN useful/JJ dyskinesias/JJ
cyclophosphamide/NN treated/VBN had/VBN hematuria/NN
cyclophosphamide/JJ abnormalities/NNS indistinguishable/JJ carcinoma/NN
VNR/NNP events/NNS risk/NN similar/JJ vindesine/VB VDS/NNP drugs/NNS cardiotoxic/JJ
fluoxetine/VBP occlusion/VBP vein/NN retinal/JJ
fluoxetine/VBP occlusion/VBP vein/NN
fluoxetine/VBP occlusion/VBP
fluoxetine/NN associated/VBN case/NN occlusion/NN retinal/JJ
fluoxetine/NN associated/VBN case/NN occlusion/NN vein/NN
fluoxetine/NN associated/VBN case/NN occlusion/NN
fluoxetine/NN associated/VBN described/VBN hypertension/NN
nafcillin/NN nephritis/NNS interstitial/JJ
nafcillin/NN nephritis/NNS
quetiapine/VBN doses/NNS high/JJ add/VBP agitation/NN
quetiapine/NN introduction/NN h/NN presented/VBD agitation/NN
quetiapine/NN reintroduction/NN withdrawal/NN led/VBN agitation/NN
quetiapine/NN reintroduction/NN withdrawal/NN enabled/VBD attribute/VB agitation/NN
quetiapine/VB attribute/VB enabled/VBD withdrawal/NN led/VBN agitation/NN
quetiapine/VB attribute/VB agitation/NN
glibenclamide/NN 1/CD fold/NNP 4/CD treatment/NN associated/VBN hazard/NN developing/VBG CAD/NNP
glibenclamide/NN treatment/NN CONCLUSIONS/NNS associated/VBN risk/NN CAD/NNP
ecstasy/JJ users/NNS Dysfunctional/VB
ecstasy/JJ users/NNS Dysfunctional/VB consolidation/NN overnight/JJ
ecstasy/JJ users/NNS Dysfunctional/VB consolidation/NN memory/NN
ecstasy/JJ users/NNS marked/VBN neurocognitive/NN sleep/NN
ecstasy/JJ users/NNS marked/VBN neurocognitive/NN impairments/NNS related/JJ
ecstasy/JJ users/NNS marked/VBN neurocognitive/NN impairments/NNS
Ecstasy/JJ users/NNS demonstrated/VBD consolidation/NN impaired/VBN
Ecstasy/JJ users/NNS demonstrated/VBD consolidation/NN overnight/JJ
Ecstasy/JJ users/NNS demonstrated/VBD consolidation/NN memory/NN
ecstasy/NN suggest/VBP underlie/VB impairments/NNS memory/NN
ecstasy/NN suggest/VBP underlie/VB impairments/NNS
ecstasy/NN users/NNS underlie/VB impairments/NNS memory/NN
ecstasy/NN users/NNS underlie/VB impairments/NNS
carboplatin/NN chemotherapy/NN treated/VBN patients/NNS motility/NN abnormal/JJ
carboplatin/NN chemotherapy/NN treated/VBN patients/NNS motility/NN ocular/NN
carboplatin/NN chemotherapy/NN treated/VBN patients/NNS motility/NN
carboplatin/NN received/VBN retinoblastoma/NN noted/VBD motility/NN abnormal/JJ
carboplatin/NN received/VBN retinoblastoma/NN noted/VBD motility/NN ocular/NN
carboplatin/NN received/VBN retinoblastoma/NN noted/VBD motility/NN
carboplatin/NNP associated/VBN fibrosis/NN
heparin/NN patient/NN alteplase/NN thrombolysis/NNS Use/NN thrombocytopenia/NN
heparin/NN induced/VBN thrombocytopenia/NN
heparin/NN embolism/NN pulmonary/JJ
heparin/NN embolism/NN
heparin/NN embolism/NN venous/NNS upper/NN induced/VBN thrombocytopenia/NN
heparin/NN embolism/NN venous/NNS thrombosis/NNS DVT/NNP
valproic/JJ acid/NN dementia/NN
acid/NN dementia/NN
valproic/JJ year/NN induced/VBN documented/VBN dementia/NN
acid/JJ year/NN induced/VBN documented/VBN dementia/NN
valproic/JJ acid/NN effect/NN system/NN effect/NN mediated/VBN hyperammonemia/NN
acid/NN effect/NN system/NN effect/NN mediated/VBN hyperammonemia/NN
valproic/JJ hyperammonemia/NN
acid/JJ hyperammonemia/NN
amphetamine/NN seizures/NNS
cocaine/NN incidence/NN seizures/NNS
amphetamine/VBP reducing/VBG incidence/NN seizures/NNS
cocaine/NN induced/VBN seizures/NNS
CE/NNP levels/NNS associated/VBN decrease/NN
CE/NNP levels/NNS associated/VBN decrease/NN output/NN in/IN
CE/NNP levels/NNS associated/VBN decrease/NN output/NN cardiac/JJ
CE/NNP levels/NNS associated/VBN decrease/NN output/NN
caffeine/NN doses/NNS scored/VBN characteristics/NNS activity/NN induction/NN clonic/JJ
caffeine/NN doses/NNS scored/VBN characteristics/NNS activity/NN induction/NN seizure/NN
pilocarpine/NN induced/VBN epilepticus/NNS status/NN
pilocarpine/NN induced/VBN epilepticus/NNS
Pilo/NNP pilocarpine/NN induced/VBN epilepticus/NNS status/NN
Pilo/NNP pilocarpine/NN induced/VBN epilepticus/NNS
carbamazepine/NN had/VBD had/VBD myocarditis/NNS
diazinon/NN activation/NN hyperlipemia/NN
diazinon/NN induced/VBN hyperlipemia/NN
ADR/NNP nephropathy/NN clearance/NN uraemia/NN
ADR/NNP progression/NN rate/NN induced/VBN glomerulosclerosis/NNS focal/JJ
ADR/NNP progression/NN rate/NN induced/VBN glomerulosclerosis/NNS segmental/JJ
ADR/NNP progression/NN rate/NN induced/VBN glomerulosclerosis/NNS
AVP/NNP effects/NNS rats/NNS hypertensive/NN
arginine/NN vasopressin/NN influence/NN compare/VB peptide/NN rats/NNS normotensive/JJ hypertensive/JJ
vasopressin/NN influence/NN compare/VB peptide/NN rats/NNS normotensive/JJ hypertensive/JJ
AVP/NNP vasopressin/NN influence/NN compare/VB peptide/NN rats/NNS normotensive/JJ hypertensive/JJ
phenylephrine/NN determined/VBN induced/VBN nitroprusside/NN hypertension/NN
Phe/NNP phenylephrine/NN determined/VBN induced/VBN nitroprusside/NN hypertension/NN
sodium/NN hypertension/NN nitroprusside/NN induced/VBN determined/VBN hypotension/NN
nitroprusside/NN induced/VBN determined/VBN hypotension/NN
SN/NNP nitroprusside/NN induced/VBN determined/VBN hypotension/NN
SN/NNP reduced/VBN hypotension/NN
hydroxychloroquine/NN taking/VBG patients/NNS loss/NN visual/JJ
hydroxychloroquine/NN taking/VBG patients/NNS loss/NN field/NN
hydroxychloroquine/NN taking/VBG patients/NNS loss/NN
hydroxychloroquine/VB attributed/VBN abnormalities/NNS visual/JJ
hydroxychloroquine/VB attributed/VBN abnormalities/NNS field/NN
hydroxychloroquine/VB attributed/VBN abnormalities/NNS
haloperidol/NN role/NN induced/VBN catalepsy/RB
pilocarpine/NN cholinomimetic/NN doses/NNS induce/VB catalepsy/RB
haloperidol/NN blocker/NN induced/VBN catalepsy/NN
pilocarpine/NN doses/NNS caused/VBD enhancement/NN catalepsy/NN
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/NN
haloperidol/NN neuroleptics/NNS produced/VBN catalepsy/NN
lorazepam/NN therapy/NN associated/VBN Myoclonus/NNS
lorazepam/NN administration/NN myoclonus/NNS
lithium/NN therapy/NN developed/VBD bradyarrhythmia/NN hypercalcemia/JJ
lithium/NN therapy/NN receiving/VBG patient/NN findings/NNS prompted/VBD conduct/VB lithium/NN associated/VBN hypercalcemia/NN
lithium/NN conduct/VB prompted/VBD findings/NNS patient/NN receiving/VBG therapy/NN developed/VBD bradyarrhythmia/NN hypercalcemia/JJ
lithium/NN associated/VBN hypercalcemia/NN
lithium/NN non/NN identified/VBD eliminating/VBG hypercalcemias/NNS
lithium/NN non/NN treated/VBN hypercalcemias/NNS
lithium/NN non/NN hypercalcemia/NN
lithium/NN patients/NNS conditions/NNS malignancies/NNS related/VBN hypercalcemias/NNS treated/VBN non/NN identified/VBD eliminating/VBG hypercalcemias/NNS
lithium/NN patients/NNS conditions/NNS malignancies/NNS related/VBN hypercalcemias/NNS
lithium/NN patients/NNS conditions/NNS malignancies/NNS related/VBN hypercalcemias/NNS treated/VBN non/NN hypercalcemia/NN
lithium/NN resulting/VBG Patients/NNS hypercalcemia/NN
lithium/NN resulting/VBG had/VBD hypercalcemia/NN
botox/NN injection/NN dysphonia/NN adductor/JJ
botox/NN injection/NN dysphonia/NN spasmodic/JJ
botox/NN injection/NN dysphonia/NN
Botox/NNP injections/NNS standard/NN care/NN dysphonia/NN adductor/NN
Botox/NNP injections/NNS standard/NN care/NN dysphonia/NN spasmodic/JJ
Botox/NNP injections/NNS standard/NN care/NN dysphonia/NN
Botox/NNP injections/NNS standard/NN care/NN dysphonia/NN ADSD/NNP
Botox/NNP injections/NNS ADSD/NNP
Botox/NNP receiving/VBG diagnosed/VBN ADSD/NNP
Botox/NNP injection/NN ADSD/NNP
Botox/NNP injections/NNS ADSD/NNP
pilocarpine/NN seizures/NNS
pilocarpine/JJ injections/NNS induced/VBN seizures/NNS
Fluvastatin/NNP Therapy/NNP Injury/NNP Drug/NNP
Fluvastatin/NNP Therapy/NNP Injury/NNP Induced/NNP
Fluvastatin/NNP Therapy/NNP Injury/NNP Acute/NNP
Fluvastatin/NNP Therapy/NNP Injury/NNP Liver/NNP
Fluvastatin/NNP Therapy/NNP Injury/NNP
fluvastatin/NN beginning/VBG appeared/VBD damage/NN liver/NN
fluvastatin/NN beginning/VBG appeared/VBD damage/NN
picrotoxin/NN aspartate/NN N/NNP induced/VBN convulsions/NNS observed/VBN observed/VBN convulsions/NNS
picrotoxin/NN aspartate/NN N/NNP induced/VBN convulsions/NNS
bemegride/NN pentylenetetrazole/NN induced/VBN convulsions/NNS
bemegride/NN pentylenetetrazole/NN induced/VBN convulsions/NNS observed/VBN observed/VBN convulsions/NNS
pentylenetetrazole/NN induced/VBN convulsions/NNS
pentylenetetrazole/NN induced/VBN convulsions/NNS observed/VBN observed/VBN convulsions/NNS
aracytine/NN dose/NN edema/NN shock/NN
C/NNP edema/NN shock/NN
aracytine/NN dose/NN edema/NN Pulmonary/JJ
aracytine/NN dose/NN edema/NN
C/NNP edema/NN Pulmonary/JJ
C/NNP edema/NN
Ara/NNP C/NNS associated/VBN hypothesize/VBP thought/VBN involved/VBN development/NN shock/NN
C/NNS associated/VBN hypothesize/VBP thought/VBN involved/VBN development/NN shock/NN
azathioprine/NN effects/NNS include/VBP anemia/NN
Azathioprine/NNP triggers/VBZ death/NN effect/NN contributing/VBG azathioprine/VB anemia/NN
azathioprine/VB anemia/NN
diethylstilbesterol/NN evidence/NN induced/VBN carcinomas/NNS renal/JJ
diethylstilbesterol/NN evidence/NN induced/VBN carcinomas/NNS
diethylstilbesterol/NN induced/VBN carcinomas/NNS renal/JJ
diethylstilbesterol/NN induced/VBN carcinomas/NNS
TDF/NNP criteria/NNS records/NNS found/VBN had/VBD syndrome/NN Fanconi/NNP
TDF/NNP criteria/NNS records/NNS found/VBN had/VBD syndrome/NN
TDF/NNP effects/NNS hospitalisation/NN incidence/NN high/JJ patients/NNS features/NNS syndrome/NN Fanconi/NNP
TDF/NNP effects/NNS hospitalisation/NN incidence/NN high/JJ patients/NNS features/NNS syndrome/NN
carbamazepine/NN associated/VBN cases/NNS nystagmus/NNS oscillopsia/NNS
Succimer/NNP chelation/NNP improves/VBZ exposed/VBD produces/VBZ impairment/NN cognitive/NN
Succimer/NNP chelation/NNP improves/VBZ exposed/VBD produces/VBZ impairment/NN
rifampicin/NN reintroduction/NN induced/VBN failure/NN 3/CD thrombopenia/NN hemolysis/NNS
rifampicin/NN reintroduction/NN induced/VBN failure/NN 3/CD thrombopenia/NN
isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN induced/VBN infarction/NN
isoproterenol/NN prevented/VBN treatment/NN pre/NN induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN prevented/VBN treatment/NN pre/NN induced/VBN infarction/NN
isoproterenol/NN induced/VBN effect/NN chebula/NNP injury/NN myocardial/JJ
isoproterenol/NN induced/VBN effect/NN chebula/NNP injury/NN
isoproterenol/NN induced/VBN damage/NN myocardial/JJ
isoproterenol/NN induced/VBN damage/NN
L/NNP observed/VBN Hypokalemia/NNP
dopa/NNP L/NNP observed/VBN Hypokalemia/NNP
L/NNP influence/NN studied/VBN patients/NNS hypokalemia/NN
dopa/NN L/NNP influence/NN studied/VBN patients/NNS hypokalemia/NN
diethylcarbamazine/NN loiasis/NNS cases/NNS encephalitis/NN
diethylcarbamazine/NN treatment/NN encephalitis/NN
DEC/NNP diethylcarbamazine/NN treatment/NN encephalitis/NN
bromocriptine/VBP infarction/NN myocardial/JJ
bromocriptine/VBP infarction/NN
Bromocriptine/NNP implicated/VBN reports/NNS infarction/NN myocardial/JJ
Bromocriptine/NNP implicated/VBN reports/NNS infarction/NN
vincristine/NN administration/NN due/JJ myeloencephalopathy/RB
Vincristine/NNP given/VBN producing/VBG encephalopathy/NN
Vincristine/NNP given/VBN producing/VBG dysfunction/NN sensory/JJ
Vincristine/NNP given/VBN producing/VBG dysfunction/NN sensory/JJ and/CC
Vincristine/NNP given/VBN producing/VBG dysfunction/NN sensory/JJ motor/NN
Vincristine/NNP given/VBN producing/VBG dysfunction/NN
mirtazapine/NN associated/VBN syndrome/NN restless/JJ
mirtazapine/NN associated/VBN syndrome/NN legs/NNS
mirtazapine/NN associated/VBN syndrome/NN
Mirtazapine/NNP associated/VBN RLS/NNP
mirtazapine/NN RLS/NNP
mirtazapine/NN treated/VBN have/VB symptoms/NNS RLS/NNP
mirtazapine/NN treated/VBN have/VB started/VBD resolved/VBN symptoms/NNS RLS/NNP
mirtazapine/NN discontinuation/NN resolved/VBN started/VBD have/VB symptoms/NNS RLS/NNP
mirtazapine/NN discontinuation/NN resolved/VBN symptoms/NNS RLS/NNP
mirtazapine/NN use/NN symptoms/NNS RLS/NNP
mirtazapine/NN use/NN relationship/NN support/VB effect/NN domperione/NN RLS/NNP
mirtazapine/NN domperione/NN effect/NN support/VB relationship/NN use/NN symptoms/NNS RLS/NNP
mirtazapine/NN domperione/NN RLS/NNP
mirtazapine/NN associated/VBN RLS/NNP
vitamin/NN E/NN lacking/VBG diet/NN giving/VBG induced/VBN myodystrophy/RB
E/NN lacking/VBG diet/NN giving/VBG induced/VBN myodystrophy/RB
oral/JJ contraceptives/NNS hypertension/NN association/NN artery/NN aneurysm/NN dissecting/JJ
oral/JJ contraceptives/NNS hypertension/NN association/NN artery/NN aneurysm/NN
contraceptives/NNS hypertension/NN association/NN artery/NN aneurysm/NN dissecting/JJ
contraceptives/NNS hypertension/NN association/NN artery/NN aneurysm/NN
adriamycin/NN ribose/JJ d/SYM induced/VBN myocardiopathy/RB
Famotidine/NNP associated/VBN delirium/NN
famotidine/NN associated/VBN reported/VBD shown/VBN propensity/NN cause/VB delirium/NN
famotidine/NN cases/NNS report/NN delirium/NN
famotidine/NN removal/NN cleared/VBD delirium/NN
thiopentone/NN use/NN associated/VBN eight/CD risk/NN 4/CD delirium/NN
lindane/NN induced/VBN role/NN oxide/NN convulsions/NNS
lindane/NN dose/NN elicited/VBN convulsion/NN shortened/VBN increased/VBN incidence/NN convulsion/JJ
lindane/NN dose/NN elicited/VBN convulsion/NN
lindane/NN dose/NN convulsion/VB decreased/VBD incidence/NN convulsion/NN
lindane/NN dose/NN convulsion/VB
lindane/NN dose/NN convulsive/JJ
lindane/JJ seizures/NNS
galactose/NN treatment/NN prevents/VBZ deficits/NNS cognitive/JJ
galactose/NN treatment/NN prevents/VBZ deficits/NNS
streptozotocin/NN treated/VBN rats/NNS prevents/VBZ deficits/NNS cognitive/JJ
streptozotocin/NN treated/VBN rats/NNS prevents/VBZ deficits/NNS
glucose/NN transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP
glucose/NN transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP '/POS
glucose/NN transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN s/JJ
glucose/NN transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN disease/NN
glucose/NN GLUT/NNP transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP
glucose/NN GLUT/NNP transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP '/POS
glucose/NN GLUT/NNP transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN s/JJ
glucose/NN GLUT/NNP transport/NN followed/VBN system/NN dysfunction/NN associated/VBN dementia/NN type/NN disease/NN
glucose/NN metabolism/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP
glucose/NN metabolism/NN dysfunction/NN associated/VBN dementia/NN type/NN Alzheimer/NNP '/POS
glucose/NN metabolism/NN dysfunction/NN associated/VBN dementia/NN type/NN s/JJ
glucose/NN metabolism/NN dysfunction/NN associated/VBN dementia/NN type/NN disease/NN
galactose/NN effects/NNS treatment/NN deficits/NNS cognitive/JJ
galactose/NN effects/NNS treatment/NN deficits/NNS
streptozotocin/NN deficits/NNS cognitive/JJ
streptozotocin/NN deficits/NNS
STZ/NNP induced/NN treatment/NN deficits/NNS cognitive/JJ
STZ/NNP induced/NN treatment/NN deficits/NNS
galactose/NN treatment/NN month/NN icv/VBP deficits/NNS cognitive/NN
galactose/NN treatment/NN month/NN icv/VBP deficits/NNS
STZ/NNP initiated/VBN treatment/NN month/NN icv/VBP deficits/NNS cognitive/NN
STZ/NNP initiated/VBN treatment/NN month/NN icv/VBP deficits/NNS
STZ/NNP development/NN prevented/VBN administration/NN month/NN icv/VBP deficits/NNS cognitive/NN
STZ/NNP development/NN prevented/VBN administration/NN month/NN icv/VBP deficits/NNS
galactose/NN exposure/NN have/VB worth/JJ investigating/VBG improvement/NN deficits/NNS cognitive/JJ
galactose/NN exposure/NN have/VB worth/JJ investigating/VBG improvement/NN deficits/NNS
isoproterenol/NN injection/NN induced/VBN injury/NN myocardial/JJ
isoproterenol/NN injection/NN induced/VBN injury/NN ischemic/JJ
isoproterenol/NN injection/NN induced/VBN injury/NN
isoproterenol/NN induced/VBN ischemia/NN myocardial/JJ
isoproterenol/NN induced/VBN ischemia/NN
puromycin/NN nephrosis/NNS
aminonucleoside/NN nephrosis/NNS
puromycin/NN aminonucleoside/NN prevented/VBD inhibited/VBD angiotensin/NN converting/VBG inhibitor/NN proteinuria/NN
aminonucleoside/NN prevented/VBD inhibited/VBD angiotensin/NN converting/VBG inhibitor/NN proteinuria/NN
PAN/NNP aminonucleoside/NN prevented/VBD inhibited/VBD angiotensin/NN converting/VBG inhibitor/NN proteinuria/NN
PAN/NNP injection/NN induced/VBN Nephrosis/NNS
PAN/NNP rats/NNS neprotic/JJ
thiotepa/NN chemotherapy/NN polyneuropathy/NN
thiotepa/NN combination/NN administration/NN related/VBN toxicity/NN neurologic/JJ
thiotepa/NN combination/NN administration/NN related/VBN toxicity/NN
TSPA/NNP combination/NN administration/NN related/VBN toxicity/NN neurologic/JJ
TSPA/NNP combination/NN administration/NN related/VBN toxicity/NN
methotrexate/NN TSPA/NNP described/VBN toxicities/NNS Neurologic/JJ
methotrexate/NN TSPA/NNP described/VBN toxicities/NNS
cytosine/JJ arabinoside/JJ IT/PRP methotrexate/NN TSPA/NNP described/VBN toxicities/NNS Neurologic/JJ
cytosine/JJ arabinoside/JJ IT/PRP methotrexate/NN TSPA/NNP described/VBN toxicities/NNS
arabinoside/JJ IT/PRP methotrexate/NN TSPA/NNP described/VBN toxicities/NNS Neurologic/JJ
arabinoside/JJ IT/PRP methotrexate/NN TSPA/NNP described/VBN toxicities/NNS
TSPA/NNP described/VBN toxicities/NNS Neurologic/JJ
TSPA/NNP described/VBN toxicities/NNS
MTX/NNP combination/NN cause/VB neurotoxicity/NN
ara/NN MTX/NNP combination/NN cause/VB neurotoxicity/NN
C/NNP MTX/NNP combination/NN cause/VB neurotoxicity/NN
TSPA/NNP agent/NN fact/NN spite/NN cause/VB neurotoxicity/NN
galantamine/NN well/JJ headaches/NNS
Valproate/NNP induced/VBN encephalopathy/NN hyperammonemic/JJ
Valproate/NNP induced/VBN effect/NN encephalopathy/NN hyperammonemic/JJ
valproate/JJ treatment/NN effect/NN encephalopathy/NN hyperammonemic/JJ
valproate/NN describe/VBP revealed/VBD hyperammonemia/NN
valproate/NN describe/VBP revealed/VBD consciousness/NN impaired/VBN
valproate/NN describe/VBP revealed/VBD consciousness/NN
D/NNP induced/VBN hyperactivity/NN
amphetamine/RB reduced/VBN induced/VBN hyperactivity/NN
Amiodarone/NNP mass/NN pulmonary/JJ
Amiodarone/NNP mass/NN
Amiodarone/NNP mass/NN glomerulonephritis/NNS membranous/NNS
Amiodarone/NNP mass/NN glomerulonephritis/NNS
amiodarone/NN developed/VBD mass/NN lung/NN
amiodarone/NN developed/VBD mass/NN
amiodarone/NN lesion/NN indicating/VBG containing/VBG composed/VBN suspected/VBN mass/NN lung/NN
amiodarone/NN lesion/NN indicating/VBG containing/VBG composed/VBN suspected/VBN mass/NN
amiodarone/NN lesion/NN pulmonary/JJ
amiodarone/NN lesion/NN
amiodarone/JJ treatment/NN complication/NN suggests/VBZ difficult/JJ diagnosis/NN amiodarone/NN lesion/NN pulmonary/JJ
amiodarone/JJ treatment/NN complication/NN suggests/VBZ difficult/JJ diagnosis/NN amiodarone/NN lesion/NN
amiodarone/NN diagnosis/NN difficult/JJ suggests/VBZ complication/NN glomerulonephritis/NNS membranous/NNS
amiodarone/NN diagnosis/NN difficult/JJ suggests/VBZ complication/NN glomerulonephritis/NNS
amiodarone/JJ treatment/NN complication/NN glomerulonephritis/NNS membranous/NNS
amiodarone/JJ treatment/NN complication/NN glomerulonephritis/NNS
coumadin/VB secondary/JJ hematomyelia/NNP Thoracic/NNP
coumadin/VB secondary/JJ hematomyelia/NNP
